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Abstract 
The opening chapter of this thesis is split in two with part one providing a summary of the 
existing methods for palladium-catalysed oxypalladation reactions resulting in the 
synthesis of oxygen containing heterocycles. Part two focuses on a niche area of 
palladium catalysis. Here, palladium-catalysed isohypsic reactions, in which the oxidation 
state of the palladium does not change throughout the entire catalytic cycle, are described 
and summarised. 
Chapter 2 describes the extension of the heteroallylation reaction to incorporate the 
synthesis of lactones and the pursuit of an enantioselective oxyallylation reaction. The 
oxyallylation reaction in the synthesis of lactones was successfully applied to include five- 
and six- membered lactone rings in good yields, with the first enantioselective 
oxyallylation reaction being developed. Building upon this work, a copper-mediated 
oxyallylation reaction was developed. Additionally, a palladium-catalysed arylallylation 
reaction and C-H−cyclisation reaction were pursued.   
Ensuing work, detailed in chapter 3, focused on the development of a novel 
isohypsic−redox sequence, combining both the palladium-catalysed isohypsic 
heteroallylation reaction with more traditional redox chemistry. The transformations 
developed give rise to the synthesis of heterocycles with complex functionality both 
quickly and efficiently using the one palladium source. 
 
Experimental procedures and data are summarised in Chapter 4.  
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1. Palladium-Catalysed Functionalisation of Alkenes in 
the Synthesis of Oxygen-Containing Heterocycles 
1.1 Introduction 
Oxygen-containing heterocycles are prevalent in natural products and have been studied 
extensively by organic and medicinal chemists due to their pharmacological and biological 
activities.[1] In particular, tetrahydrofurans and lactones with five- and six-membered ring 
sizes are common motifs found in natural product classes such as lignans 1.1,[2] 
spiroketals 1.2[3] and macrocycles 1.3[4] (Figure 1.1). Due to their biological activity, 
oxygen-containing natural products continue to play a significant role in the design and 
development of drugs in the treatment of diseases.[5] 
 
Figure 1.1: Oxygen-containing natural products 
Synthetic tetrahydrofurans have also been shown to exhibit powerful pharmacological 
activity. Zidovudine  1.4, is an antiretroviral medication used for the treatment of HIV/AIDS 
(Figure 1.2).[6] It is currently on the world health organisation’s list of essential medicines, 
which further highlights the importance of oxygen-containing heterocycles. 
 
Figure 1.2: Structure of Zidovudine 1.4 
The aforementioned importance of tetrahydrofurans and lactones has resulted in their 
synthesis being of significant importance. New technologies and methodologies in the 
construction of oxygen-containing heterocycles are highly sought after. Amongst the most 
common methods for the construction of oxygen-containing heterocycles are acid 
catalysed cyclisations, ring-closing metathesis,[7] haloetherification,[8] and hetero-
Diels−Alder reactions.[9]  Additionally, functionalisation of alkenes by transition metal 
catalysis has been used to construct oxygen-containing heterocycles. Various metal 
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catalysts such as Cu,[10] Ag,[11] Pt,[12] Ni[13] and Au[14] have all been employed in the 
synthesis of oxygen-containing heterocycles, however, by far the most prevalent 
transition-metal catalyst is Pd.[15] 
Over the years, palladium-catalysis has added numerous strings to the organic chemists 
bow. The importance of this transition-metal to the synthetic chemist was emphasised 
when the 2010 Nobel Prize in chemistry was awarded to Richard F. Heck, Ei-ichi Negishi 
and Akira Suzuki in recognition to their contribution to the field of palladium-catalysis.  
In 1959, Wacker Chemie published a report detailing the reaction for the catalysed 
aerobic oxidation of ethylene with water to acetaldehyde.[16] The reaction owes its success 
to the fact that the Pd(II) catalyst could be regenerated by the Cu(II) co-catalyst in the 
presence of oxygen (Scheme 1.1). The Lewis acid Pd(II) catalyst coordinates to ethylene 
generating palladium-complex 1.5. In turn, this reverses the nucleophilicity of the alkene 
making it electrophilic and activating it for attack from the water molecule. Attack on the 
alkene forms a Pd(II)-alkyl intermediate with a β-hydroxyl group 1.6. A hydride shift affords 
vinyl alcohol, which quickly tautomerises to give acetaldehyde and Pd(0). The Pd(II)-
catalyst is regenerated by the oxidation of Pd(0) by CuCl2. The mechanism of the Wacker 
reaction has been studied considerably and much debate has centred around whether the 
water or hydroxide attacks from the same face as the Pd(II)-catalyst (cis-oxypalladation) 
or form the opposite face of the Pd(II)-catalyst (trans-oxypalladation).[17] 
 
Scheme 1.1: Catalytic cycle of the Wacker reaction 
After the success and the development of the Wacker process, it was reported that 
palladium(II) salts could activate alkenes for nucleophilic attack from a range of 
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nucleophiles giving rise to new C−O, C−N, and C−C bond formation under oxidative and 
non-oxidative conditions.[18] As well as intermolecular reactions, Wacker-type cyclisations 
have also been developed for alkenes bearing a tethered nucleophile (Scheme 1.2). 
 
Scheme 1.2: Nucleopalladation in the synthesis of heterocycles 
Alkene difunctionalisation via palladium-catalysis is the most common method for the 
construction of oxygen-containing heterocycles using transition metal catalysis.[13] This 
report will describe the wide range of multiple-bond forming reactions which have been 
coupled with palladium-catalysed oxycyclisation.  
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1.2 Oxypalladation of Alkenes 
1.2.1 Wacker-type cyclisations 
A number of different nucleophiles can attack a double bond that Pd(II) has coordinated 
to, however, the first part of this review will focus on the intramolecular formation of C−O 
bonds. In 1973, Hosokawa et al. published a report that detailed the first intramolecular 
oxypalladation reaction using a palladium(II) salt.[19] Herein, the authors reported the 
cyclisation reaction of the sodium salt of phenol 1.10 using one equivalent of 
PdCl2(MeCN)2 onto an unactivated alkene. Oxypalladation onto an unactivated alkene 
was subsequently followed by β-hydride elimination to give the more thermodynamically 
stable product 2-methyl benzofuran 1.11 in a 31% yield (Scheme 1.3). Although the yield 
was low, this was an important discovery in the synthesis of oxygen-containing 
heterocycles through the use of palladium. 
 
Scheme 1.3: Wacker-type cyclisation of sodium salt of 2-allyl phenol 1.10 
Improving on this methodology, Hosokawa and co-workers published a paper that 
describes the direct cyclisations of allyl phenol derivatives.[20] By changing the catalyst 
from PdCl2(MeCN)2 to Pd(OAc)2 it was found that the sodium salts of phenols were not 
required. Varying the ratio of substrates such as 2-(but-2’-en-1’-yl)phenol 1.12 to 
Pd(OAc)2 was found to vary the ratio of products 1.13 to 1.14. Furthermore, the reaction 
was made catalytic by employing re-oxidation conditions using Cu(OAc)2−O2 as the re-
oxidant (Scheme 1.4). It was proposed, that under the optimised conditions (Scheme 1.4), 
that the lack of formation of benzofuran 1.14, the reaction proceeds through a cis-
oxypalladation mechanism. Similar Wacker-type cyclisations were also extended to 
aliphatic alcohols in a paper published by Hosokawa and co-workers in 1976 using a 
similar catalyst and solvent system as that detailed below.[21] 
 
Scheme 1.4: Wacker-type cyclisation of 2-(but-2’-en-1’-yl)phenol 1.12 
In addition to the synthesis of benzofurans and tetrahydrofurans, Hegedus and co-workers 
reported the first Pd(II)-cyclisation of allyl benzoic acid substrates in the synthesis of 
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isocoumarins – a motif often observed in natural products.[22] Through employing 
Cu(OAc)2−O2 as the re-oxidant the reaction was made catalytic. A consequence of the 
catalytic variant was that the reaction time had to be elongated from 3 h to 119 h and the 
yield dropped from 86% to 41% (Scheme 1.5). It was noted by the authors that the 
coordination of the carboxylate group prior to attack on the alkene is unknown, and thus, 
whether trans- or cis-oxypalladation is taking place is unclear. 
 
Scheme 1.5: Oxypalladation reaction in the synthesis of isocoumarin 1.16 
Building on their pioneering work, Hosokawa and co-workers developed an 
enantioselective Pd(II)-catalysed cyclisation reaction using a catalytic amount of (−)-β-
pinene as the chiral ligand achieving a 12% ee (Scheme 1.6). If excess (−)-β-pinene was 
used, the cyclisation of allyl phenol 1.12 did not occur. This result suggests that 
coordination of the alkene on the substrate 1.12 is in direct competition with the olefin on 
the (−)-β-pinene molecule, thus, excess will retard oxidative cyclisation. The difficulty of 
improving on the 12% ee achieved by Hosokawa and co-workers is emphasised by the 
duration of no reported advancements. Almost 20 years passed before new reports of 
enantioselective Pd(II)-catalysed alkene functionalisation began to appear in the literature 
again.[18c] 
 
Scheme 1.6: Enantioselective cyclisation using a (−)-β-pinene ligand 
Since Hosokawa and co-workers seminal work on enantioselective oxypalladation 
reactions, their initial result has been improved upon. The most common ligand class in 
the Pd(II)-catalysed oxidative cyclisation reactions are bidentate nitrogen ligands. Stoltz 
and co-workers found that the natural product (−)-sparteine 1.20 was the most effective 
ligand in the enantioselective reaction of allyl phenols to benzofuran derivatives, which 
used O2 as the re-oxidant (Scheme 1.7).
[23] Surprisingly, the extent of asymmetry induced 
in the synthesis of dihydrobenzofuran 1.19 relied heavily upon which palladium salt was 
used.  Electron donating groups around the aromatic ring caused the yield to drop, 
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however, the enantioselectivity remained high. Conversely, electron withdrawing 
substituents around the ring caused the enantioselectivity to fall as low as 20% ee. 
Hayashi and co-workers developed Boxax ligand 1.21 and achieved an enantioselectivity 
of 96% ee and a yield of 80%.[24] Zhang et al. developed tetraoxazoline ligand 1.22, which 
became axially chiral upon chelation with either one or two palladium centres. 
Interestingly, the enantioselectivites were dependent upon the ratio of ligand to 
palladium(II) salt and it is proposed that the ratio of mono- and bi-metallic complexes in 
the reaction mixture has a significant effect on enantioselectivity observed.[25] 
 
Scheme 1.7: Enantioselective Wacker-type cyclisations in the synthesis of benzofuran 
1.19 
 
1.2.2 Mechanistic Considerations 
The following reactions discussed will have one common first step in the synthesis of 
oxygen-containing heterocycles: oxypalladation. Oxypalladation is known to occur via one 
of two mechanisms: cis- or trans-oxypalladation (Scheme 1.8).[18c, 26] Cis-oxypalladation is 
when the palladium(II) catalyst coordinates to both the tethered hydroxyl group and the 
olefin and nucleophilic attack occurs leading to intermediate 1.25.[23, 27] Conversely, trans-
oxypalladation occurs when the palladium(II) catalyst coordinates solely to the alkene and 
the tethered hydroxyl nucleophile attacks from the opposite side generating intermediate 
1.27. Whether the mechanism proceeds via cis- or trans-oxypalladation has important 
implications on the stereochemical outcome of the reaction. In turn, this can have a 
significant bearing on the development of enantio- and diastereo-selective oxypalladation 
reactions.[18c] 
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Scheme 1.8: Cis- and trans-oxypalladation reactions 
In order to determine whether a cis- or trans-oxypalladation reaction is taking place, 
deuterium labelling experiments can be performed (Scheme 1.9). Through analysis of the 
products 1.29 and 1.30, whether the reaction proceeds through cis- or trans-
oxypalladation can be deduced by the presence of deuterium in the product. 
 
Scheme 1.9: Deuterium labelling experiments  
The nature of the mechanism, whether the reaction proceeds through cis- or trans-
oxypalladation, has been studied in depth.[18c] It has been found that small changes in 
substrate, catalyst and reaction conditions can result in changes to the mechanism.  
Another consideration, when developing a second bond forming event, is the rate of β-
hydride elimination relative to the other transformation being developed (Scheme 1.10). 
Generally, β-hydride elimination is an intramolecular process that is fast and can lead to 
inactive catalysts.  
 
Scheme 1.10: Competing pathways of alkylpalladium(II) intermediates 1.31 
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To avoid β-hydride elimination, and promote further transformations, there are 3 main 
methods to consider (Scheme 1.11). Through the use of gem-disubstituted alkene 1.34, 
strategy 1 removes β-hydrogens in the intermediate 1.35 and thus cannot undergo β-
hydride elimination. Strategy 2 involves stabilising alkylpalladium(II) intermediate 1.38, 
thus slowing down the rate of β-hydride elimination. Strategy 3 involves using processes 
that are more rapid than β-hydride elimination, such as oxidation to Pd(IV) species 1.40 
from alkylpalladium(II) intermediate 1.37, and thus circumventing β-hydride elimination. 
 
 
Scheme 1.11: Strategies to circumvent β-hydride elimination 
 
1.3 Alkene Difunctionalisation via Wacker-Type Cyclisation 
1.3.1 C−O and sp3−sp2 C−C  Alkene Difunctionalisation 
As described previously, oxypalladation followed by β-hydride elimination by palladium-
catalysis is one way to synthesise heterocycles. In the aforementioned reaction, 
functionalisation has taken place at one of the carbons on the alkene. Difunctionalisation 
occurs when two new bonds are formed over the alkene. The functionalisation steps that 
are formed after the initial oxypalladation reaction can deliver a wide range of heterocyclic 
products (Scheme 1.12). The following review will focus on the formation of new C−C 
bonds which are formed after the initial oxypalladation reaction.  
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Scheme 1.12: Transformations of the alkylpalladium(II) intermediate 1.42 
In 1984, Semmelhack and co-workers reported a new alkoxylation and subsequent 
carbonylation in the synthesis of tetrahydrofuran and pyran derivatives.[28] Additionally, the 
developed methodology was used in the stereoselective synthesis of the methyl ester 
1.50 of a glandular secretion from the civet cat (Scheme 1.13).  In an atmosphere of 
carbon monoxide, the alkylpalladium(II) intermediate formed in the heterocyclisation step 
undergoes a migratory insertion with the carbon monoxide which is subsequently trapped 
with alcohols to afford esters.  
 
Scheme 1.13: Synthesis of the methyl ester of a glandular secretion civet cat 1.50 
In 2013, using the methodology developed by Semmelhack and co-workers, the Tietze 
group applied an enantioselective variant in the total synthesis of (−)-diversinol 1.54.[29] 
The key step in the total synthesis starts with phenol 1.52 which is cyclised 
enantioselectively using catalytic amounts of Pd(TFA)2 with the (S,S) Bn-boxax ligand 
1.55, under an atmosphere of carbon monoxide and using methanol as the solvent 
(Scheme 1.14). The desired chroman was synthesised in an 80% yield and a 96% ee. A 
further 13 steps were required to reach the desired (−)-diversinol 1.54. 
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Scheme 1.14: Enantioselective oxycarbonylation of 1.52 
Pd(II)-alkyl intermediates can undergo carbopalladation onto electron deficient alkenes. 
Semmelhack and co-workers continued their seminal alkene difunctionalisation work by 
using gem-disubstituted hydroxy alkene 1.56 in the presence of palladium(II). Cyclisation, 
to give alkylpalladium(II) intermediate 1.57 then undergoes carbopalladation on Heck 
acceptors such as methyl acrylate, styrene and methyl vinyl ketone in the synthesis of 
tetrahydrofuran derivatives  1.58 (Scheme 1.15).[30] When cyclohexene or hexene were 
the Heck acceptor, the reaction did not proceed to the desired heterocyclised product. 
This discovery led the authors to propose that formation of Pd(II)-alkyl intermediate 1.57 is 
reversible under the reaction conditions. Through the use of CuCl in an O2 atmosphere the 
reaction was made catalytic and was used to synthesise tetrahydrofuran product 1.60 in 
89% yield (Scheme 1.15). The use of mono-substituted alkene starting materials afforded 
none of the desired heterocyclised products and produced only unwanted side products. 
 
Scheme 1.15: Tandem oxypalladation−vinylation reaction 
The methodology developed by Semmelhack et al. was extended to an enantioselective 
version of the oxypalladation−vinylation reaction by Tietze and co-workers in the synthesis 
of α-tocopherol 1.63 (Scheme 1.16).[31] A significant step in the total synthesis was the 
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cyclisation of mono-protected phenol 1.61 using a catalytic amount of Pd(TFA)2 and (S,S)-
iPr-boxax ligand 1.64 afforded chroman 1.62. The highest yield was 84% with a 96% ee 
with methyl acrylate as the Heck acceptor.  
 
Scheme 1.16: Enantioselective tandem oxypalladation−vinylation reaction 
Wolfe et al. published reports that describe a new strategy in the heterocyclisation and 
alkene difunctionalisation class of reactions (Scheme 1.17). [32] Treatment of naphthyl 
bromide 1.65 with a Pd(0) catalyst and DPE-Phos as the ligand and hydroxy alkene 1.36 
generated tetrahydrofuran 1.66. The reaction worked well with aryl and vinyl bromides; 
however, the methodology was less successful with gem-disubstituted alkenes. The 
protocol developed was successfully modified and extended to an aminoarylation reaction 
of alkenes,[33] an intramolecular alternative[34] and in the synthesis of isoxazolidines.[35] 
 
Scheme 1.17: Oxyarylation reaction of hydroxyl alkene 1.36 
In order to deduce the mechanism for the reaction, Wolfe and co-workers performed 
deuterium labelling experiments.[36] Experimentation, led to the proposed mechanism 
below (Scheme 1.18). Oxidative addition of the Pd(0) catalyst into an aryl bromide 
generates the active palladium(II) catalyst. Reaction of the alcohol 1.67 with NaOtBu and 
Pd(Ar)(X) would lead to Pd(Ar)(OR) transition state 1.68. Insertion of the olefin into the 
Pd−O bond could lead to alkylpalladium(II) intermediate 1.69. Reductive elimination of 
species 1.69 would lead to the observed product 1.70. The mechanistic pathway outlined 
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below explains the trans-tetrahydrofuran stereochemistry of the products observed 
(Scheme 1.18). 
 
Scheme 1.18: Proposed mechanistic pathway for the oxyarylation of alcohols 1.67 
In 2015, Wolfe and co-workers reported a palladium-catalysed enantioselective 
oxyarylation reaction of hydroxy alkenes.[37] Through rigorous screening, it was found that 
Pd2(dba)3 combined with TADDOL-derived ligand 1.77 provided the best 
enantioselectivities. In order to obtain good yields and high enantioselectivities, it was 
required that the nucleophile was a tertiary alcohol, which is shown by the low yields and 
enantioselectivity observed in tertrahydrofuran 1.73 (Scheme 1.19). Mono-substituted 
alkenes generated a range of substrates, a sample of which can be seen below in 
products 1.74 and 1.75. The reaction also proceeded well with gem-disubstituted alkenes 
to yield tetrahydrofuran derivatives such as 1.76 in high yields and high ee’s. A limitation 
of the reaction is that the use of substrates bearing internal alkenes were unreactive under 
the conditions outlined (Scheme 1.19). 
 
Scheme 1.19: Enantioselective oxyarylation reaction of hydroxyl alkenes 
 
1.3.2 C−O and sp3−sp C−C Alkene Difunctionalisation 
In 2010, Waser et al. published an article on the oxyalkynylation reaction of unactivated 
alkenes with tethered alcohol and carboxylic acid nucleophiles using triisopropylsilyl 
ethynylbenziodoxolone (TIPS-EBX) reagent 1.79 (Scheme 1.20).[38] Generally, the 
reaction afforded the heterocyclised products in good yields. One exception was when 
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there was a methyl substituent para to the hydroxyl group, which afforded the 
dihydrobenzofuran in 34% yield. More electron rich substituents than methyl, around the 
aromatic ring, did not generate any of the corresponding dihydrobenzofuran. In the 
synthesis of lactones, more electron rich aryl substituents could be placed around the 
aromatic ring. Furthermore, oxyalkynylation reaction of aliphatic alcohols was 
unsuccessful; however, the oxyalkynylation reaction worked well for aliphatic acids. Mono-
substituted alkenes in the synthesis of lactones performed the oxyalkynylation reaction 
better than mono-subsituted phenols with far superior yields.  
 
Scheme 1.20: Oxyalkynylation reaction of phenols and carboxylic acids 
The hypervalent iodide reagent, TIPS-EBX 1.79, is a strong oxidant that allows the allows 
the oxidation of alkylpalladium(II) intermediates to alkylpalladium(IV) intermediates, which 
is key for this particular oxyalkynylation reaction. The proposed mechanism can be seen 
below (Scheme 1.21). Oxypalladation of phenol 1.83 by a palladium(II) catalyst will 
produce alkylpalladium intermediate 1.84. Oxidative addition into the iodo-alkynylbond of 
the hypervalent iodide species yields alkylpalladium(IV) intermediate 1.85 which quickly 
undergoes reductive elimination to afford the dihydrobenzofuran 1.86 and reproduce the 
palladium(II) catalyst.  
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Scheme 1.21: Mechanism of oxyalkynylation reaction 
As described above, one major drawback of the oxyalkynylation reaction using the strong 
oxidant TIPS-EBX 1.79, was its inability to cyclise aliphatic alcohols in good yields. Using 
the hypervalent iodine reagent and the conditions developed for the heterocyclisation 
reaction of phenols, aliphatic hydroxyl alkene 1.36 afforded less than 25% of the desired 
tetrahydrofuran 1.89 (Scheme 1.22). Through the use of Wolfe-type conditions a highly 
successful oxyalkynylation reaction was developed by the Waser group. [39] Using a Pd(0) 
catalyst, triisopropylsilyl ethynyl bromide, the desired tetrahydrofuran product 1.89 was 
afforded in 92% yield. Secondary alcohols were also tolerated to give tetrahydrofurans in 
good to excellent diastereoselectivities. 
 
Scheme 1.22: Oxyalkynylation reaction of aliphatic alcohol 1.36 
A modification of the reaction conditions allowed the use of bromoacetylenes substituted 
with aliphatic groups.[40] Changing the palladium catalyst from Pd2(dba)3 to Pd(dba)2 and 
altering the catalyst to ligand ratio the reaction proceeded in good yields and excellent 
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diastereoselectivities (Scheme 1.23). Optimisation of the desired reaction revealed that 
the choice of base also had an effect on the outcome of the reaction. LiOtBu and KOtBu 
were screened; however, only traces of the desired product could be detected. The use of 
NaHMDS gave a modest yield of 24% of tetrahydrofuran 1.90, indicating that the sodium 
counter-ion plays a significant role in the reaction.  
 
Scheme 1.23: The use of aliphatic bromoacetylenes as electrophiles 
While tetrahydrofuran products 1.90 and 1.92 are structurally similar to the previously 
discussed oxyalkynylation poducts obtained using TIPS-EBX 1.79 (Scheme 1.20), the 
process is mechanistically different (Scheme 1.24). Similarities exist between the 
mechanism detailed below and the mechanism described in detail by Wolfe and co-
workers (Scheme 1.18). A probable first step is the oxidative addition of the Pd(0) catalyst 
to alkynyl bromide 1.93 to generate the intermediate 1.94 (Scheme 1.24). Ligand 
exchange on the Pd(II)-catalyst followed by intramolecular oxypalladation on 1.95 to give 
palladium(II)-alkyne intermediate 1.96 would be in agreement with the excellent trans-
diastereoselectivity observed, if the two substituents are in the pseudo-equatorial 
positions in the transition state 1.97. Tetrahydrofuran intermediate 1.96 then undergoes 
reductive elimination to generate the product 1.92. 
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Scheme 1.24: Mechanism for the Pd(0)-catalysed oxyalkynylation 
The report also described a method for the indirect synthesis of a new C−O and C−C 
sp3−sp3 bond. Waser et al. detail a one-pot oxyalkynylation reaction and hydrogenation 
procedure in the synthesis of 2-alkyl tetrahydrofuran 1.98 (Scheme 1.25).[40] This indirect 
method for the synthesis for a new C−C sp3−sp3 in the oxyalkynylation−hydrogenation 
reaction in the alkene difunctionalisation requires a new palladium catalyst to be added to 
the mixture and thus the reaction suffers from a lack of elegance. 
 
Scheme 1.25: Indirect synthesis of C−C sp3−sp3 in the oxyalkynylation−hydrogenation 
reaction 
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1.3.3 C−O and sp3−sp3 C−C Alkene Difunctionalisation 
Complexity, in the form of chiral, non-aromatic molecules towards the synthesis of 
preclinical drug candidates has not been a priority for the pharmaceutical industry. 
Instead, achiral, aromatic molecules were favoured. High-throughput drug discovery 
practices tended towards compounds of which analogues could be easily constructed, 
which often led to high aromatic ring count. However, these practices have been found to 
have a detrimental effect on clinical success rate.[41] 
Highly complex molecules, those with more chiral and sp3 centres (more saturation), have 
the opportunity to access more chemical space. There has been a demonstrated 
correlation between the fraction of sp3 carbons (Fsp3) where Fsp3 = (number of sp3 
hybridised carbons / total carbon count) and the higher clinical trial success rate (Figure 
1.3).  
number of sp3-hybridised carbons
total carbon count
Fsp3 =
 
Figure 1.3: Mean Fsp3 change as development proceeds 
At the start of this work, there was no report in the literature of a palladium-catalysed 
oxypalladation reaction which leads to the construction of a new sp3−sp3 carbon−carbon 
bond. The one-pot oxyalkynylation−hydrogenation procedure described by Waser and co-
workers, demonstrates an indirect formation of a new sp3−sp3 carbon−carbon bond 
(Scheme 1.25). It also suffers from low functional group tolerance due to the nature of the 
aggressive hydrogenation protocol.[40] 
In 1986, Canty and co-workers published a procedure which described the synthesis of a 
palladium-catalysed sp3−sp3 carbon−carbon bond. [42] In the presence of methyl iodide, in 
acetone at room temperature, dimethylpalladium(II)-bipy complex 1.99 produces ethane 
(Scheme 1.26). It was proposed that the reaction proceeded through  an oxidative 
addition of methyl iodide into dimethylpalladium(II)-bipy complex 1.99 yielding 
palladium(IV) intermediate 1.100. Subsequent reductive elimination results in the 
palladium(II) iodide complex 1.101 and the bubbling of ethane through the reaction 
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mixture, which was detected by 1H NMR. The work conducted by Canty et al. represents 
the first example of an sp3−sp3 carbon−carbon bondformation that proceeds via a 
palladium(IV) intermediate.  
 
Scheme 1.26: Oxidative addition of methyl iodide into a palladium(II) complex 
The palladium(IV) intermediate was confirmed by concentration of the reaction mixture 
which yielded x-ray quality crystals. 1H NMR and crystallographic analysis allowed 
palladium(IV) complex 1.100 to be fully characterised. Before palladium(IV) intermediate 
1.100 was isolated and analysed, palladium(IV) intermediates were proposed by a 
number of groups working in this area, however they were undetected.[43] The all 
important crystal structure can be seen below (Figure 1.4). It is worth noting that the 
palladium(IV) complex 1.100 is more stable than one would presume, and the release of 
ethane occurs slowly at room temperature. 
 
Figure 1.4: X-ray crystal structure of Pd(IV) intermediate 1.100 
Combining the palladium(IV) chemistry in the synthesis of sp3−sp3 carbon−carbon bond, 
developed by Canty and co-workers, and the palladium(II)-catalysed heterocyclisation 
reaction would not only expand the repertoire, but potentially add finesse in the synthesis 
of heterocyclic targets (Scheme 1.27). Unfortunately, the palladium-catalysed 
oxyalkylation reaction has not been developed, and is a large gap in the methodology 
currently available. Its development would constitute a significant advancement if this 
reactivity could be harnessed in a heterocyclisation reaction. 
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Scheme 1.27: Theoretical palladium-catalysed oxyalkylation reaction 
However, in the pursuit of the palladium-catalysed oxyalkylation reaction the France group 
has developed a new palladium(II)-catalysed alkene difunctionalisation reaction of 
unactivated alkenes with tethered nucleophiles and external electrophiles. The reaction 
facilitates the formation of oxygen- and nitrogen-containing heterocycles and a new 
sp3−sp3 carbon−carbon bond (Scheme 1.28).[44] Additionally, the terminal alkene can also 
be used as a handle for further transformations. 
 
Scheme 1.28: Palladium(II)-catalysed oxyallylation reaction 
The oxyallylation reaction is a significant advance on the already established 
methodologies. Until recently, the procedures available in the palladium-catalysed alkene 
difunctionalisation reactions would involve the formation of a new C−C bond to a new sp- 
or sp2-hybridised carbon centre. As mentioned previously, the synthesis of new sp3−sp3 
carbon−carbon bond is of increasing importance in the synthesis of drug candidates as it 
has been shown that the Fsp3 content of a molecule increases with each stage of drug 
development. 
The operationally simple methodology, carried out at ambient atmosphere, was successful 
with more than 20 oxygen-containing cyclised products. The reaction also shows high 
functional group tolerance, with strong electron-withdrawing and electron-donating groups 
placed around the aromatic ring. The synthesis of benzofurans, isobenzofurans, 
isobenzopyrans and aliphatic furan derivatives proceeded in good yields. A cross-section 
of substrates can be seen below (Figure 1.5). The synthesis of benzofurans with a 
halogen around the aromatic ring is of particular significance, as the bromide can be used 
as a handle for further chemical transformations. Additionally, spirocyclic compounds, a 
motif often displayed in natural products, were also synthesised under the optimised 
conditions. Furthermore, the construction of two six-membered lactams was also effective, 
when a change of base was employed.  
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Figure 1.5: Range of nucleoallylation products 
The effectiveness and practicality of the oxyallylation reaction was demonstrated further in 
the synthesis of citalopram − a widely prescribed selective serotonin reuptake inhibitor 
(SSRI) for the treatment of depression (Scheme 1.29). Oxyallylation precursor 1.108, was 
synthesised in two steps from commercially available cyanophthalide 1.107. With the 
desired benzylic alcohol 1.108 in hand, it was subjected to the oxyallylation conditions to 
give the late stage cyclised intermediate 1.109. Subsequent dihydroxylation/oxidative 
cleavage followed by reductive amination gave citalopram in 5 steps.  
 
Scheme 1.29: Synthesis of citalopram 
In order to decipher between the various mechanisms possible, a mechanistic study was 
undertaken by the France group. Treatment of benzylic alcohol 1.110, with palladium(II) 
and dideutero-allyl bromide resulted in the chemoselective transformation to 
isobenzofuran 1.111 as the sole product (Scheme 1.30). The mechanistic experiment 
allowed the proposal of a somewhat unusual redox-neutral catalytic cycle. The initial 
oxypalladation of benzylic alcohol 1.110 forms cyclised alkylpalladium(II) intermediate 
1.112. In turn, this intermediate will undergo carbopalladation with the dideutero-allyl 
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bromide to form a new alkylpalladium(II) intermediate 1.113 which experiences a β-halide 
elimination to generate isobenzofuran 1.111 as the only product.  The palladium(II) 
catalyst does not change oxidation state throughout the catalytic cycle, a process known 
as isohypsic.[45] 
 
Scheme 1.30: Proposed isohypsic oxyallylation mechanism 
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1.4 Palladium(II)-Catalysed Isohypsic Reactions 
The synthesis of carbon−carbon bonds is of immense importance in organic chemistry. 
Amongst the most common methods for their construction in the early 20th century were 
the Grignard,[46] Diels−Alder[47] and the Wittig[48] reactions, all of which won the Nobel prize 
for their contributions to chemistry. In the last quarter of the 20th century a new class of 
carbon−carbon bond forming reactions have emerged, which involved transition-metal 
catalysis. Within this class, the most prominent and most important in organic synthesis is 
the palladium-catalysed cross-coupling reactions which also won the Nobel prize in 2010. 
Their influence and utility on the organic chemistry field has been shown on numerous 
occasions; for example, by playing a major role in the total synthesis of many natural 
products.[49] 
The general mechanism for the cross coupling reactions follows the pathway outlined 
below (Scheme 1.31). The first step in the cross-coupling reactions is an oxidative 
addition of R−X to Pd(0) to give an organopalladium(II) compound. In the second step, the 
organic group R’ is transferred to palladium in a process called transmetallation. In this 
way, the two organic groups are assembled on the same palladium atom via palladium-
carbon bonds. The palladium(II) intermediate then rearranges in order to allow coupling. 
In the final step the R’ and R groups couple with one another to give a new 
carbon−carbon single bond and R−R’ is released from palladium. In this process Pd(II) is 
reduced to Pd(0) and therefore the final step is called a reductive elimination.  
 
Scheme 1.31: General mechanism in palladium cross coupling reactions 
Generally, the oxidation state of palladium-catalysed reactions throughout the catalytic 
cycle is either Pd(0)/Pd(II), following a redox process. Chemistry can also take place 
outside the traditional Pd(0)/Pd(II) cycles. More and more processes are emerging that 
contain proposed catalytic cycles with the palladium centre in higher oxidation states.[50] 
Reactions, such as the Catellani reaction,[51] have proposed mechanisms which involve 
29 
 
the metal centre change through various oxidation states such as: Pd(0)/Pd(II)/Pd(IV). 
Other palladium-catalysed high oxidation state reactions, particularly C−H activation, see 
the metal change between Pd(II)/Pd(IV) oxidation states.[52] There is also a small, but 
appreciable, class of palladium(II)-catalysed reactions where the oxidation state of the 
palladium does not change throughout the entirety of the catalytic cycle. The all 
palladium(II)-catalysed reactions are known as redox-neutral or isohypsic reactions. 
As well as palladium, isohypsic reactions are known to occur for a number of transition 
metals in certain oxidation states such as rhodium,[53] ruthenium,[54] cobalt[55] and gold.[56] 
The isohypsic nature of a transition metal catalysed reaction is a peculiarity often 
associated with gold-catalysis. The fundamental reaction pathway of Au(I) catalysis can 
be seen below, where it activates a C−C triple bond (Scheme 1.32). Coordination to the 
alkyne forms aurated intermediate 1.114, which activates the alkyne for nucleophilic 
attack. Attack from a nucleophile followed by subsequent deprotonation−reprotonation 
sequence regenerates the active catalyst and the desired product. 
 
Scheme 1.32: Fundamental reaction pathway of Au(I) catalysis 
The following sections will contain a detailed discussion into a number of palladium(II)-
catalysed isohypsic catalytic processes, which will lead to the synthesis of new 
carbon−carbon bonds and carbon−heteroatom bonds. 
It must be noted, that this far from exhaustive short review has focused on reactions that 
involve a proposed formation of a palladium−carbon bond at any point throughout the 
catalytic cycle. This was a conscious decision, as it allowed the avoidance of reactions in 
which the palladium(II) species acts as a Lewis acid; for example, a palladium(II)-
catalysed aldol reaction.[57] 
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1.4.1 Carbon−Heteroatom Bond Formation 
The vast majority of palladium(II)-catalysed isohypsic reactions form new carbon−carbon 
bonds, however, some reactions do form new carbon−heteroatom bonds. Although 
palladium(II)-catalysed isohypsic carbon−heteroatom bond forming reactions are even 
rarer than their carbon−carbon bond forming counterparts among the most famous of all 
isohypsic reactions is the Overman rearrangement. Here, a new carbon−nitrogen bond is 
formed in a [3,3]-sigmatropic rearrangement of allylic trichloroacetimidates. Initially 
developed as a rearrangement that is induced thermally and in the presence of Hg(II) 
salts, it involves a 1,3 transposition of alcohol and amine functionality.[58] Not long after, a 
palladium(II)-catalysed variant emerged which required lower temperatures, shorter 
reaction times, lower catalyst loading and also circumvented the use of Hg(II) and the 
inherent toxicity of the metal (Scheme 1.33).[59] It wasn’t until much later, that Overman 
and co-workers developed a successful asymmetric variant to the [3,3]-sigmatropic 
rearrangement of allylic trichloroacetimidates with both high yields and high ee’s using 
COP-Cl 1.121 as the catalyst (Scheme 1.33).[60] The enantioselective Overman 
rearrangement worked well with (E)-alkenes to give (S)-allylic trichloroacetamides 1.118, 
however, (Z)-alkenes were less reactive and gave the corresponding (R)-allylic 
trichloroacetamides in poor yields and moderate enantioselectivities. In order to access 
the (R)-allylic trichloroacetamides the enantiomer of COP-Cl 1.121 must to be prepared 
and used.  
 
Scheme 1.33: Palladium(II)-catalysed Overman rearrangement of (E)-allylic 
trichloroacetimidates 
Extensive mechanistic studies on the palladium(II) catalysed [3,3]-sigmatropic 
rearrangement of allylic trichloroacetimidates have been conducted by the Overman 
group.[61] In the cyclisation induced rearrangement mechanism, coordination of 
palladium(II) to the olefin generates intermediate 1.122 (Scheme 1.34). Subsequently, 
nitrogen attacks the activated alkene to produce cyclic intermediate 1.123. Collapse of this 
intermediate produces the desired allylic trichloroacetamide and releases the palladium(II) 
catalyst.  
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Scheme 1.34: Mechanism of the Overman rearrangement 
Additionally, Overman et al. reported the development of an asymmetric palladium(II)-
catalysed synthesis of chiral allylic esters (Scheme 1.35).[62] Prochiral (Z)-allylic 
trichloroacetimidates in the presence of 1 mol% COP-OAc 1.126 at room temperature, 
react efficiently with carboxylic acids to give the allylic esters in excellent yields and ee’s. 
A range of aliphatic (Z)-allylic trichloroacetimidates bearing oxygen containing functional 
groups worked well under the optimised conditions (Scheme 1.35). Both aromatic and 
aliphatic carboxylic acids provided the corresponding esters in excellent ee’s of 91−99%. 
Reaction of the (E)-stereoisomer of 1.124 under the reaction conditions provided the 
enantiomer of allylic ester 1.125 in low yield and enantioselectivity (42%, 54% ee). 
 
Scheme 1.35: Synthesis of chiral allylic ester 1.125 using COP-OAc 1.126 
An analogous reaction in the synthesis of chiral allylic ethers was also published by 
Overman and co-workers, using the same COP-OAc 1.126 catalyst.[63] Herein, it is 
reported that (Z)-allylic trichloroacetimidates provide branched allylic aryl ethers in high 
yield and enantiopurity under mild reaction conditions (Scheme 1.36).  Phenol 
nucleophiles worked well and could contain electron-donating or mild electron-withdrawing 
groups with excellent enantioselctivities. Phenols containing strong electron withdrawing 
groups such as nitro and cyano in various positions around the aromatic ring, either failed 
to furnish any of the desired product or the corresponding allylic ether was furnished in 
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moderate enantioselecivity. Reactions of (E)-allylic trichloroacetimidates under the 
optimised reaction conditions, provided low yields. 
 
Scheme 1.36: Synthesis of chiral allylic ether 1.129 using COP-Ac 1.126 
A detailed study into the mechanism of the palladium(II)-catalysed asymmetric synthesis 
of chiral allylic esters and ethers by the Overman group was reported in the literature.[64] In 
the overall SN2’-displacement of (Z)-allylic trichloroacetimidates to form chiral allylic esters 
it was proposed the first step was chelation from the nitrogen and the olefin, which would 
form palladacycle intermediate 1.130 (Scheme 1.37). This in turn would activate the (Z)-
alkene for nucleophilic attack from carboxylic acid 1.131. Deuterium labelling experiments 
revealed that the attack from the carboxylic acid occurs from the opposite face from the 
palladium in an anti acyloxypalladation addition sequence and this, in turn, would give 
alkylpalladium(II) intermediate 1.132. β-elimination, via syn deoxypalladation,  would 
produce the desired chiral allylic ester 1.125 and regenerate the palladium(II) catalyst.  
 
Scheme 1.37: Proposed mechanism of the palladium(II)-catalysed asymmetric synthesis 
of chiral allylic esters  
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1.4.2 Carbon−Carbon Bond Formation 
Palladium(II)-catalysed conjugate additions[65] to enones have emerged as a cheaper 
alternative to the already established Rh-catalysed[66] procedures. The advantages of 
using a palladium(II) catalyst extend beyond cost alone, as the reactions can be tolerant 
of air and moisture. Asymmetric palladium(II)-catalysed Michael-type additions have been 
developed in recent years.[67] In addition, Lee and co-workers have disclosed a procedure 
that involves a cationic, ligandless palladium(II) catalyst and a reaction that is highly 
tolerant of steric hinderance (Scheme 1.38).[68]  Initial investigations showed that boroxine 
was the reactive reagent and not the boronic acid equivalent. The addition of NaNO3 was 
found to improve the yield through decreasing the formation of side products. The 1,4 
conjugate addition of boroxine 1.134 to enone 1.133 proceeds in a high yield and 
excellent diastereoselectivity, with the reaction below representative of the selectivity 
observed in the reaction with dr’s ranging from 8:1 to >20:1.  
 
Scheme 1.38: Diastereoselective palladium(II)-catalysed 1,4 conjugate addition 
The proposed mechanism for the reaction by Lee et al. was outlined in a subsequent 
paper and can be seen below (Scheme 1.39).[69] Transmetallation of the cationic 
palladium(II) catalyst with the boroxine species is the first step in the reaction mechanism.   
Migratory insertion of the alkene into the Pd−C bond, on the opposite face of the bulky 
alkyl group in the γ-position, would give intermediates 1.136 and 1.137. Consequent 
protonolysis would provide the desired the conjugate addition product 1.138 and 
regenerate the palladium(II) catalyst.  
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Scheme 1.39: Proposed mechanism of the diastereoselective palladium(II)-catalysed 1,4 
conjugate addition 
In 2015, an asymmetric Michael-type addition to nitrostyrenes was published by Zhang 
and co-workers.[70] Herein, it is reported that the addition of boronic acids to nitroalkenes 
bearing electron-donating and electron-withdrawing groups produced biaryl products such 
as 1.141 in high enantioselectivities using iPr-isoquinox 1.142 as the ligand to induce 
asymmetry (Scheme 1.40). The use of aliphatic nitroalkenes failed to return any product. 
The scope of the arylboronic acids was also explored. Aromatic boronic acids with both 
electron-donating and electron-withdrawing groups worked well, with high ee’s. However, 
it was found that aromatic boronic acids bearing electron-donating groups performed 
better; this was attributed to higher nucleophilicity of the more electron-rich aryl group. 
 
Scheme 1.40: Palladium(II)-catalysed asymmetric addition of arylboronic acids to 
nitrostyrenes 
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Palladium(II)-catalysed asymmetric 1,2 addition of boronic acids to N-sulfonyl imines is 
known in the literature.[71] Asymmetric arylation of five-membered cyclic N-sulfonyl 
ketimines has been reported by Zhang.[72] Recently, Hayashi and co-workers reported the 
1,2 addition of aryl boronic acids to six-membered rings of N-sulfonyl ketimines such as 
1.143.[73] Five-membered imines easily undergo arylation but are difficult to cleave to yield 
the corresponding methylamine. In contrast, six-membered imines are less reactive 
towards arylation whereas the sulfamidates 1.145 are known to undergo ring opening 
without loss of enantiopurity. The arylation of ketimines, via palladium-catalysis, is not 
traditionally a facile process and often methodology falls short when ketimines such as 
1.143 are used in place of aldimines as substrates. However, as can be seen below, the 
optimised reaction conditions tolerate various aliphatic groups on the imine and a range of 
boronic acids (Scheme 1.41). The use of palladium(II)-catalysed boronic acids as 
nucleophiles has always had one drawback: the use of preformed imines. Manolikakes 
and co-workers have developed an elegant enantioselective, three-component one-pot 
synthesis of α-aryl N-sulfonamides.[74] An example of the strategy and its success is 
detailed below (Scheme 1.41).  
 
Scheme 1.41: Palladium(II)-catalysed 1,2 addition of aryl boronic acids to imines 
The carbocyclisation of alkynes and alkenes offers a route to rapidly building chemicial 
compexity quickly from simple starting materials. Lu et al. have previously developed the 
cyclisation of enynes by palladium(II)-catalysis in the synthesis of racemic 
butyrolactones.[75] An asymmetric palladium(II) variant was developed by Lu and co-
workers in the cyclisation of enynes using various catalyst systems, an example of which 
is outlined below, with acetic acid as the solvent (Scheme 1.42).[76] The proposed 
mechanism of the reaction involves trans-acetoxypalladation of the triple bond, followed 
by intramolecular carbopalladation onto the alkene. The final step in the mechanism is the 
β-acetoxy elimination to generate the butyrolactone 1.152 in good yield and 
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enantioselectivity. In developing the reaction it was found that the bidentate nitrogen 
ligands used in the reaction inhibit β-hydride elimination and protonolysis.  
 
Scheme 1.42: Palladium(II)-catalysed asymmetric synthesis of butyrolactone 1.152 
Transition-metal-mediated C−H activation is an important class of chemical reaction in 
organic chemistry.[77] Aminoquinoline is a common bidentate directing group used to 
cleave C−H bonds, which is due to a number of advantages: readily available, easily 
incorporated and removed and can be attached to a wide variety of the carboxylic acid 
precursors.[78] In 2015, Wei and co-workers published a palladium(II)-catalysed isohypsic  
C−H functionalisation−cyclisation reaction in the synthesis of isoindolinones using AQ as 
the chelating auxiliary (Scheme 1.43).[79] 
 
Scheme 1.43: Palladium(II)-catalysed synthesis of isoindolinone 1.157 
A plausible mechanism, presented by the authors, for the C−H 
functionalisation−cyclisation reaction has the first step as the palladium(II)-mediated 
aminoquinoline directed C−H activation (Scheme 1.44). Next, the arylpalladium(II) 
intermediate 1.158 reacts with an anhydride to form a palladacycle 1.159. β-acetoxy 
elimination generates late stage palladium(II) intermediate 1.160. Intramolecular 
dehydration furnishes the desired product and regenerates the palladium(II) catalyst in the 
redox neutral process. Electron-donating and electron-withdrawing groups can be 
tolerated around the aromatic ring. In order to make the reaction more applicable, a 
variety of carboxylic acids were used in the reaction as electrophiles, however, the use of 
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(tBuCO)2O in the reaction mixture was required, as an in situ formation of an anhydride 
was a prerequisite for the reaction to proceed. 
 
Scheme 1.44: Proposed mechanism of the C−H functionalisation−cyclisation reaction 
Transition-metal catalysed chain walking is a process whereby a transition-metal 
undergoes a rapid β-hydride elimination−reinsertion sequence, gradually moving along 
the carbon backbone. Often, chain walking is an undesirable side reaction; the need to 
suppress this process is paramount due to the unwanted isomerisation of alkenes. In 
2012, Kochi and co-workers published a paper that utilised this well established process 
in a palladium(II)-catalysed cycloisomerisation of dienes akin to 1,8 diene 1.161 (Scheme 
1.45). It was found that 1,10 phenanthroline palladium(II) catalyst 1.164 was the system 
best suited for the reaction and generated desired unsaturated bicyclo[4.3.0]nonane 1.162 
with the least amount of isomerised side product. Cyclohexene was added to the reaction 
as it prevented isomerisation in the desired final bicyclo[4.3.0]nonane 1.162. A number of 
isomers, albeit in low quantities, of bicyclo[4.3.0]nonane 1.162 was formed. In order to 
determine the efficiency of the developed reaction the products were hydrogenated using 
platinum oxide to furnish saturated product 1.163 in excellent diastereoselectivity.  
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Scheme 1.45: Palladium(II)-catalysed cycloisomerisation of 1,8 diene 1.161 
Kochi et al. propose the following mechanism for the isohypsic palladium(II)-catalysed 
cycloisomerisation reaction (Scheme 1.46). The terminal olefin reacts preferentially over 
the internal, more sterically encumbered olefin and alkylpalladium(II) intermediate 1.165 is 
formed. Chain walking along the aliphatic spine of the molecule occurs via a β-hydride 
elimination−reinsertion sequence until it reaches the position where it can coordinate to 
the alkene forming intermediate 1.168. Alkene insertion into the palladium(II)-alkyl 
intermediate will form cyclised alkylpalladium(II) 1.169. Syn β-hydride elimination gives the 
palladium(II) hydride catalyst and bicyclo[4.3.0]nonane 1.162. 
 
Scheme 1.46: Mechanism for the isohypsic palladium(II)-catalysed cycloisomerisation 
reaction 
Another well precedented isohypsic process is the palladium(II)-catalysed alkene 
polymerisation.[80] The self-propagating polymerisation process maintains the metal centre 
in the +2 oxidation state, via an alkylpalladium(II) intermediate undergoing a  
carbopalladation step on another alkene monomer. This process repeats. Theoretically, if 
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enough monomer(s) is present this process can go on indefinitely, unless an unwanted 
side reaction such as β-hydride elimination occurs or an additive is added to prevent 
polymerisation from occurring. An example of palladium(II)-catalysed vinylic 
polymerisation of norbornene 1.170 and norbornene carboxylic acid esters 1.171 can be 
seen below (Scheme 1.47).[81] Using palladium(II) pre-catalyst in the presence of AgSbF6 
the active palladium(II) catalyst 1.175 was formed. Chlorobenzene, although an unusual 
solvent choice, was highly practical as the polymer was soluble in this medium. 
Norbornene carboxylic acid methyl esters 1.171 were used in varying amounts of 
exo/endo ratios with the yield of any co-polymerisation reaction not exceeding 46%. 
 
Scheme 1.47: Palladium(II)-catalysed vinylic polymerisation of norbornene 1.170 and 
norbornene carboxylic acid esters 1.171 
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1.5 Summary 
Palladium catalysis is an area of research that has seen a surge of activity since it was 
first developed decades ago. The literature examples outlined in this chapter emphasise 
the versatility of the metal and illustrate the various transformations that can occur, with 
catalytic cycles involving various oxidation states: Pd(0), Pd(II) or Pd(IV). 
The oxypalladation of alkenes to afford oxygen-containing heterocycles is a well-studied 
area of research that has seen a recent revitalisation of interest. In addition to the 
development of asymmetric example of Wacker-type cyclisations, the contributions of 
Wolfe and Waser groups has seen an expansion in the scope of the C−C bond formation 
capabilities of these reactions. Recently, the France group have published a report in 
which a new C−O bond was formed and a new sp3−sp3 C−C bond has been constructed. 
This is a particularly valuable piece of methodology as many natural products and 
pharmaceuticals contain heterocycles with alkyl chains.  
A small, but appreciable, class of palladium(II)-catalysed reactions where the oxidation 
state of the palladium does not change throughout the entirety of the catalytic cycle are 
established. More specifically known as an isohypsic reaction. Unique reactivity and 
transformations are available for all palladium(II) catalytic cycles. Further exploration of 
isohypsic palladium-catalysed reactions could be of immense use and importance to the 
synthetic community.  
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2. Synthetic Approaches Towards the 
Heterocyclisation of Alkenes 
2.1 Oxyallylation Reaction of Unactivated Alkenes 
2.1.1 Introduction and Aims 
As discussed previously (Chapter 1), oxygen-containing heterocycles are crucial 
intermediates in organic synthesis and are a common structural motif in natural products 
and pharmaceutically active compounds. Lactones are a structurally important heterocycle 
and are a functional group ubiquitously found in many different classes of molecules. 
Lactone rings are found in antibiotics,[82]enzymes,[83] neurotransmitters,[84] anti-cancer 
drugs,[85] phytoestrogens, statins (e.g. lovastatin 2.1),[86] hormones (e.g. aldactone 2.2), 
many natural products and building blocks in nature such as ascorbic acid 2.3, 
nepetalactone 2.4 and kavain 2.5 (Figure 2.1). 
 
Figure 2.1: Lactone motif in drugs and natural building blocks 
The aim of this project was to extend the scope of the previously optimised oxyallylation 
methodology to include the synthesis of lactones (Scheme 2.1). The proposed 
palladium(II)-catalysed heterocyclisation of tethered carboxylic acids onto unactivated 
alkenes would be followed by allylation using an allylic halide. In theory, this would open 
up the oxyallylation reaction to a host of potential new intermediates and products and 
thus significantly expand the already well developed methodology. 
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Scheme 2.1: Proposed extension of oxyallylation reaction 
The proposed reaction would construct a lactone heterocycle and furnish a new sp3−sp3 
C−C bond in a single step. This would represent a significant advance as it would be the 
first example of a sp3−sp3 C−C bond forming reaction using carboxylic acids as the 
nucleophile in alkene difunctionalisation reactions. All previous formation of lactones, 
briefly discussed in Chapter 1, form new sp3−sp2 or sp3−spC−C bonds via reactions like 
oxycarbonylation and oxyalkynylation reactions. Increased Fsp3 content in drug 
candidates has been directly linked to the chance of success and is, consequently, a 
major goal of the pharmaceutical industry (Figure 1.3). 
The oxyallylation reaction mechanism for benzylic alcohols was investigated previously 
within the France group. Although it is known that changing the nucleophile from an 
alcohol to an acid can impact the cis- and trans-oxypalladation step, it is postulated that 
the overall mechanism will essentially have a similar pathway (Scheme 2.2).[18c] The 
palladium(II) catalyst would activate the alkene on carboxylic acid 2.6, triggering 
nucleophilic attack from the acid, forming cyclic alkylpalladium(II) intermediate 2.7. This 
will then undergo a carbopalladation reaction on the allyl halide electrophile forming late 
stage intermediate 2.8. Subsequent β-halide elimination will garner the desired lactone 2.9 
and regenerate the palladium(II) catalyst. 
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Scheme 2.2: Proposed catalytic cycle 
 
2.1.2 Gem-disubstituted Alkene Substrates 
The utilisation of carboxylic acids as substrates towards the synthesis of lactones via 
oxypalladation is a well precedented process.[15] In particular, the oxyalkynylation protocol 
reported by Waser and co-workers in 2010 bears similar reactivity to the desired 
oxyallylation reaction this project aims to develop (Scheme 2.3).[38] Palladium(II)-alkyl 
intermediate 2.11 is a common intermediate in each process. Waser and co-workers 
demonstrated the trapping of alkylpalladium(II) intermediate 2.11 with TIPS-EBX 1.79, a 
strong oxidant, to furnish the desired lactone 2.12. This work aims to trap the 
alkylpalladium(II) intermediate 2.11 with an allyl halide species in a similar fashion to the 
previously described oxyallylation reaction of alcohols. β-hydride elimination is a common 
competing pathway in the oxypalladation reaction of mono-substituted alkenes when 
attempting to difunctionalise the olefin. Due to this, it was prudent to begin the 
investigation into the oxyallylation reaction in the synthesis of lactones, with gem-
disubstituted alkene substrates. 
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Scheme 2.3: Common reactivity between this work and Waser’s oxyalkynylation 
The similarity between Waser and co-workers’oxyalkynylation reaction and the desired 
oxyallylation prompted the use of benzoic acid 2.10. The first step in the synthesis of 
benzoic acid 2.10 is the Wittig olefination of o-bromoacetophenone 2.14 (Scheme 2.4). 
Following the procedure of Waser and co-workers,[38] a solution of ketone 2.15 was added 
to a prepared suspension of methyl triphenylphosphonium bromide and potassium tert-
butoxide in THF at room temperature, affording alkene 2.15 in 91% yield. Aryl bromide 
2.15 then underwent lithium−halogen exchange with nBuLi in Et2O which was 
subsequently quenched with CO2 to afford carboxylic acid 2.10.  
 
Scheme 2.4: Synthesis of benzoic acid 2.10 
Previous exploration of the oxyallylation reaction of alcohols found that the allyl halide 
electrophile has an effect on the overall yield and rate of reaction. The reaction of phenol 
1.83 required allyl chloride as the electrophile in order to proceed in a good yield of 70% 
(Scheme 2.5). Conversely, the reaction of benzylic alcohol 1.110 required allyl bromide to 
proceed well in 77% yield. 
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Scheme 2.5: Oxyallylation reaction using different allyl halide electrophiles 
Based on the above experiments, expanding the oxyallylation methodology in the 
synthesis of lactones began with probing the effect the allyl halide electrophile has on the 
reaction. Pleasingly, utilising allyl chloride as the electrophile afforded the desired lactone 
2.13 in a 37% yield, confirming the theory that the methodology could be expanded to 
include lactones in the scope of products available (Table 2.1, entry 1). Dramatic 
improvements were made with a change to allyl bromide increasing the yield to 85% 
whilst simultaneously shortening the reaction time significantly to 5 h (entry 2). Through 
these observations, and based on the premise that increasing the leaving group ability 
would improve the reaction, allyl iodide was tried as the electrophile, however, none of the 
desired lactone 2.13 was observed. Literature examples have shown acetate to be a good 
leaving group in palladium-catalysed β-elimination reactions; because of this allyl acetate 
was selected as the electrophile,however, none of the desired product was afforded (entry 
4).[87] 
 
Entry X Time (h) Yield 
(2.13) 
1 
2 
3 
4 
Cl 
Br 
I 
OAc 
24 
5 
24 
24 
37% 
85% 
Not Detected 
Not Detected 
Table 2.1: Varying the allyl electrophile in the synthesis of lactone 2.13 
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Investigations into circumventing the need to synthesise acids in the oxyallylation reaction 
were undertaken (Scheme 2.6). It was proposed, that starting from the ester 2.18, and 
subjecting it to the reaction conditions, it would hydrolyse the ester bond in situ through 
the adventitious water, forming the acid 2.10. This would then undergo the oxyallylation 
reaction to form the desired lactone 2.13. In order to synthesise acid substrates, many are 
made via the ester. As a result, the ability to avoid pre-forming the acids would be 
advantageous and would save a step in the synthesis of various target molecules.  
 
Scheme 2.6: Proposed oxyallylation of esters 
As stated above, a common way to synthesise acids is to saponify esters; however, in the 
synthesis of benzoic methyl ester 2.18 it was easier to methylate benzoic acid 2.10 
(Scheme 2.7). The main, practical reason is that sufficient amounts of the benzoic acid 
had already been synthesised, thus methylating the benzoic acid 2.10 would be a facile 
reaction.Placing benzoic acid 2.10 in refluxing methanol with potassium hydroxide as 
base and methyl iodide as electrophile, afforded the desired ester 2.18 in good yield. 
 
Scheme 2.7: Synthesis of benzoic methyl ester 2.18 
Subjecting the benzoic methyl ester 2.18 to the standard oxyallylation conditions for 24 h 
resulted in no formation of the desired lactone 2.13 (Table 2.2, entry 1). Increasing the 
temperature to 75 °C did not improve the result as none of the product was detected 
(entry 2). In an attempt to force the reaction, the temperature was then increased to 100 
°C and left to stir for two days. However, the result was disappointing as no desired 
lactone 2.13 was formed (entry 3). 
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Entry Temperature 
(°C) 
Time (h) Result 
2.10 : 2.13 
1 50 24 1.0 : 0.0 
2 75 24 1.0 : 0.0 
3 100 48 1.0 : 0.0 
Table 2.2: Attempted oxyallylation reaction using ester starting material 
Next, the goal was to analyse the effect different functional groups around the aromatic 
ring would have on the newly developed oxyallylation reaction. In general, a large number 
of steps would be required to access aryl substituted analogues of benzoic acid 2.10. 
However, one example of a substrate that could be quickly accessed is methoxy-
substituted benzoic acid 2.23 (Scheme 2.8). A previous project carried out within the 
France group had followed the synthesis outlined below and had left a sizeable amount of 
methoxy-substituted benzoic methyl ester 2.22.[44] Saponification of methoxy-substituted 
benzoic methyl ester 2.22 overnight using 2 M aq. NaOH in ethanol resulted in the desired 
methoxy-substituted benzoic acid 2.23 in 78% yield (Scheme 2.8). 
Scheme 2.8: Synthesis of methoxy-substituted benzoic acid 2.23 
Upon treatment of benzoic acid 2.23 with catalytic Pd(hfacac)2, NaHCO3 and allyl bromide 
in toluene at 50 °C, complete conversion of the starting material was observed after the 
reaction was left to stir overnight (Scheme 2.9). The desired product 2.24 was obtained in 
a 79% yield. 
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Scheme 2.9: Oxyallylation of methoxy-substituted benzoic acid 2.23 
The heterocyclisation reactions outlined thus far have contained alkenes substituted with 
a methyl group, and so, the effect of increasing the steric bulk was investigated. Waser 
and co-workers reported the oxyalkynylation reaction of diphenyl alkene 2.24 with a 
tethered carboxylic acid nucleophile, affording heterocyclised product 2.27 in a 70% yield 
(Scheme 2.10).[38] 
 
Scheme 2.10: Oxyalkynylation reaction of diaryl alkene 2.24 
Following the procedure outlined by Waser and co-workers,[38] carboxylic acid 2.24 was 
prepared by Grignard reaction of phenylmagnesium bromide with o-bromoacetophenone 
2.14 followed by dehydration to afford alkene 2.26. The bromide 2.26 then underwent 
lithium−halogen exchange and the aryllithium was subsequently quenched with CO2 to 
afford carboxylic acid 2.24 (Scheme 2.11). The product was reported to be unstable under 
storage. 
 
Scheme 2.11: Synthesis of diaryl substrate 2.24 
Reaction of diaryl substrate 2.24 under the standard oxyallylation conditions using allyl 
bromide gave poor conversion of the starting material, and resulted in a low conversion to 
the desired lactone 2.27. Addition of a further 5 mol% of catalyst was required to force the 
reaction to complete conversion and to obtain the desired lactone 2.27 in a good yield of 
70% (Scheme 2.12). 
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Scheme 2.12: Oxyallylation reaction of diaryl substrate 2.24 
A greater understanding as to whether steric or electronic factors were more influential in 
the sluggish heterocyclisation of biphenyl substrate 2.24 was required. tert-Butyl 
substituted alkene substrate 2.30 was identified as the substrate that could conceivably 
answer the aforementioned unknowns. As part of another project within the France group, 
tert-butyl substrate 2.30 was already synthesised.[44] The synthesis of which is outlined 
below (Scheme 2.13). 
 
Scheme 2.13: Synthesis of tert-Butyl substrate 2.30 
The oxyallylation reaction of tert-butyl substrate 2.30 using allyl bromide proceeded well. 
Using only 5 mol% of catalyst at 50 °C the reaction afforded lactone 2.31 in 79% yield in 4 
hours (Scheme 2.14). The improvement in yield, reaction time and catalyst loading 
suggests that the electronics of the alkene substrate play a more important role in the 
reaction conversion than sterics.  
 
Scheme 2.14: Oxyallylation of tert-butyl substrate 2.30 
Waser and co-workers demonstrated that the oxyalkynylation reaction can be performed 
successfully using trisubstituted olefin substrate 2.32. Benzoic acid 2.32, when placed 
under the optimised conditions for the oxyalkynylation reaction, undergoes oxypalladation 
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to form internal alkylpalladium(II) intermediate 2.34 (Scheme 2.15). This is then followed 
by a β-hydride elimination−reinsertion sequence which causes the palladium to chain walk 
generating terminal alkylpalladium(II) intermediate 2.35. This will then undergo the 
oxidative addition with TIPS-EBX 1.79 to form a high valent Pd(IV) intermediate followed 
by reductive elimination to garner the desired lactone in 56% yield. 
 
Scheme 2.15: Oxyalkynylation of 2.32 
Based on this interesting result, itwas proposed that a similar sequence could be 
performed using the optimised conditions for the oxyallylation reation. Following the 
protocol by Waser and co-workers, the synthesis of trisubstituted alkene 2.32 was 
embarked upon (Scheme 2.16). Initiating the synthesis with a Wittig olefination, o-
bromoacetophenone 2.14 was added to a prepared suspension of ethyl 
triphenylphosphonium bromide and potassium tert-butoxide in THF 80 °C, affording 
alkene 2.36 in 74% yield. Aryl bromide 2.36 then underwent lithium−halogen exchange 
with nBuLi in Et2O and the resulting aryllithium was subsequently quenched with CO2 to 
afford carboxylic acid 2.32. 
 
Scheme 2.16: Synthesis of trisubsituted alkene 2.32 
Treatment of trisubstituted alkene 2.32 to the oxyallylation conditions with allyl bromide 
and 5 mol% of catalyst led to complete conversion of the starting material. However, none 
of the desired product 2.37 was observed (Scheme 2.17). Instead, the product of β-
hydride elimination, lactone 2.38 was formed in an 84% yield. Under the reaction 
conditions it is proposed that oxypalladation would lead to either terminal alkylpalladium(II) 
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intermediate 2.35 or internal alkylpalladium(II) intermediate 2.34 which would 
subsequently undergo β-hydride elimination to generate the unwanted heterocyclised 
product 2.38. For trisubstituted alkene substrate 2.32, it was disappointing that the rate of 
a β-hydride elimination pathway was greater than the rate of the desired oxyallylation 
reaction.  
 
Scheme 2.17: Heterocyclisation of trisubstituted alkene 2.32 
The success of the aromatic alkenes with tethered carboxylic acid nucleophiles prompted 
the investigation to expand to incorporate aliphatic acids. Here, the aim was to allow 
aliphatic acids to undergo the oxyallylation reaction in the synthesis of 5-membered 
lactone rings. Spurred on by the success of Waser and co-workers’palladium-catalysed 
oxyalkynylation of aliphatic acids it was decided to begin the pursuit with the synthesis of 
acid 2.6. The renewable feedstock levulinic acid 2.39 was converted into 4-methylpent-4-
enoic acid 2.6 in one step from commercially available starting materials (Scheme 
2.18).[38] This was achieved through a Wittig olefination reaction which used both nBuLi 
and methyltriphenylphosphonium bromide to give 2.6 in 66% yield. 
 
Scheme 2.18: Synthesis of aliphatic substrate 2.6 
With aliphatic substrates now the focus of investigation, 4-methylpent-4-enoic acid 2.6 
was treated to the optimised oxyallylation conditions. Through monitoring the reaction, it 
was noticed that a further 5 mol% of catalyst was required (Scheme 2.19). The reaction 
afforded the desired aliphatic lactone 2.9 in a modest yield of 61%. The lower yield can be 
attributed to the free rotation of the linear acid 2.6, thus obtaining the ideal reactive 
rotamer was more difficult. 
52 
 
 
Scheme 2.19: Oxyallylation reaction of aliphatic carboxylic acid 2.6 
Based on this result, it was hypothesised that restricting the free rotation would increase 
reactivity and thus yield. As a result, gem-dimethyl carboxylic acid 2.41 was identified as a 
suitable substrate to confirm the proposed theory. The gem-dimethyl analogue of aliphatic 
acid 2.6 was synthesised in one step (Scheme 2.20). Isobutyric acid 2.40 was initially 
treated with sodium hydride and diisopropyl amine. The addition of nBuLi followed by the 
addition of methallyl chloride yielded the desired product 2,2,4-trimethylpent-4-enoic acid 
2.41 in 63% yield. 
 
Scheme 2.20: Synthesis of gem-dimethyl aliphatic acid 2.41 
As predicted, the yield of the isolated gem-dimethyl aliphatic lactone 2.42 increased to 
79% (Scheme 2.21). However, the reaction still required an additional 5 mol% of catalyst 
after 5 hours. The improvement can be attributed to the gem-dimethyl effect which is the 
name given to the acceleration of a cyclisation due to the replacement of hydrogen atoms 
with methyl groups on a carbon tethering the two reactive centres.[88] 
 
Scheme 2.21: Oxyallylation of acid gem-dimethyl aliphatic acid 2.41 
Following a literature procedure, malonic acid 2.45 was synthesised in 2 steps to assess 
whether the reaction could tolerate an unprotected carboxylic acid that was not involved in 
the cyclisation.[89] It is possible, that through coordination of the non-participating acid, 
substrate 2.42 could potentially deactivate the palladium-catalyst. Three equivalents of 
dimethyl malonate 2.43 was reacted with sodium hydride and one equivalent of methallyl 
chloride in THF and subsequent reflux to afford malonate 2.44 in 73% yield. 
Saponification with 2 M aq. NaOH gave the desired diacid 2.45 in quantitative yield. 
53 
 
 
Scheme 2.22: Synthesis of malonic acid 2.45 
Malonic acid 2.45 was placed under the developed oxyallylation reaction condition for the 
synthesis of lactones; however, it never afforded any of the desired lactone 2.46 (Scheme 
2.23). Conditions were then varied, with changes in temperature, base and catalyst 
loading. Regardless of the parameters changed,none of the desired product was 
observed via 1H NMR analysis. Unfortunately, the main product formed in the reaction 
was unidentifiable. 
 
Scheme 2.23: Attempted oxyallylation reaction of malonic acid 2.45 
A further target of the project was to extend the oxyallylation of carboxylic acids to include 
a substrate with a halogen atom bonded to the molecule. A halogen atom attached to the 
substrate would be useful, as it can be used as a handle for further transformations. 
However, problems arose when attempting to devise a synthesis. The main problem was 
the use of chemistry that involved nBuLi or palladium. As can be seen above, this rules 
out all the benzoic acid substrates. After much deliberation and research, bromo-
pentenoic acid 2.50 was identified as a viable substrate, as reactions that could 
conceivably interact with the halogen, when synthesising 2.50, were circumvented 
(Scheme 2.24). The synthesis of acid 2.50 began with a SN2 reaction of p-
bromoacetophenone 2.47 on ethylbromoacetate to furnish ester intermediate 2.48, which 
subsequently underwent a Wittig olefination to give 4-(bromophenyl)pent-4-enoate 2.49 in 
a 71% yield. Hydrolysis of the ester to the corresponding acid then resulted in the desired 
bromo-pentenoic acid 2.50 in a 79% yield. 
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Scheme 2.24: Synthesis of halogen-containing acid 2.50 
Upon treatment of aliphatic acid 2.50 to the optimised oxyallylation reaction, no desired 
product was observed (Scheme 2.25). Numerous attempts were made by varying the 
catalyst loading. Starting with 5 mol%, then increasing to 5 + 5 mol% and finally 10 mol%  
of catalyst loading, resulted in none of the desired lactone 2.51 observed via 1H NMR 
analysis, with only starting material recovered. Two major factors are potentially 
contributing to the lack of heterocyclisation. Firstly, the phenyl substituent tethered to the 
alkene of acid 2.50 is withdrawing electrons away from the double bond, and as witnessed 
with a previous example (Scheme 2.12), has a deleterious effect on the rate and yield. 
Secondly, as discussed previously, this is complicated by the reactive rotamer effect.[88] 
Although individually not enough to prevent the oxyallylation reaction, combined they exert 
a detrimental effect which results in the lack of desired lactone 2.51 being formed. 
 
Scheme 2.25: Attempted oxyallylation of bromo-pentenoic acid 2.50 
Efforts were then focused on the construction of 6-membered lactones as it would extend 
the substrate scope and increase the effectiveness of the oxyallylation reaction even 
further. With the success in the construction of 5-membered lactones using benzoic acid 
substrates, it was reasoned that starting from methallylbenzoic acid 2.54 would be 
prudent. The substrate was synthesised in 2 steps following a literature procedure 
(Scheme 2.26).[38] Allylation of aryl iodide 2.52 with 2-methallylchloride yielded 
methallylbenzyl ester 2.53. Subsequent ester hydrolysis afforded the desired 
methallylbenzoic acid 2.54. 
55 
 
 
Scheme 2.26: Synthesis of methallylbenzoic acid 2.54 
 
Initial attempts towards the oxyallylation reaction of lactone 2.55 were made using the 
then optimal conditions, with 5 mol% catalyst in toluene and with allyl bromide as the 
electophile (Scheme 2.27). Low conversion of starting material resulted in a low yield of 
21% of desired lactone 2.55. 
 
Scheme 2.27: Oxyallylation of methallylbenzoic acid 2.54 
 
Dissatisfied with result above, improving upon the 21% yield was the priority. In an 
attempt to improve the yield, the catalyst loading was increased. Starting at 5 mol%, a 
further 5 mol% was added after 5 h (Table 2.3, entry 1). Incomplete conversion of the 
methallylbenzoic acid 2.54 was still an issue; however, the yield almost doubled which 
was encouraging.  Increasing the temperature to 80 °C still resulted in a large amount of 
unreacted starting material 2.54 with the desired lactone 2.55 being formed in equal 
amounts. Additionally, O-allylated side product 2.56 was observed via 1H NMR analysis of 
the crude material. Increasing the concentration did result in more of the desired lactone 
2.55; however, there was still an abundance of benzoic acid 2.54 (entry3). Increasing both 
the temperature and concentration resulted in equal amounts of starting material 2.54, 
desired lactone 2.55 and O-allylated side product 2.56 (entry 4). As such a change in 
strategy to a weaker base was envisioned to improve the ailing reaction,as it would limit 
formation of the O-allylated side product 2.56. However, this change also brought an 
unsatisfactoryresult as a large amount of unreacted starting material 2.54 remained and 
proto-demetallated product 2.57 was the major product (entry 5). In order to improve the 
conversion an increase in temperature or concentration was employed with KH2PO4 kept 
constant as the base. As before, complete conversion of starting material did not arise 
when either the temperature or concentration increased (entries 6 and 7). The increase in 
temperature and concentration resulted in a slight increase of desired product 2.55, yet 
also furnished gem-dimethyl lactone 2.57 in greater amounts. When both the temperature 
and concentration are increased simultaneously, sole formation of gem-dimethyl lactone 
2.57 was observed (entry 8). However, when the temperature is increased further to 100 
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°C the O-allylated product 2.56 is formed exclusively (entry 9). Excluding a base from the 
reaction and varying the temperature was also attempted in the pursuit of ideal conditions; 
however,the results were not encouraging (entries 10 and 11).  Increasing the strength of 
the base was hypothesised to deprotonate the benzoic acid 2.54. The carboxylate would 
be more nucleophilic, resulting in the formation of the desired 6-membered lactone 2.55 
(entry 12). The nucleophilicity did increase; however, it resulted in the sole formation of 
the O-allylated compound 2.56.  
 
Entry Conc. (M) Temp. (°C) Base Result 
2.54 : 2.55 : 2.56 : 2.57 
1 0.3 50 NaHCO3 2.0 : 1.0 (41%): 0.0 : 0.0 
2 0.3 80 NaHCO3 2.0 : 2.0 : 1.0 : 0.0 
3 0.6 50 NaHCO3 1.4 : 1.0 : 0.0 : 0.0 
4 0.6 80 NaHCO3 1.0 : 1.0 : 1.0 : 0.0 
5 0.3 50 KH2PO4 2.0 : 1.0 : 0.0 : 2.4 
6 0.3 80 KH2PO4 2.5 : 1.0 : 0.0 : 2.5 
7 0.6 50 KH2PO4 2.0 : 1.0 : 0.0 : 4.0 
8 0.6 80 KH2PO4 0.0 : 0.0 : 0.0 : 1.0 
9 0.3 100 KH2PO4 0.0 : 0.0 : 1.0 : 0.0 
10 0.3 50 No Base 0.0 : 0.0 : 0.0 : 1.0 
11 0.3 80 No Base 0.0 : 1.0: 0.0 : 4.0 
12 0.3 50 K2CO3 0.0 : 0.0 : 1.0 : 0.0 
Table 2.3: Optimisation of oxyallylation reaction for 6-membered lactone ring 2.55 
After much screening, optimised conditions were discovered. Simply changing the allyl 
halide electrophile from allyl bromide to allyl chloride in the presence of toluene, NaHCO3 
and Pd(hfacac)2 catalyst (5 + 5 mol%) the reaction afforded the desired 6-membered 
lactone 2.55 in 62% yield (Scheme 2.28). 
 
 
Scheme 2.28: Optimised conditions for the synthesis of 2.55 
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At this juncture, it must be noted that the switching of allyl halide to allyl chloride and its 
effect on the reaction came as a surprise. Previous oxyallylation experiments had shown 
that allyl chloride had a deleterious effect on the conversion, rate and yield of reaction. 
With this new information, substrates that did not heterocyclise or required a higher 
catalyst loading in order to result in complete conversion of starting material were 
examined. Substituting allyl bromide for allyl chloride resulted in no improvement in the 
aforementioned reactions.  
Due to their importance in medicinal chemistry, the synthesis of nitrogen-containing 
substrates amenable to the oxyallylation conditions was the next objective. As such both 
pyrrole and indole derivatives were chosen. Both pyrrolecarboxylic acid 2.59 and 
indolecarboxylic acid 2.61 were synthesised in two steps from commercially available 
starting materials pyrrole methyl ester 2.58 and indole ethyl ester 2.60 (Scheme 2.29). 
The first step in the synthesis of both substrates is the allylation of the nitrogen atom using 
methallyl chloride in DMF, with sodium hydride as the base. The intermediates were then 
saponified by 2 M aq. NaOH, to give the desired pyrrole 2.59 and indole 2.61 in 64% and 
46% yields, over two steps. 
 
Scheme 2.29: Synthesis of pyrrole 2.59 and indole 2.61 substrates 
 
Pyrrole 2.59 and indole 2.61 were next subjected to the oxyallylation reaction conditions. 
More focus was directed towards the pyrrole 2.59 variant (Table 2.4). This was intentional, 
because the two compounds bear structural similarities; it was assumed conditions that 
would work for one would work for the other. However, irrespective of the reaction 
conditions the formation of the desired pyrrole lactone 2.62 was not observed via 1H NMR 
analysis of the crude material. Catalyst  loading, base, temperature and electrophile were 
varied (Table 2.4, entries 1 – 8). Unfortunately, each time the reaction mixture quickly 
turned black, alluding to the formation of Pd(0).  
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Entry Pd(hfacac)2 
(mol%) 
X  Base Temp (°C) Result 
2.59 : 2.62 
1 5 Br NaHCO3 50 1 : 0 
2 5 Cl NaHCO3 50 1 : 0 
3 10 Br NaHCO3 80 1 : 0 
4 10 Cl NaHCO3 80 1 : 0 
5 10 Br KH2PO4 50 1 : 0 
6 10 Cl KH2PO4 50 1 : 0 
7 
8 
10 
10 
Br 
Cl 
No Base 
No Base 
50 
50 
1 : 0 
1 : 0 
Table 2.4: Attempted oxyallylation of pyrrole 2.59 
 
Reactions on indole 2.61 were run simultaneously (Table 2.5). Again, variables such as 
catalyst loading, temperature and electrophile were changed, however, were also 
unsuccessful in synthesising the desired compound 2.63 (Table 2.5, entries 1−4). As with 
previous results on pyrrole substrate 2.59, the reaction mixture quickly turned black, 
hinting at formation of Pd(0) under the reaction conditions.  
 
Entry Pd(hfacac)2 
(mol %) 
X  Temp (°C) Result 
2.61 : 2.63 
1 5 Br 50 1 : 0 
2 5 Cl 50 1 : 0 
3 10 Br 80 1 : 0 
4 10 Cl 80 1 : 0 
Table 2.5: Attempted oxyallylation of indole 2.61 
 
The consequences of the Pd(0) formation allowed other reactions to dominate with the 
major products an unwanted, complex mixture of O-allylated product 2.64 and O-allylated 
products with allyl group on the aromatic ring generating compounds 2.65 and 2.66 
(Figure 2.2). Attempts to purify and isolate the allylated products were futile as they elute 
off the column as one in petroleum ether with an Rf value of 0.8. 
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Figure 2.2: Allylated side products 
 
Glycine-derived aliphatic acid 2.70 was chosen because the glycine motifis present in 
many bioactive molecules and molecules found throughout nature. Substrate 2.70 was 
synthesised in 3 steps initially starting with the protection of the amine functionality in the 
presence of Boc anhydride at reflux, which quantitatively yielded the desired Boc-
protected amine 2.68 (Scheme 2.30). The second step involved the deprotonation of the 
nitrogen with sodium hydride in THF followed by the addition of methallyl chloride to give 
allylated carbamate 2.69. Saponification with 2 M aq. NaOH to give the desired glycine 
derived carboxylic acid 2.70 was achieved in quantitative yield. Compound 2.69 exists as 
two rotamers and as such had to be analysed with high temperature 1H NMR to confirm its 
synthesis. Compound 2.70 also existed as two rotamers and was also analysed with high 
temperature 1H NMR to confirm its synthesis. 
 
Scheme 2.30: Synthesis of glycine derived substrate 2.70 
 
With the desired glycine derived carboxylic acid 2.70 at hand, it was then subjected to 
oxyallylation conditions. Unfortunately, results did not provide any of the desired product 
2.71.Varying the allyl halide electrophile from allyl chloride resulted in no formation of the 
desired lactone 2.71 (Scheme 2.31).  
 
Scheme 2.31: Attempted oxyallylation of glycine derived substrate 2.70 
 
60 
 
In the attempted oxyallylation reaction on glycine derived substrate 2.70, the major 
product that was formed was the O-allylation product 2.72 in a 94% yield (Scheme 2.32). 
A possible reason for the sole formation of O-allylated 2.72 is because of the hybridisation 
of the nitrogen atom being sp2 hybridised as opposed to sp3 hybridised. This increases the 
bond angle from approximately 109° to 120°, thus keeping the reactive centres further 
apart. As such it can be determined that O-allylation is a more facile reaction than the 
Pd(II)-induced heterocyclisation. Additionally, product 2.72 is a rotamer and as such its 
synthesis had to be confirmed by variable temperature 1H NMR. 
 
 
Scheme 2.32: Formation of side product 2.72 
 
Based on the success of the palladium(II)-catalysed heterocyclisation of aliphatic acids to 
form 5-membered lactones, commercially available hexenoic acid 2.73 was selected as a 
potentially viable substrate to expand the reaction into 6-membered lactones starting from 
aliphatic acids. Hexenoic acid 2.73 was submitted to the reaction conditions (Scheme 
2.33). Unfortunately, the desired product was not observed via 1H NMR  analysis of the 
crude mixture and only starting material was recovered. One possible reason for the 
failure of hexenoic acid 2.73 to cyclise is that it was unable to acquire a reactive 
conformation.[88] This can be ascribed to the barrier of cyclisation being higher than for the 
corresponding cyclisation for 5-membered lactones.  
 
Scheme 2.33: Attempted oxyallylation of hexenoic acid 2.73 
 
2.1.3 Mono-substituted Alkene Substrates 
Oxyallylation reactions of unactivated mono-substituted alkenes have been previously 
demonstrated within the France group. Mixed results were obtained with only 2-allyl 
phenol 2.75 successfully performing the oxyallylation reaction in a synthetically viable 
yield (Scheme 2.34). A modification of the standard palladium-catalysed oxyallylation 
conditions were required to circumvent the synthesis of benzofuran 2.78. Increasing the 
catalyst loading to 10 mol%, increasing the concentration, doubling the number of 
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equivalents of allyl chloride and lowering the temperature to room temperature was 
necessary to furnish the desired benzofuran 2.77 in a 61% yield. 
 
Scheme 2.34: Oxyallylation of 2-allyl phenol 2.75 
Palladium-catalysed reactions of mono-substituted alkenoic acids, in comparison to their 
hydroxyl counterparts, have not been studied as extensively. Early examples include the 
work of Yoshida[90] and Larock[91] in the synthesis lactones via palladium catalysis. 
Additionally, the previously discussed report on oxyalkynylation from Waser and co-
workers reported examples of mono-substituted alkenes in good yields (Scheme 2.35).[38] 
 
Scheme 2.35: Oxyalkynylation of mono-substituted alkenoic acids 
The success of benzoic acid substrates in the oxyallylation reaction of gem-disubstituted 
alkenes for the synthesis of 5-membered lactones, prompted the synthesis of 2-vinyl 
benzoic acid 2.79. Wittig olefination of aldehyde 2.83 in THF at reflux yielded the desired 
2-vinyl benzoic acid 2.79, albeit in a lowly 32% yield (Scheme 2.36). 
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Scheme 2.36: Synthesis of 2-vinyl benzoic acid 2.79 
The results of of Waser and co-workers for mono-substituted alkenes led to 2-vinyl 
benzoic acid 2.79 being subjected to the oxyallylation conditions developed for the gem-
disubstituted analogue. Unfortunately, the reaction never went to full conversion of 2-vinyl 
benzoic acid 2.79 and none of the desired oxyallylated lactone 2.86 was observed 
(Scheme 2.37). Analysis of the crude material revealed no formation of compound 2.86 
but instead gave unreacted starting material 2.79, isocoumarin 2.84 and exo-methylene 
lactone 2.85 in a ratio of 4.7: 1.1: 1.0 respectively. 
 
Scheme 2.37: Attempted oxyallylation of 2-vinyl benzoic acid 2.79 
The analysis of previous palladium-catalysed oxyallylation results indicates that 
cyclisations to form 5-membered lactones are a more facile process, when compared to 
the synthesis of the 6-membered lactones. This led to the screening of conditions to 
optimise the oxyallylation reaction for 2-vinylbenzoic acid 2.79 (Table 2.6). Initially, the 
conditions employed were similar to those developed for the only successful mono-
substituted alkene to undergo the Pd(II)-catalysed oxyallylation reaction, with a yield that 
was acceptable (Scheme 2.34). Catalyst loading was initially lower at 5 mol% (entry 1 and 
2); however, desired lactone 2.86 was not detected by analysis of 1H NMR of the crude 
mixture. As such, the catalyst loading was increased to 10 mol%, yet still no desired 
product was observed, with only unwanted side products formed(entry 3). However, when 
the temperature was lowered to room temperature, a small amount of the desired 
oxyallylated lactone 2.86 was observed via analysis of the 1H NMR of the crude mixture 
(entry 4). The base was also varied in an attempt to limit the synthesis of O-allylated 
compound 2.87; however, this resulted in the sole formation of isocoumarin 2.84 (entries 5 
and 6). When allyl bromide was replaced with allyl chloride a more favourable ratio was 
observed, but still not ideal (entry 7). The reaction temperature was then decreased to 
room temperature, however, no desired product formed (entry 8). It should be noted that 
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all reactions listed below resulted in low conversion of starting material, and as a result, it 
was more prudent to focus more on the ratio of products formed. 
 
Entry Base Temp. 
(°C) 
Catalyst 
Loading 
Allyl X Ratio 
2.84 : 2.87 : 2.86 : 2.85 
1 NaHCO3 50 5 mol% Br (5 equiv.) 1.0 : 1.0 : 0.0 : 0.0 
2 NaHCO3 50 5 mol% Br  2.0 : 1.0 : 0.0 : 0.0 
3 NaHCO3 50 10 mol% Br 1.8 : 1.0 : 0.0 : 1.0 
4 NaHCO3 r.t. 10 mol% Br 2.6: 1.6 : 1.0 : 0.0 
5 - 50 10 mol% Br 1.0 : 0.0 : 0.0 : 0.0 
6 KH2PO4 50 10 mol% Br 1.0 : 0.0 : 0.0 : 0.0 
7 NaHCO3 50 10 mol% Cl 1.0 : 3.5 : 1.3 : 0.0 
8 NaHCO3 rt 10 mol% Cl 1.0 : 6.0 : 0.0 : 0.0 
NB – No reaction went to complete conversion of starting material and conversion was poor 
Table 2.6: Attempted optimisation of oxyallylation reaction for 2-vinyl benzoic acid 2.79 
Simply by swapping allyl bromide with allyl chloride, it was observed that the reaction 
synthesised less side products (unwanted heterocyclic compounds 2.84 and 2.85) that 
involved the formation of Pd(0) and thus could lead to the deactivation of the Pd(II) 
catalyst, which is required for the isohypsic reaction. With this, it was reasoned that a 
change in catalyst could conceivably improve the ratio in favour of the desired lactone 
2.86, and improve conversion. As such, screening of the palladium(II) salt used in the 
reaction was investigated (Table 2.7, entries 1 – 5). Here, it proves that a change away 
from Pd(hfacac)2 as the catalyst has a deleterious effect on the reaction, and worsens the 
ratio of desired lactone 2.86 to side products and, as such, no improvements were 
observed. It should be noted that all reactions listed below resulted in low conversion of 
starting material, and as a result, it was more prudent to focus more on the ratio of 
products formed. 
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Entry Catalyst Ratio 
2.84 : 2.87 : 2.86 : 2.85 
1 Pd(OAc)2 4.3 : 3.3 : 1.0 : 4.0 
2 Pd(TFA)2 0.0 : 1.0 : 0.0 : 0.0 
3 PdCl2(C6H5CN)2 1.0 : 3.0 : 0.0 : 0.0 
4 PdCl4Na2 1.3 : 1.0 : 0.0 : 0.0 
5 PdCl2 11 : 3.5 : 1.0 : 0.0 
NB – No reaction went to complete conversion of starting material and conversion was poor 
Table 2.7: Catalyst screening  
With Pd(hfacac)2 as the catalyst, the combination of solvent and allyl halide electrophile 
was investigated (Table 2.8). When the reaction was performed in dichloromethane at 50 
°C, only the isocoumarin product 2.84 was formed (entries 1 and 2). Lowering the 
temperature to room temperature yielded the desired lactone 2.86 in a reasonable ratio to 
side products only when allyl bromide is employed as the electrophile (entries 3 and 4), 
although, still not as favourable as previously observed (Table 2.6, entry 7).  Changing the 
solvent to EtOAc and THF did not improve the ratio, and in each instance favoured the 
synthesis of side products that led to the formation of Pd(0) (entries 5 – 8). It should be 
noted that all reactions listed below resulted in low conversion of starting material, and as 
a result, it was more prudent to focus more on the ratio of products formed. 
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Entry AllylX Solvent Temp. (°C) Ratio 
2.84 : 2.87 : 2.86 : 2.85 
1 Cl CH2Cl2 50 1.0 : 0.0 : 0.0 : 0.0  
2 Br CH2Cl2 50 1.0 : 0.0 : 0.0 : 0.0 
3 Cl CH2Cl2 r.t. 1.0 : 0.0 : 0.0 : 0.0 
4 Br CH2Cl2 r.t. 1.2 : 1.6 : 1.0 : 0.0 
5 Cl EtOAc 50 2.3 : 3.6 : 1.0 : 0.0 
6 Br EtOAc 50 4.3 : 1.0 : 0.0 : 0.0 
7 Cl THF 50 2.0 : 1.0 : 0.0 : 3.9 
8 Br THF 50 4.0 : 5.0 : 1.0 : 2.5 
NB – No reaction went to complete conversion of starting material 
Table 2.8: Effect of varying solvent and allyl halide on reaction  
With allyl chloride, toluene and Pd(hfacac)2at 10 mol% catalyst loading seeming to be 
superior than other possible conditions, it was decided to maintain them as constants. A 
change in concentration to 0.3 M was first investigated; however, this negated the 
formation of desired compound 2.86 (Table 2.9, entry 1). The base was also varied; 
however, this did not improve on the best result obtained previously (entry 2). Variation in 
the allyl chloride stoichiometry (entries 3 – 5) was also examined, with the use of 20 
equivalents marginally improving upon the best previous result. Next, additives were also 
screened. From the literature, the addition of chloride salts is known to suppress β-hydride 
elimination in Wacker-type reactions and, thus, should prevent the formation of unwanted 
lactones 2.84 and 2.85.[92] The addition of LiCl to the reaction resulted in the sole 
formation of isocoumarin 2.84, with none of the desired product observed (entry 7). Other 
additives like benzoquinone (entry 8) and H2O were added; however, no improvement 
was observed, with O-allylated side product 2.87 being the main product (entry 9). It 
should be noted that all reactions listed below resulted in low conversion of starting 
material, and as a result, it was more prudent to focus more on the ratio of products 
formed. 
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Entry Additive Ratio 
2.84 : 2.87 : 2.86 : 2.85 
1a - 4.4 : 2.0 : 1.0 : 0.0 
2b - 1.4 : 6.4 : 2.0 : 1.0 
3c - 1.0 : 6.3 : 1.0 : 0.0 
4d - 1.0 : 10.0 : 1.3 : 0.0 
5e - 1.0 : 5.6 : 2.0 : 0.0 
6f - 9.3 : 1.0 : 1.4 : 0.0 
7 LiCl (10 equiv.) 1.0 : 0.0 : 0.0 : 0.0  
8 BQ (2 equiv.) 1.0 : 0.0 : 0.0 : 0.0 
9 H2O (0.4 mL) 1.3 : 6.0 : 1.0 : 0.0 
a
0.3 M
b
 base changed to KH2PO4 
c 
20 equiv. of allyl chloride 
d
 5 equiv. of allyl chloride 
e
 no solvent
f
 80 °CNB – No reaction 
went to complete conversion of starting material 
Table 2.9: Attempted optimisation of 2-vinyl benzoic acid 2.79 
Next, the commercially available 2-(cyclopent-2-enyl)acetic acid 2.88 was subjected to the 
optimised conditions developed for the oxyallylation of  gem-disubstituted alkenes bearing 
a tethered carboxylic acid group. However, none of the desired product was isolated. 
Instead the β-hydride elimination product 2.89 was isolated in 78% yield (Scheme 2.38).  
 
Scheme 2.38: Attempted oxyallylation reaction of cyclopentene carboxylic acid 2.88 
 
With the above result in hand, it was obvious that oxyallylation reaction of aliphatic acids 
was not going to be a facile process. As such, commercially available pentenoic acid 2.81 
was chosen as a more suitable substrate due to the success of its gem-disubstituted 
analogue in previous studies. Analysing the best results from the previous investigations 
with mono-substituted alkenenoic acids, the investigations began by using reaction 
conditions from Table 2.6 entry 7, in the hope that an improvement in the ratio would be 
observed. The allyl halide electrophile was varied from allyl bromide to allyl chloride; 
however, each reaction only returned starting material (Scheme 2.39). 
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Scheme 2.39: Attempted oxyallylation of aliphatic acid 2.81 
Previous studies within the France group proved to be successful for the aminoallylation 
of mono-substituted alkene substrates. When 2-allyl tosylamide 2.91 was treated with 5 
mol% of Pd(hfacac)2 in a biphasic mixture of toluene/H2O at 50 °C with KH2PO4 as the 
base afforded the desired lactam in an excellent 95% yield (Scheme 2.40). 
 
Scheme 2.40: Aminoallylation reaction of mono-substituted alkene 2.91 
The success of the tosylamide 2.91 inspired the study of its carboxylic analogue. 
Subjecting 2-allylbenzoic acid 1.15 to the standard oxyallylation conditions gave a 
promising initial result, which was the focus of much optimisation (Table 2.10, entry 1). 
Varying the concentration resulted ina large amount of starting material 1.15, with the 
main palladium-catalysed product the unwanted β-hydride elimination isocoumarin 1.16 
(entries 2 and 3). From the literature,[93] it is known that through increasing the halide 
concentration, the halide can block coordination sites on the palladium which in turn 
prevents β-hydride elimination. Due to this LiCl and and N(nButyl)4Cl were added, 
however, the addition of chloride salts appears to retard the synthesis of of desired 
lactone 2.93, and instead side products are formed preferentially if at all (entries 4 and 5). 
As the use of LiCl afforded a small amount of the desired lactone 2.93, it was decided to 
increase the equivalents of LiCl and allyl chloride as well as increase the concentration, in 
order to favour the synthesis of desired oxyallylated lactone 2.93 (entry 6). This did result 
in complete conversion of 2-allyl benzoic acid 1.15 and a small amount of the desired 
product 2.93 with none of the unwanted isocoumarin 1.16. However, the reaction did 
result in the O-allylated side product 2.94 as the predominant product.   Varying 
concentration and temperature resulted in no formation of the oxyallylation product 2.93 
(entries 7–10). With the concentration at 0.8 M, changing to a weaker base of KH2PO4 
resulted in no formation of desired lactone 2.93 and raising the temperature to 80 °C 
resulted in none of the desired lactone 2.93 (entries 11 and 12).  
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Entry Conc. AllylCl  
Equiv. 
Temp 
 (°C) 
Base/ Additive Result 
1.15 : 2.93 : 1.16 : 2.94 
1 0.3 5 50 NaHCO3 1.0 : 1.0 : 6.0 : 0.0 
2 0.8 5 50 NaHCO3 3.0 : 1.0 : 2.0 : 3.0 
3 0.2 5 50 NaHCO3 5.0 : 1.0 : 2.0 : 0.0 
4 0.8 5 50 NaHCO3/ LiCl (1 
equiv.) 
0.0 : 1.0 : 8.0 : 8.0 
5 0.8 5 50 NaHCO3/ N(nButyl)4Cl 
(1 equiv.) 
0.0 : 0.0 : 0.0 : 1.0 
6 1.0 10 50 NaHCO3/ LiCl (10 
equiv.) 
0.0 : 1.0 : 0.0 : 4.0 
7 1.0 10 50 NaHCO3 0.0 : 0.0 : 1.0 : 0.0 
8 No solvent 5 50 NaHCO3 0.0 : 0.0 : 0.0 : 1.0 
9 No solvent 5 80 NaHCO3 0.0 : 0.0 : 0.0 : 1.0  
10 No solvent 5 rt NaHCO3 1.0 : 0.0 : 0.0 : 0.0 
11 0.8 5 50 KH2PO4 5.0 : 0.0 : 1.0 : 0.0 
12 0.8 5 80 KH2PO4 2.5 : 0.0 : 1.0 : 0.0 
Table 2.10: Attempted optimisation of 2-allyl benzoic acid 1.15 
 
In summary, attempts to extend the oxyallylation reaction to the synthesis of lactones 
starting from a mono-substituted alkene, in good yield, have proved challenging. The 
desired 5- and 6-membered lactones suffered from poor conversion in some cases, or the 
predominant reaction pathway forming unwanted side products. Attempts to redirect the 
reaction pathway towards synthesising the oxyallylated lactone products in a synthetically 
viable yield have, thus far, remained elusive. Changes in temperature, catalyst, base allyl 
halide, concentration and the addition of additives have proved unsatisfactory.  
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2.2 Enantioselective Oxyallylation Reaction of Unactivated 
Alkenes 
2.2.1 Gem-disubstituted Alkene Substrates 
The ability for chemists to control which enantiomer the reaction performed within the 
laboratory will produce is highly advantageous. A large number of natural products[94] and 
pharmaceuticals[95] contain stereogenic centres, which are often enantioselectively placed 
in the molecule through transition metal chemistry, with the use of chiral ligands.[96] 
 
For the optimised racemic palladium(II)-catalysed oxyallylation reaction, the catalyst 
employed was palladium(II) hexafluoroacetylacetonate. Early investigations conducted 
within the France group revealed that varying the Pd(hfacac)2 catalyst in the oxyallylation 
reaction of alcohols had a detrimental effect on the conversion to the desired oxyallylation 
product (Table 2.11).[97] 
 
Entry “Pd” Time Resulta 
1.83 : 2.16 
1 Pd(hfacac)2 16 h 0 : 1 
2 Pd(OAc)2 22 h 1 : 0.05 
3 Pd(acac)2 22 h 1 : 0.1 
4 Pd(TFA)2 22 h 1 : 0 
5 PdCl2 28 h 1 : 2 
6 Pd2dba3 18 h 1 : 0 
a
Approximate ratio of 1.83 : 2.16 based on 
1
H NMR spectroscopy of unpurified reaction mixture 
Table 2.11: Previous Pd catalyst screen in the oxyallylation optimisation[97] 
 
Based on the results above, it was believed that the electronics of the Pd(hfacac)2 play an 
integral role. In order to make an enantioselective variant of the reaction, it was 
hypothesised thatchiral catalysts with similar electronics were required (Figure 2.3).[98] 
 
Figure 2.3: Potential Pd(II) chiral catalysts 
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As can be seen above (Figure 2.3), both of the ligands on the palladium(II) centre  only 
have one fluorinated electron-withdrawing group, as opposed to the two on the 
Pd(hfacac)2 catalyst. Due to the change in electronics, an achiral variant was synthesised 
in order to test for reactivity in the oxyallylation reaction (Scheme 2.41). Na2PdCl4 was 
added to a solution of dione 2.98 in EtOH and 1 M aq. NaOH and was left to stir overnight 
at room temperature and afforded the desired palladium(II) trifluoroacetylacetonate 
catalyst [Pd(tfacac)2] 2.99 in a 36% yield. 
 
Scheme 2.41: Synthesis of Pd(tfacac)2 2.99 
 
The reactivity of Pd(tfacac)2 2.99 was investigatedwith the benzoic acid substrate 2.10 
(Table 2.12, entry 1). Utilising Pd(tfacac)2 successfully resulted in the complete conversion 
of the starting material to the desired oxyallylated lactone 2.13. In order to determine 
whether traces of Na2PdCl4 in the newly synthesised Pd(tfacac)2 could catalyse the 
reaction Na2PdCl4 was employed as the catalyst in the oxyallylation reaction (entry 2). 
Again,this resulted in the complete conversion of starting material. Benzoic acid 2.10 was 
treated with Pd(OAc)2, Pd(acac)2, Pd(TFA)2 and PdCl2. Irrespective of catalyst employed, 
it culminated in complete conversion of benzoic acid 2.10 (Table 2.12, entries 3 − 6). 
Surprised by the reactivity of the benzoic acid substrate 2.10, when compared to the 
phenol (Table 2.11), the oxyallylation was attempted with no palladium source in the 
reaction mixture (entry 7). As expected, no desired lactone was observed via 1H NMR of 
the crude material. 
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Entry “Pd” Resulta 
2.10 : 2.13 
1 Pd(tfacac)2 2.99 0 : 1 
2 Na2PdCl4 0 : 1 
3 Pd(OAc)2 0 : 1 
4 Pd(acac)2 0 : 1 
5 Pd(TFA)2 0 : 1  
6 PdCl2 0 : 1 
7 No catalyst 1 : 0 
a
Approximate ratio of 2.10 : 2.13 based on 
1
H NMR spectroscopy of unpurified reaction mixture 
Table 2.12: Pd catalyst screen for benzoic acid 2.10 
 
The high reactivity of the benzoic acid substrate 2.10 in the oxyallylation reaction led to 
the belief that it would be ideal for developing the enantioselective version. From a 
previous project within the France group, a palladium(II) perfluoro camphor catalyst 
[Pd(pfc)2] was synthesised (Scheme 2.43). Due to the similar electronics and the success 
of both Pd(hfacac)2 and Pd(tfacac)2 catalysts, it was reasoned that Pd(pfc)2 could be 
employed as a chiral catalyst for the enantioselective oxyallylation reaction. Under 
standard oxyallylation reaction conditions in the synthesis of lactone 2.13 the reaction 
proceeded well, yielding the desired lactone in a 70% yield. However, no 
enantioselectivity was observed (Scheme 2.42). 
 
Scheme 2.42: Attempted enantioselective oxyallylation reaction with Pd(pfc)2 catalyst 
The [3,3]-sigmatropic rearrangement, otherwise known as the Overman rearrangement, of 
allylic trichloroacetimidates 2.100 by the palladium(II) catalyst (S)-(+)-COP-Cl 1.121 
exhibits high enantioselectivity and yields (Scheme 2.43). Its relevance to the 
palladium(II)-catalysed oxyallylation reaction stems from the reaction mechanism, which 
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also proceeds through an isohypsic mechanism via a β-elimination pathway. Additionally, 
(S)-(+)-COP-Cl 1.121 is commercially available making it readily available for testing.  
 
Scheme 2.43: Overman rearrangement with (S)-(+)-COP-Cl 1.121 
The mechanistic similarities between the oxyallylation and Overman rearrangement led to 
the belief (S)-(+)-COP Cl 1.121 would be an ideal catalyst for the creation of the 
enantioselective oxyallylation reaction.[64, 99] The yields when using (S)-(+)-COP Cl 1.121 
as a catalyst were good; however, the enantioselectivity was poor at a lowly 6% (Scheme 
2.44). The temperature of the reaction was decreased to room temperature, however, no 
conversion of the starting material was observed. Furthermore, (S)-(+)-COP-Cl 1.121 was 
filtered through a silica plug to purify, prior to use; however, no improvement to the 
enantioselectivity was observed. Although variants of the catalyst are available, where the 
chloride is replaced with another ligand, their purchase or synthesis was not pursued.[100] 
 
Scheme 2.44: Oxyallylation with (S)-(+)-COP-Cl 1.121 
The success of the Overman rearrangement in CH2Cl2 at room temperature prompted the 
enantioselective oxyallylation to be attempted under similar conditions (Scheme 2.45). 
Varying the solvent and lowering the temperature had a negligible effect on the 
enantioselectivity, as it was only increased slightly. 
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Scheme 2.45: Similar conditions to the Overman rearrangement 
With the lack of success using palladacycle (S)-(+)-COP Cl 1.121, more traditional routes 
such as a Pd(II) salt plus ligand were sought. Previous studies conducted within the 
France group, in the optimisation of the palladium(II)-catalysed oxyallylation of alcohols 
with ligands, revealed that the presence of nitrogen and phosphine based ligands had a 
deleterious effect on the conversion of starting material. Hitherto, the effect of ligands on 
the oxyallylation reaction of carboxylic acids was unknown. With palladium(II) chloride as 
the catalyst, nitrogen based quinox 2.104 and bipyridine 2.105 ligands were screened 
(Table 2.13, entries 1 and 2). Mixed results were observed with the quinox ligand 2.104 
resulting in formation of the desired product and bipyridine 2.105 retarding the formation 
of desired lactone 2.13. The temperature was increased from 50 °C to 80 °C due to low 
conversion of the starting material; however, this resulted in an increase in the formation 
of O-allylated side product 2.103. Next, phosphorous based ligands were investigated as 
they are used ubiquitously in metal-catalysed reactions. Again, mixed results were 
observed, with triphenylphosphine 2.106 resulting in small formation of the desired 
product and tricyclohexylphosphine 2.107 retarding the formation of desired lactone 2.13 
(entries 3 and 4). The temperature was increased from 50 °C to 80 °C due to low 
conversion of the starting material; however, this resulted in an increase in the formation 
of O-allylated side product 2.103. Finally, to determine the effect of catalyst/ligand 
combination, Pd(TFA)2/Bipyridine 2.105 was investigated. Bipyridine 2.105 was chosen as 
the ligand as it garnered none of the desired lactone 2.13. Interestingly, improvements 
were observed, with some oxyallylated product 2.13 formed. Low conversion again led to 
the increase in temperature, however, again this resulted in an increase in O-allylated side 
product 2.13 (entry 5). 
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Entry Pd/ Ligand Temp. 
(°C) 
Result 
2.13 : 2.103 
1 PdCl2/Quinox 2.104 50 then 80 1.0 : 1.3 
2 PdCl2/Bipyridine 2.105 50 then 80 0.0 : 1.0 
3 PdCl2/PPh3 2.106 50 then 80 1.0 : 5.6 
4 PdCl2/PCy3 2.107 50 then 80 0.0 : 1.0 
5 Pd(TFA)2/Bipyridine 2.105 50 then 80 1.0 : 1.3 
a
Approximate ratio of 2.10 : 2.13 based on 
1
H NMR spectroscopy of unpurified reaction mixture 
Table 2.13: Achiral ligand screen  
 
A literature example by Stoltz and co-workers employed conditions remarkably similar to 
those developed for the oxyallylation reactions, and represents an ideal precedent 
(Scheme 2.45).[23] Additionally, Stoltz et al. reported that a change in palladium salt had a 
dramatic effect on the enantioselectivity. 
 
Scheme 2.45: Asymmetric oxypalladation reaction using (−)-sparteine 1.20 
Initially, Pd(TFA)2 was chosen as a suitable catalyst to screen ligands with because it 
catalysed the achiral oxyallylation reaction of benzoic acid  2.10, with complete 
consumption of starting material, and is most electronically similar to Pd(hfacac)2. 
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Additionally, it is commonly used in asymmetric oxypalladation reactions as the palladium 
catalyst.[18c] Many ligands were screened when using benzoic acid 2.13 as the substrate 
(Table 2.14). The initial bidentate nitrogen ligand screen was relatively unsuccessful. 
Bisoxazoline 2.110, pyBOX 2.111 and (−)-sparteine 1.20 all resulted in no conversion to 
the desired lactone (entries 1 – 3). (S)-BINAM 2.112 did result in a 10% yield; however no 
enantioselectivity was induced by the ligand (entry 4). Because the use of (S)-BINAM 
2.112 ligand garnered some of the desired lactone 2.13, a different catalyst was 
attempted in the hope it would improve the result. A combination of Pd(OAc)2/(S)-BINAM 
2.112 resulted in an 81% yield of racemic lactone 2.13 (entry 5). The diamine ligand 2.113 
afforded enantioenriched product in a 10% ee (entry 6). With this as the best result, the 
catalyst was then varied to Pd(OAc)2 and PdCl2. However, no product was detected when 
the catalyst was varied from Pd(TFA)2 (entries 6 and 7). 
 
Entry Catalyst/Ligand Result (2.13) 
1 Pd(TFA)2/bisoxazoline 2.110 Not Detected 
2 Pd(TFA)2/pyBOX 2.111 Not Detected 
3 Pd(TFA)2/(−)-sparteine 1.20 Not Detected 
4 Pd(TFA)2/(S)-BINAM 2.112 10%, 0% ee 
5 Pd(OAc)2/(S)-BINAM 2.112 81%, 0% ee 
5 Pd(TFA)2/diamine 2.113 5%, 10% ee 
6 Pd(OAc)2/diamine 2.113 Not Detected 
7 PdCl2/diamine 2.113 Not Detected 
Table 2.14: Bidentatenitrogen ligand screen 
Concurrently, the palladium-catalysed oxyallylation reactions with chiral bidentate 
phosphine ligands were performed. The addition of dppe 2.114, and bisphosphine 2.115 
resulted in no formation of the desired lactone 2.13 (Table 2.15, entry 1 and 2). Utilising 
(S)-T-BINAP 2.116, afforded the desired lactone in an 81% yield, albeit as a racemic 
mixture (entry 3). 
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Entry Catalyst/ Ligand Result (2.13) 
1 Pd(TFA)2/ dppe 2.114 Not Detected 
2 Pd(TFA)2/ bisphosphine 2.115 Not Detected 
3 Pd(TFA)2/ (S)-T-BINAP 2.116 81%, 0% ee 
Table 2.15: Bidentatephosphine ligand screen 
Stahl and co-workers have successfully used quinox ligands in enantioselective 
aminopalladation reactions with conditions similar to the oxypalladation reaction. Herein, 
they report that a change in the palladium(II)-catalyst has a dramatic effect on the 
enantioselectivity (Scheme 2.46). A variant of the ligand seen below was chosen as a 
ligand to begin screening conditions as it is 1) commercially available and 2) the same 
ligand class Stahl et al. reported as the starting point to developing their aminopalladation 
reaction enantioselectively.[101] 
 
Scheme 2.46: Aminopalladation with Quinox 2.119 as ligand 
Based on the Stahl publications, the catalyst was varied (Table 2.16). Initial investigations 
provided an encouraging result (Table 2.16, entry 1). Changing the catalyst of the reaction 
(entries 2 – 6) all yielded the desired product 2.13. For the most part, no major 
improvement in the enantioselectivity was observed, with the largest increase being the 
use of Pd(OAc)2 and the biggest decrease being the use of PdCl4Na2 as catalyst (entries 
4 and 6 respectively). A change of solvent to CH2Cl2, resulted in no improvement in 
enantioselectivity (entries 7 – 10) and in the Pd(TFA)2 and PdCl2 examples, the Pd(II) salts 
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afforded the racemic product (entries 9 and 10). Finally, the most successful reaction 
using Pd(OAc)2 as the catalyst was next repeated at room temperature and allowed to stir 
for 7 days (entry 11). Unfortunately, the decrease in temperature did not result any 
increase in enantioselectivity or yield. 
 
Entry Catalyst Solvent Result (2.13) 
1 Pd(TFA)2 Toluene 9%, 9% ee 
2 PdCl2 Toluene 21%, 9% ee 
3 Pd(hfacac)2 Toluene 3%, 7% ee 
4 Pd(OAc)2 Toluene 9%, 18% ee 
5 Pd(O3STol)2(MeCN)2 Toluene 10%, 11% ee 
6 PdCl4Na2 Toluene 4%, 0% ee 
7 Pd(OAc)2 CH2Cl2 7%, 18% ee 
8 Pd(O3STol)2(MeCN)2 CH2Cl2 6%, 9% ee 
9 Pd(TFA)2 CH2Cl2 20%, 0% ee 
10 PdCl2 CH2Cl2 53%, 0% ee 
11* Pd(OAc)2 Toluene 9%, 16% ee 
*r.t. 7 days 
Table 2.16: Oxyallylation reaction with (S)-iPr-Quinox ligand 2.120 
Stahl and co-workers also reported a dramatic increase in enantioselecitivity when (S)-Ph-
Pyrox ligand 2.121 was used in place of a quinox ligand (Scheme 2.47).[101a] Based on the 
results gathered (Table 2.16) and the precedent set by the Stahl group, it was believed 
that a change in ligand might give a similar increase in enantioselectivity. 
 
Scheme 2.47: Use of (S)-Ph-Pyrox ligand 2.121 in aminopalladation reactions 
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As the (S)-Ph-Pyrox ligand 2.121 is not commercially available, its synthesis was required 
(Scheme 2.48). The first step was the coupling of picolinic acid 2.122 and (S)-(+)-2-
phenylglycinol 2.123, which reacted to yield the amide product 2.124 in 91% yield. 
Tosylation of the primary alcohol 2.124 induced an intramolecular nucleophilic attack on 
the now activated alcohol. This resulted in the closing of the oxazoline ring to give (S)-Ph-
Pyrox 2.121 in a 90% yield.[101a] 
 
Scheme 2.48: Synthesis of (S)-Ph-Pyrox 2.121 
With ligand 2.121 in hand, screening of the ligand with palladium(II)-catalysts was 
subsequently undertaken (Table 2.17). Starting with Pd(OAc)2, which previously gave the 
best result, using (S)-iPr-Quinox 2.120 as the ligand, provided no enantioselectivity (Table 
2.17, entry 1). Further screening resulted in lower ee’s than was hoped, with Pd(TFA)2 
yielding no desired lactone 2.13 (entry 2). Next, PdCl2 and Pd(O3STol)2(MeCN)2 when 
employed as the catalyst gave poor enantioselectivity with 6% ee and 3% ee respectively 
(entries 3 and 4). 
 
Entry Catalyst Result (2.13) 
1 Pd(OAc)2 16%, 0% ee 
2 Pd(TFA)2 Not detected 
3 PdCl2 32%, 6% ee 
4 Pd(O3STol)2(MeCN)2 15%, 3% ee 
Table 2.17: Screening of catalysts with (S)-Ph-Pyrox 2.121 
The lack of success with benzoic acid 2.10 led to the investigation of other possible 
enantioselective oxyallylation reactions. Following a literature procedure, phenol substrate 
1.83 was synthesised in two steps by reacting phenol 2.125 with 2-methylallyl chloride, 
which generates allylated intermediate 2.126 in quantitative yield (Scheme 2.49).[44] Next, 
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compound 2.126 undergoes a thermally induced Claisen reaction, performed in the 
microwave, to give 2-(2-methylallyl)phenol 1.83 in 80% yield. 
 
Scheme 2.49: Synthesis of 2-(2-methylallyl)phenol 1.83 
With the substrate synthesised, potential asymmetric heterocyclisation of phenol 1.83 was 
also examined. PdCl2 was chosen as the catalyst; previous screening experiments 
performed within the France group showed PdCl2 was the second best catalyst for the 
racemic oxyallylation reaction, second only to Pd(hfacac)2. Both palladium(II) catalysts 
ligands were then screened (Table 2.18). Unfortunately, addition of a bidentate phosphine 
or nitrogen ligand to the reaction, with palladium(II) chloride as the catalyst, resulted in no 
conversion of starting material and prevented conversion to the desired benzofuran 2.16 
(entries 1 – 7). Only the use of (S)-iPr-Quinox 2.120 as the ligand afforded any 
benzofuran 2.16. Disappointingly, benzofuran 2.16 was a racemic mixture (entry 8). A 
brief screen using a different Pd(II)-catalyst was undertaken in the hope of improving 
reactivity and enantioselectivity (entries 8 – 11). As can be seen below, the change of 
catalyst had no desirable effect on the reaction; no desired benzofuran 2.16 was detected 
by 1H NMR of the crude mixture. 
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Entry Catalyst Ligand Result (2.16) 
1 PdCl2 dppe 2.114 Not Detected 
2 PdCl2 diphosphine 2.115 Not Detected 
3 PdCl2 (S)-T-BINAP 2.116 Not Detected 
4 PdCl2 Bisoxazoline 2.110 Not Detected 
5 PdCl2 (−)-sparteine 1.20 Not Detected 
6 PdCl2 diamine 2.113 Not Detected 
7 PdCl2 cyclohexyl diamine 2.127 Not Detected 
8 PdCl2 (S)-iPr-Quinox 2.120 7%, 0% ee 
9 Pd(hfacac)2 Diphosphine 2.115 Not Detected 
10 Pd(hfacac)2 bisoxazoline 2.110 Not Detected 
11 Pd(hfacac)2 (S)-iPr-Quinox 2.120 Not Detected 
Table 2.18: Ligand screen with phenol 1.83 
Conventional methods of inducing enantioselectivity in the oxyallylation reaction, using 
chiral ligands co-ordinated to the metal, were proving fruitless. As a result, an alternative 
method was sought.[102] Recent literature has reported the use of chiral phosphoric acids, 
which can induce asymmetry through hydrogen bonding. An elegant example is by List 
and co-workers using chiral phosphoric acids in the Tsuji–Trost reaction (Scheme 
2.50).[103] The hypothesis behind the use of a chiral phosphoric acid to induce 
enantioselectivity was that the reaction in question proceeds through a π-allyl cationic 
intermediate 2.130, whereby the phosphate would form the counter-anion. The 
intermediate 2.130 is proposed to hydrogen bond to the substrate. This assembly resulted 
in the synthesis of many α-branched aldehydes like 2.131, forming quaternary centres 
stereoselectively with high enantioselectivity. 
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Scheme 2.50: Stereoselective Tsuji–Trost reaction utilising a chiral phosphoric acid 
Another elegant example, developed by List and co-workers, is the enantioselective 
Overman rearrangement (Scheme 2.51).[104] Interestingly, it was discovered (through an 
X-ray crystal structure of the catalyst) that the chiral phosphate actually acts as a chiral 
ligand and not a chiral counter-ion. As a chiral ligand it gave excellent yields and 
enantioselecivities in conjunction with an achiral palladacycle 2.134. 
 
Scheme 2.51: Chiral phosphoric acids used as chiral ligands 
Investigations thus far have revealed that the addition of a ligand to the palladium(II)-
catalysed oxyallylation reaction has adverse and unfavourable effects. Based on the 
reports by List and co-workers and the reports of others,[105] the aim was to develop an 
asymmetric cooperative catalytic oxyallylation reaction, through the use of chiral 
phosphoric acids (Scheme 2.52). It is hypothesised that through hydrogen bonding an 
asymmetric oxypalladation reaction would ensue, leading to an enantioenriched product. 
 
Scheme 2.52: Proposed oxyallylation with chiral phosphoric acids 
With the potential of chiral phosphoric acids to induce enantioselectivity, the aim was to 
synthesise the most commonly used chiral phosphoric acid, (S)-TRIP.[106] Synthesis began 
by protection of the BINOL 2.138 with methyl iodide, which gave dimethylated product 
2.139 in a quantitative yield (Scheme 2.53). Next, with the addition of nBuLi, lithiation 
occurred ortho to both methoxy groups. With the addition of bromine, compound 2.140 
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was synthesised in a modest yield of 44%. The nickel-catalysed Kumada coupling 
between dibrominated compound 2.140, and the freshly synthesised Grignard reagent 
2.142 proceeded well to afford compound 2.143, which was not purified and was 
subjected to the next step. Deprotection of the hydroxyl groups using BBr3 garnered 
2.144, which again was not purified. The resulting diol 2.144 is then reacted with POCl3 
and hydrolysed. The resulting solid is recrystallised from MeCN, which gave (S)-TRIP in 
31% yield over 3 steps (Scheme 2.53). 
 
 
 
 
Scheme 2.53: Synthesis of (S)-TRIP 
With the synthesis of (S)-TRIP, the usual substrates were initially subjected to the 
standard palladium(II)-catalysed oxyallylation reaction conditions for substrates: benzoic 
acid 2.10, phenol 1.83 and benzylic alcohol 1.110 (Scheme 2.54). Benzoic acid 2.10 and 
benzylic alcohol 1.110 both underwent the oxyallylation reaction and generated their 
respective products in good yields. Conversely, the oxyallylation reaction of phenol 1.83 
proceeded poorly, and only gave the benzofuran 2.16 in a 3% yield. All reactions only 
afforded racemic products with no enantioselectivity was observed.  
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Scheme 2.54: Use of (S)-TRIP in oxyallylation reactions at 50 °C 
As enantioselectivity was not induced by the phosphoric acid at 50 °C it was decided that 
the reaction temperature would be decreased to room temperature. Yields for the reaction 
both increased in the synthesis of lactone 2.10 and isobenzofuran 2.17. However, 
enantioselectivity was not induced by (S)-TRIP as only racemic mixtures were isolated 
(Scheme 2.55). It must be noted, that without the use of (S)-TRIP both reactions gave 
poor conversion of their respective starting materials when the reaction is performed at 
room temperature. 
 
Scheme 2.55: Use of (S)-TRIP in oxyallylation reactions at room temperature 
The addition of (S)-TRIP with Pd(hfacac)2 does not give any of the the enantioenriched 
isobenzofuran 2.17. It was hypothesised that a change in the palladium(II)-catalyst could 
improve the enantioselectivity, whilst keeping the reaction mixture at room temperature. 
Unfortunately, with a change in catalyst from the standard Pd(hfacac)2 (Table 2.19, entry 
1) to Pd(OAc)2 and Pd(TFA)2,  the product 2.17 was still racemic (entries 2 and 3). 
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Entry Catalyst Result (2.17) 
1 Pd(hfacac)2 76%, 0% ee 
2 Pd(TFA)2 55%, 0% ee 
3 Pd(OAc)2 74%, 0% ee 
Table 2.19: Catalyst screen with (S)-TRIP 
Interestingly, when benzylic alcohol 1.110 was reacted with either Pd(OAc)2 or Pd(TFA)2 
with no catalytic (S)-TRIP in the reaction mixture at room temperature, incomplete 
conversion of starting material to the desired isobenzofuran 2.17 occurs (Table 2.20, 
entries 1 and 3). When (S)-TRIP was added, complete conversion to the desired 
isobenzofuran 2.17 is observed via 1H NMR of the crude mixture (entries 2 and 4). With 
these observations, it is clear that the addition of 15 mol% of (S)-TRIP, is having a 
catalytic effect on the reaction and cooperative catalysis is occurring, albeit not 
enantioselectively. To prove that (S)-TRIP is not catalysing the reaction on its own a 
reaction without palladium was performed, and only returned starting material (entry 5). 
 
Entry Catalyst (S)-TRIP (15 
mol%) 
Result 
1.110 : 2.17 
1 Pd(OAc)2 None 1 : 1.8 
2 Pd(OAc)2 Yes 0 : 1 
3 Pd(TFA)2 None 1 : 2 
4 Pd(TFA)2 Yes 0 : 1 
5 - Yes 1 : 0 
Table 2.20: Effect of (S)-TRIP of the conversion of starting material 1.110 
Thus far, very little success in developing a highly enantioselective palladium(II)-catalysed 
oxyallylation reaction of  unactivated alkenes had been achieved. With the evident 
catalytic effect (S)-TRIP was having on the reaction it was deemed worthwhile to screen 
other chiral phosphoric acids, with different bulky groups in the ortho-position (Scheme 
2.56).  Unfortunately, screening different phosphoric acids did not provide much success. 
Enantioselectivities varied from 0 – 15%. Large bulky tBu phosphoric acid 2.145 and 4-
mesityl benzene 2.146 only provided a racemic mixture of isobenzofuran 2.17. 4-
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Trifluoromethyl benzene 2.147 and 3,5-dimesityl benzene 2.148 gave low ee’s of 4% and 
5% respectively. Although higher enantioselectivities were achieved by 3,5-
dimethoxybenzene 2.149, 2,4,6-trimethyl benzene 2.150 and 3,5-ditrifluoromethyl 
benzene 2.151; however, the enantioselectivities observed were still disappointingly low, 
with ee’s of isobenzofuran 2.17 being 12%, 10% and 15% respectively (Scheme 2.56).   
 
NB- Chiral phosphonic acids kindly donated by the Watson Group, University of Strathclyde 
Scheme 2.56: Screening of chiral phosphoric acids 
2.2.2 Enantioselective Oxyallylation reaction of  Mono-substituted Alkenes 
The success of the 2-allyl phenol substrate 2.75, the only mono-substituted alkene 
substrate to undergo the oxyallylation reaction in favourable yields, prompted 
investigations into the possibility of developing an enantioselective oxyallylation reaction 
2-allyl phenol 2.75. Buoyed by the fact that many asymmetric oxypalladation reactions are 
known for similar substrates, and actually work better for mono-substituted alkenes,it was 
decided to opt for the traditional ligand plus Pd(II)-catalyst strategy.[18c] 
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Scheme 2.57: Oxyallylation reaction of 2-allyl phenol 2.75 
Screening was undertaken with bidentate nitrogen and phosphine ligands such as: (S)-
iPr-Quinox 2.120, (–)-sparteine 1.20, (S)-T-BINAP 2.116 and bisoxazoline 2.110 (Table 
2.21). The ligands were initially screened against PdCl2, however, no desired product was 
observed via 1H NMR of the crude material (entries 1 – 4). As a result, a change of tactic 
was employed, in the form of changing the catalyst to Pd(hfacac)2. As before, no product 
was observed and only starting material was recovered (entries 5 – 8). 
 
Entry Catalyst/ Ligand Result 
2.75 : 2.77 
1 PdCl2/ (S)-iPr-Quinox 2.120 1 : 0 
2 PdCl2/ (–)-sparteine 1.20 1 : 0 
3 PdCl2/ (S)-T-BINAP 2.116 1 : 0 
4 PdCl2/ bisoxazoline 2.110 1 : 0 
5 Pd(hfacac)2/ (S)-iPr-Quinox 2.120 1 : 0 
6 Pd(hfacac)2/ (–)-sparteine 1.20 1 : 0 
7 Pd(hfacac)2/ (S)-T-BINAP 2.116 1 : 0 
8 Pd(hfacac)2/ bisoxazoline 2.110 1 : 0 
Table 2.21: Screening of catalyst and ligand at room temperature 
The previous reactions were performed at room temperature. However, with no 
conversion to the desired benzofuran 2.77, the temperature was increased to 50 °C. The 
same experiments as before were performed,with the same result (Table 2.22, entries 1 – 
8). If the temperature was increased above 50 °C the formation of O-allylated side product 
2.145 formed preferentially. 
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Entry Catalyst/ Ligand Result 
2.75 : 2.77 
1 PdCl2/ (S)-iPr-Quinox 2.120 1 : 0 
2 PdCl2/ (–)-sparteine 1.20 1 : 0 
3 PdCl2/ (S)-T-BINAP 2.116 1 : 0 
4 PdCl2/ bisoxazoline 2.110 1 : 0 
5 Pd(hfacac)2/ (S)-iPr-Quinox 2.120 1 : 0 
6 Pd(hfacac)2/ (–)-sparteine 1.20 1 : 0 
7 Pd(hfacac)2/ (S)-T-BINAP 2.116 1 : 0 
8 Pd(hfacac)2/ bisoxazoline 2.110 1 : 0 
Table 2.22: Screening of ligands at 50 °C 
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2.3 Palladium-Catalysed Oxyallylation Conclusions 
The oxyallylation project has been divided into three sections: gem-disubstituted alkene 
substrates in the synthesis of lactones, the development of the mono-substituted alkene 
oxyallylation reaction in the synthesis of lactones and the enantioselective oxyallylation 
reaction. Gem-disubstituted substrates undergo the desired heterocyclistaion reaction and 
could be applied to a range of substrates in good yields (Figure 2.5). Benzoic acids, 
aliphatic acids, substitution on the aromatic ring as well as large bulky electron donating 
and electron withdrawing groups on the alkene could all be tolerated under the optimised 
conditions.  
 
Figure 2.4: Successful oxyallylation reaction substrates in the synthesis of lactones 
Attempts to extend the oxyallylation reaction to incorporate lactones from a mono-
substituted alkene, in good yield, have proved challenging. The desired 5- and 6-
membered lactones suffered from poor conversion in some cases, or the predominant 
reaction pathway forming unwanted side products. Attempts to redirect the reaction 
pathway towards synthesising the oxyallylated lactone products in a synthetically viable 
yield have, thus far, remained elusive. Changes in temperature, catalyst, base allyl halide, 
concentration and the addition of additives have proved unsatisfactory.  
 
Additionally, the oxyallylation reaction has been made enantioselective, the first of its kind 
for gem-disubstituted alkene substrates. However, the enantioselectivities are still low and 
require further optimisation for it to be synthetically viable. Attempts at developing an 
enantioselective oxyallylation reaction for mono-substituted alkene substrates returned 
none of the desired product, racemic or enantioenriched. 
 
 
 
89 
 
2.4 Copper-Facilitated Oxyallylation Reaction of Unactivated 
Alkenes 
Copper-catalysed oxycyclisations are known in the literature and have given rise to new 
reactivity and products. Recently, the synthesis of heterocycles has particularly piqued the 
interest of organic chemists. The low cost of copper salts also helps its appeal and their 
ability to move between oxidation states of 0 to +3 allows for rich mechanistic 
possibilities.[107] Copper has an affinity for amines and alcohols as well as π bonds, so 
makes it an attractive metal in the synthesis of heterocycles. Recent reports by Chemler 
and co-workers have demonstrated the enantioselective copper(II)-catalysed 
intramolecular[108] and intermolecular[109] carboetherification reaction of unactivated 
alkenes (Scheme 2.58). Herein, high yields and high enantioselectivities are reported.  
 
Scheme 2.58: Copper(II)-catalysed carboetherification of unactivated alkenes 
The mechanism for each reaction is proposed to follow similar pathways. Oxycupration 
occurs across the alkene with a concomitant formation of an unstable alkylcopper(II) 
species 2.151 (Scheme 2.59). This undergoes homolysis to generate a copper(I) side 
product and a carbon radical 2.152. In the case of the intramolecular carboetherification 
reaction, the radical adds to a tethered arene and subsequent re-aromatisation in 
oxidising conditions provides the desired bicyclic product 2.153. The intermolecular 
carboetherification reaction the carbon radical intermediate 2.152 is intercepted by a vinyl 
arene. Subsequent oxidation results in the desired compound 2.154 (Scheme 2.59). 
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Scheme 2.59: Proposed intra- and intermolecular carboetherification mechanism 
In 2015, a copper(I)-catalysed hydroalkoxylation reaction of unactivated alkenes was 
reported.[110] Starting with aliphatic alcohol 2.150, the use of CuMes at 10 mol%, Xantphos 
at 10 mol% in toluene at 100 °C for 24 h generated the desired tetrahydrofuran derivative 
2.155 in an excellent 97% yield (Scheme 2.60). Additionally, the authors report that an 
enantioselective version has been developed – the first of its kind. 
 
Scheme 2.60: Copper(I)-catalysed intramolecular hydroalkoxylation of unactivated 
alkenes 
It is well known in the literature, that a common way to synthesise copper(I) alkoxides is 
with mesitylcopper(I) in the presence of an alcohol (Scheme 2.61).[111] Once the Cu−O 
bond is formed the copper in intermediate 2.156 coordinates to the terminal π bond 
forming intermediate 2.157. The insertion of the alkene into the Cu−O bond of the 
copper(I) alkoxide affords the heterocyclised copper(I) intermediate 2.158. Finally, 
protonolysis of the heterocyclised copper(I) intermediate 2.158 affords the desired 
compound 2.155. 
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Scheme 2.61: Proposed catalytic cycle for copper(I)-catalysed intramolecular 
hydroalkoxylation 
Buchwald and co-workers have employed carboxylic acids in copper-catalysed cyclisation 
reactions and as such this led to the use of benzoic acid substrate 2.10 in preliminary 
investigations.[112] Based on the studies described above, a copper-catalysed oxyallylation 
study was undertaken. The ability of both copper(I) and copper(II) salts to induce 
heterocyclisation reactions led to a screening of various copper salts (Table 2.23).  As a 
starting point for the copper-catalysed oxyallylation reaction, the conditions utilised were 
similar to those in the palladium(II)-catalysed oxyallylation reaction. Screening various 
copper salts proved successful. With the use of Cu(hfacac)2 or Cu(acac)2 at 5 mol% 
loading, trace amounts of the desired oxyallylation product 2.13 was observed (entries 7 
and 8). All other copper salts did not return any of the desired product. 
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Entry Copper Salt 
(5 mol%) 
Result 
(2.13) 
1 CuBr Not Detected 
2 CuCN Not Detected 
3 CuI Not Detected 
4 CuCl2 Not Detected 
5 CuBr2 Not Detected 
6 Cu(ClO4)2 Not Detected 
7 Cu(hfacac)2 Trace 
8 Cu(acac)2 Trace 
9 Cu(OAc)2 Not Detected 
10 Cu(SO4)2 Not Detected 
Table 2.23: Initial copper salt investigation 
With Cu(acac)2 and Cu(hfacac)2 forming trace amounts of the desired lactone with a 
catalyst loading of 5 mol% the next step was to increase the loading (Table 2.24). 
Increasing the copper(II) loading of Cu(acac)2 to 20 mol%, 100 mol% and 300 mol% 
resulted in no formation of the desired lactone 2.13 (entries 1 – 3). Next, the Cu(hfacac)2 
loading was increased to 20 mol%, 100 mol% and 300 mol%; however, each experiment 
only resulted in trace amounts of the desired lactone 2.13 (entries 4 – 6). 
 
Entry Copper Salt 
(mol%) 
Result 
(2.13) 
1 Cu(acac)2 (20 mol%) Not Detected 
2 Cu(acac)2 (100 mol%) Not Detected 
3 Cu(acac)2 (300 mol%) Not Detected 
4 Cu(hfacac)2 (20 mol%) Trace 
5 Cu(hfacac)2 (100 mol%) Trace 
6 Cu(hfacac)2 (300 mol%) Trace 
Table 2.24: Increase loading of copper(II) salts 
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The lack of improvement observed when increasing the copper(II) salt loading led to the 
screening of Cu(hfacac)2 with benzylic alcohol 1.110 (Table 2.25). Unfortunately, the use 
of 20 mol%, 100 mol% and 300 mol% loading of Cu(hfacac)2 resulted in no formation of 
isobenzofuran 2.17 (entries 1 – 3). 
 
Entry Cu(hfacac)2 (mol%) Result (2.17) 
1 20 mol% Not Detected 
2 100 mol% Not Detected 
3 300 mol% Not Detected 
Table 2.25: Screening of Cu(hfacac)2  loading with benzylic alcohol 1.110 
Phenol 1.83 was also screened with various loadings of Cu(hfacac)2 (Table 2.26). At 20 
mol% of Cu(hfacac)2 no benzofuran 2.16 was formed (entry 1). However, when the 
Cu(hfacac)2 loading was increased to 100 mol%, the desired benzofuran 2.16 was 
observed (entry 2). When the Cu(hfacac)2 loading was increased further to 300 mol% the 
ratio improved again and afforded the benzofuran 2.16 in a 28% yield (entry 3). 
 
Entry Cu(hfacac)2 
(mol%) 
Result  
1.83 : 2.16 
1 20 mol% Not Detected 
2 100 mol% 2.0 : 1.0 
3 300 mol% 1.2 : 1.0 (28%) 
Table 2.26: Screening of Cu(hfacac)2 loading with phenol 1.83 
With Cu(hfacac)2 at 300 mol% still returning large amounts of unreacted starting material, 
other copper salts were screened (Table 2.27). Unfortunately, no desired benzofuran 2.16 
was detected, irrespective of copper salt employed (entries 1 – 5). 
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Entry Copper Salt (300 
mol%) 
Result  
(2.16) 
1 CuBr Not Detected 
2 CuI Not Detected 
3 CuBr2 Not Detected 
4 Cu(OAc)2 Not Detected 
5 Cu(acac)2 Not Detected 
Table 2.27: Copper salt screen with phenol substrate 1.83 
With Cu(hfacac)2 as the best copper salt, the solvent applied in the oxyallylation reaction 
was investigated (Table 2.28). As can be seen below, the use of aprotic, non-polar 
solvents such as hexane and CH2Cl2 favours the Cu(hfacac)2  facilitated oxyallylation 
reaction of unactivated alkenes (entries 2 and 3). When hexane and CH2Cl2 were 
employed equal amounts of phenol 1.83 and benzofuran 2.16 were observed via analysis 
of the 1H NMR of the crude material. 
 
Entry Solvent (0.3 M) Result  
1.83 : 2.16 
1 MeCN 1 : 0 
2 CH2Cl2 1 : 1 
3 Hexane 1 : 1 
4 tert-Amyl-OH 1 : 0 
5 EtOAc 1 : 0 
6 THF 1 : 0 
Table 2.28: Solvent screen for the Cu(hfacac)2 facilitated oxyallylation reaction 
To conclude, the results obtained for phenol substrate 1.83 serve as a promising start. 
The inability to achieve full conversion even with super stoichiometric metal led to 
cessation. 
 
95 
 
2.5 The Pd(II)-Catalysed Arylallylation of Activated Alkenes 
The following section proposes a Pd(II)-catalysed arylallylation reaction of activated 
alkenes, inspired by recent reports in the literature. In 2010, Zhu and co-workers reported 
the Pd(II)-catalysed oxidative hetero-functionalisation of acrylanilide derivitives 2.159, with 
both C–C and C–X bond formation (Scheme 2.62).[113] With Pd(OAc)2 in acetic acid at 100 
°C, it was noted that the carboacetoxylated product 2.160 was formed. A change of 
conditions with the use of PdCl2 in MeCN at 80 °C resulted in the carboaminated product 
2.161. 
 
Scheme 2.62: Zhu and co-workers Pd(II)-catalysed synthesis of oxindoles 
Palladium(II)-catalysed oxidative dicarbonation of alkenes is a challenging transformation. 
The Liu group, in 2011, published an intriguing paper where oxindoles 2.162 are 
synthesised through an oxidative arylalkylation of activated alkenes (Scheme 2.63).[114] In 
one step, the alkene undergoes a dicarbonation reaction forming a sp2–sp3 C–C bond and 
a sp3–sp3 C–C bond. 
 
Scheme 2.63: Liu and co-workers Pd(II)-catalysed arylalkylation of activated alkenes 
Mechanistic investigations were conducted by Liu and co-workers and based on the 
evidence gathered the following mechanism was proposed (Scheme 2.64). Co-ordination 
of the palladium(II) salt to the alkene, followed by nucleophilic attack from the aromatic 
ring to give complex 2.165. Sp3 C–H activation occurs next, which is promoted in the 
presence of PhI(OPiv)2 and AgF to generate palladium(IV) intermediate 2.166. Lastly, 
reductive elimination occurs to give oxindole 2.162 and regenerates the palladium(II) 
catalyst. 
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Scheme 2.64: Proposed mechanism for the oxidative arylalkylation of activated alkenes 
Liu et al. also reported the oxidative aryltrifluoromethylation of activated alkenes (Scheme 
2.65).[115] Herein, inexpensive trifluoromethylating reagent in TMSCF3 was employed and 
the development of an efficient way to synthesise CF3-substituted oxindoles was 
described. Oxindoles such as 2.167 are biologically active and trifluoromethylating 
techniques can be of great use (Scheme 2.65). Mechanistic studies indicate that the 
mechanism for the reaction is similar to that depicted above.  
Scheme 2.65: Pd(II)-catalysed aryltrifluoromethylation of activated alkenes 
Using the Zhu and Liu  papers as the foundation of the work, the aim of the project within 
the France group was to submit acrylanilide 2.159 to similar palladium(II)-catalysed 
conditions, involving an electrophilic allyl halide (Scheme 2.66). Hypothetically, the 
palladium(II)-induced arylpalladation would lead to intermediate 2.170, which 
carbopalladates onto the allyl species followed by β-halide elimination to give the oxindole 
2.169. If successful, there will be many advantages to synthesising oxindoles using this 
methodology: 
97 
 
1) due to the isohypsic mechanism, no oxidants are required 
2) the alkene undergoes a dicarbonation reaction forming an sp2–sp3 C–C bond and 
a sp3–sp3 C–C bond and, as previously mentioned, is rare in Pd(II)-catalysed 
alkene difunctionalisation reactions 
3) terminal alkene in oxindole product can be used as a handle for further 
transformations 
4)  with the C–H functionalisation reaction the prefunctionalisation of the substrate is 
not required to induce cyclisation. 
 
Scheme 2.66: Proposed methodology for the synthesis of oxindoles 
The bioactive nature of oxindoles makes them ideal targets in the synthesis of 
pharmaceuticals. Success of the project would lead to the synthesis of a potential target, 
SSRI Amedalin 2.172 (Figure 2.5).[116] 
 
Figure 2.5: SSRI Amedalin 2.172 
Initially, conditions screened were focused on the oxyallylation reaction developed within 
the France group as the final step in the proposed mechanism, β-halide elimination, is the 
same. Starting with Pd(hfacac)2 as the catalyst at 50 °C, using either allyl chloride or allyl 
bromide, resulted in no conversion. As a result, the temperature of the reaction was 
increased to 100 °C, but no conversion to the desired oxindole 2.169 was observed via 1H 
NMR analysis of the crude mixture (Table 2.29, entries 1 and 2). In conjunction with the 
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aforementioned experiments, reactions were conducted using the analagous conditions 
albeit with a change of catalyst to Pd(O3STol)2(MeCN)2 (entries 3 and 4). Cationic 
Pd(O3STol)2(MeCN)2 was selected because it is very electrophilic, and according to the 
mechanisms proposed by Liu et al., this feature could prove useful in the arylpalladation 
step. With this hypothesis, it was disappointing to observe, via 1H NMR analysis of the 
crude mixture, that there was no conversion to the desired product 2.169. 
 
Entry Pd(II) 
(10 mol%) 
Temp. 
(°C) 
Allyl 
X 
Result 
2.159 : 2.169 
1 Pd(hfacac)2 50 – 100 Br 1 : 0 
2 Pd(hfacac)2 50 – 100 Cl 1 : 0 
3 Pd(O3STol)2(MeCN)2 50 – 100 Br 1 : 0 
4 Pd(O3STol)2(MeCN)2 50 – 100 Cl 1 : 0 
Table 2.29: Initial screening conditions for the attempted synthesis of oxindole 2.169 
The success of Zhu and co-workers carboactetoxylation reaction led us to try conditions 
analogous to those outlined above. As such, Pd(OAc)2at 10 mol% and acetic acid as the 
solvent at 100 °C was employed. Initially, the reactions were performed without any 
additives at 0.1 M; however, this resulted in only unreacted starting material (Table 2.30, 
entries 1 and 2). The addition of PhI(OAc)2  replicating Zhu’s conditions, at 0.1 M 
concentration, resulted in no conversion to the desired product (entries 3 and 4). 
Increasing the concentration to 1.0 M, with the addition of PhI(OAc)2, also resulted in none 
of the desired oxindole 2.169. 
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Entry  Concentration 
(M) 
Allyl X Additive 
(equiv.) 
Result 
2.159 : 2.169 
1 0.1  Br - 1 : 0 
2 0.1 Cl - 1 : 0 
3 0.1 Br PhI(OAc)2  (2) 1 : 0 
4 0.1 Cl PhI(OAc)2  (2) 1 : 0 
5 1.0  Br PhI(OAc)2  (2) 1 : 0 
6 1.0  Cl PhI(OAc)2  (2) 1 : 0 
Table 2.30: Attempted arylallylation of activated alkene using Zhu’s conditions 
Literature examples show that the palladium-catalysed synthesis of oxindoles were often 
performed successfully when Pd(OAc)2 was the catalyst and MeCN wasthe solvent and, 
as such, were kept constant for the following reactions. The reactions listed below, 
indicate attempts at optimising the arylallylation reaction. The use of various bases, metal 
salts, ligands and combinations thereof, whilst varying the allyl halide species, garnered 
none of the desired arylallylated product 2.169, which was deemed so via 1H NMR 
analysis of the crude material (Table 2.31, entries 1 – 13). 
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Entry Allyl X Additive (Equiv.) Result 
2.159 : 2.169 
1 Br NaHCO3 (2) 1 : 0 
2 Cl NaHCO3 (2) 1 : 0 
3 Br NaHCO3 (2), AgF (4) 1 : 0 
4 Cl NaHCO3 (2), AgF (4) 1 : 0 
5 Br NaHCO3 (2), CsF (4) 1 : 0 
6 Cl NaHCO3 (2), CsF (4) 1 : 0 
7 Br NaHCO3 (4), AgNO3 (4) 1 : 0 
8 Cl NaHCO3 (2), AgNO3 (4) 1 : 0 
9 Br NaHCO3 (2), AgNO3 (4), BiPy 
(0.12) 
1 : 0 
10 Br NaHCO3 (2), AgF (4), BiPy (0.12) 1 : 0 
11 Br NaHCO3 (2), CsF (4), BiPy (0.12) 1 : 0 
12 Br NaHCO3 (2), BiPy (0.12) 1 : 0 
13 Br NaHCO3 (2), CsF 
(4),Yb(OTf)3.xH2O (0.2) 
1 : 0 
Table 2.31: Attempted optimisation of arylallylation reaction 
The desired product was eventually observed via 1H NMR analysis of the crude mixture 
(Table 2.32). The result arose when the conditions employed were similar to those used 
by Zhu and co-workers to synthesise spirooxindole 2.161 (Scheme 2.62). Initially, catalyst 
PdCl2 was utilised as the Zhu group achieved success using this Pd(II) salt (entries 1 and 
2).  Unfortunately, no conversion to the desired product was observed and starting 
material was left unreacted. The catalyst was then varied to Pd(hfacac)2 as it is more 
electrophilic than its PdCl2 counterpart and previous success was achieved when it was 
used as the catalyst in the oxyallylation reactions developed within the France group 
(entries 3 and 4). When allyl bromide was the electrophile, the desired product was 
observed (entry 3). This result could not be produced with regularity, with the best ratio 
shown. Attempts at reproducing this result often only returned acrylanilide 2.159. 
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Entry Pd(II) 
(10 mol%) 
Allyl 
X 
Result 
2.159 : 2.169 
1 PdCl2 Br 1 : 0 
2 PdCl2 Cl 1 : 0 
3 Pd(hfacac)2 Br 7.7 : 1 
4 Pd(hfacac)2 Cl 1 : 0 
Table 2.32: Palladium(II)-catalysed arylallylation reaction of activated alkene 
Although encouraging, improvements and consistency were desired. With this, a series of 
metal salts were added to the reaction in an attempt to improve upon the ratio of starting 
material to desired oxindole 2.169 (Table 2.33). Unfortunately, no improvements were 
observed and all reactions only returned starting material (entries 1 – 6).  
 
Entry Additive 
(2 equiv.) 
Result 
2.159 : 2.169 
1 KOAc 1 : 0 
2 NaHCO3 1 : 0 
3 K2CO3 1 : 0 
4 Cs2CO3 1 : 0 
5 KH2CO3 1 : 0 
6 AgOAc 1 : 0 
Table 2.33: Effect of metal salts on arylallylation reaction 
The lack of improvement observed with the addition of metal salts, prompted an 
investigation into the change of solvent, with all other conditions remaining constant 
(Table 2.34). Irrespective of the solvent employed, no desired oxindole 2.169 was 
observed via 1H analysis of the crude material (entries 1 – 9). 
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Entry Solvent 
(0.1 M) 
Result 
2.159 : 2.169 
1 Dioxane 1 : 0 
2 tert-Amyl-OH 1 : 0 
3 Toluene 1 : 0 
4 EtOAc 1 : 0 
5 THF 1 : 0 
6 EtOH 1 : 0 
7 TFE 1 : 0 
8 CH2Cl2 1 : 0 
9 C2H4Cl2 1 : 0 
Table 2.34: Solvent screen for arylallylation reaction 
With the addition of metal salts and a change of solvent proving fruitless, a change in 
catalyst was next investigated (Table 2.35). Irrespective of palladium salt employed at 80 
°C, no desired product 2.169 was observed (entries 1 – 7). The lack of success, instigated 
revisiting the original reaction with Pd(hfacac)2 however with the temperature increased 
from 80 °C to 100 °C (entry 8). However, none of the desired oxindole 2.169 was 
observed at the elevated temperature. 
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Entry Pd Catalyst Allyl X Temp. (°C) Result 
2.159 : 2.169 
1 Pd(OAc)2 Br 80 1 : 0 
2 Pd(OAc)2 Cl 80 1 : 0 
3 Pd(TFA)2 Br 80 1 : 0 
4 Pd(TFA)2 Cl 80 1 : 0 
5 Pd(PPh3)4 Br 80 1 : 0 
6 Pd(dba)3 Br 80 1 : 0 
7 Pd(allyl)(Cl) Br 80 1 : 0 
8 Pd(hfacac)2 Br 100 1 : 0 
Table 2.35: Catalyst screen for arylallylation reaction 
In summary, preliminary results prove that arylallylation of activated alkenes can be 
achieved. However, attempts to improve on the ratio (Table 2.32, entry 3), have remained 
difficult with reproducibility also an issue.  
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2.6 Sequential sp3 C–H Activation–Cyclisation Towards the 
Synthesis of Heterocycles 
In 2005, Daugulis and co-workers reported the use of a quinoline directing group in the 
activation of sp3 C–H bonds at the β-position.[117] Herein, it was reported that the coupling 
of amides with aryl iodides in good yields (Scheme 2.67). In this seminal publication, an 
entire field of palladium-catalysed sp3 C–H activation using transition metal catalysis was 
created. 
 
Scheme 2.67: Sp3 C–H activation–arylation reaction 
The practicality of palladium-catalysed quinolone-directed sp3 C–H bond activated 
methodology in synthesis was epitomised in a report by Baran and co-workers.[118] The 
synthesis of the proposed structure of Pipercyclobutanamide A 2.179, included key steps 
that were performed using quinoline as a directing group (Scheme 2.68). 
 
Scheme 2.68: Pipercyclobutanamide A 2.179 
Since the seminal Daugulis report, numerous publications have been released detailing 
the use of the quinoline directing group in Pd(II)-catalysed C–H activation reactions.[119] 
Below, in the coupling of (2-bromoethynyl)triisopropylsilane with amide 2.180 is a coupling 
reaction that has a significance to the sp3 C–H activation methodology the France group 
wishes to develop (Scheme 2.69).[119a] This one example, demonstrates that sp3 C–H 
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activation, using the quinoline directing group, can occur with an alkoxy group bonded to 
the β-position of an amide.  
 
Scheme 2.69: Sp3 C–H activation of β-methoxy amide 2.181 
The use of the quinoline directing group in the palladium-catalysed sp3 C–H activation of 
β-methoxy amide 2.180 provided the inspiration that heterocycles could be synthesised 
using the quinolone directing group. The hypothesis: starting with substrate 2.182 and 
using a Pd(II)-catalyst, sp3 C–H activation in the β-position would give palladated 
intermediate 2.184. Next, the palladacycle intermediate 2.184 would carbopalladate to 
give 2,3-disubstituted furan intermediate 2.185. Subsequent β-hydride elimination would 
yield the desired product 2.183. 
 
Scheme 2.70: Proposed sp3 C–H activation–cyclisation methodology 
The synthesis of amide 2.182 began with reduction of commercially available pentenoic 
acid 2.186 to yield pentenol 2.187, which was used directly without further purification 
(Scheme 2.71).[120] Coupling of pentenol 2.187 with tert-butyl acrylate gave ester 
intermediate 2.188.[121] Next, the ester bond was hydrolysed using TFA in CH2Cl2.
[121] With 
aliphatic acid 2.189, the acid chloride was formed in situ, which was coupled with 8-
aminoquinoline to yield the desired amide 2.182.[122] 
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Scheme 2.71: Synthesis of amide 2.182 
Using a number of conditions found in the literature (such as those observed in Scheme 
2.69), conditions for the proposed sp3 C–H activation–cyclisation methodology were 
screened.[119b] The palladium catalyst, Pd(OAc)2, was constant throughout all the 
reactions. Additionally, the temperature was kept constant at 110 °C. This was because 
successful sp3 C–H activations, using similar substrates to amide 2.182, were subjected to 
Pd(OAc)2 and high temperatures. Different solvents and additives were screened that had 
previously proved successful in other systems (Table 2.36). Screening conditions have 
proven unsuccessful; no cyclised products have been observed via 1H NMR of the crude 
mixture (entries 1 – 14).The only product observed throughout the initial screening was 
2.190, which is formed by ortho-C–H activation. 
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Entry Solvent (Conc.) Additives (equiv.) Result 
2.182 : 2.183 
1 Toluene (0.2 M) AgOAc (1.2), BQ (2) 1: 0 
2 Toluene (0.2 M) AgOAc (1), LiCl (1) 1: 0 
3 Toluene (0.2 M) Cu(OAc)2 (1), Cs2CO3 (1) 1: 0 
4 Toluene (0.2 M) AgOAc (1), Cs2CO3 (1) 1: 0 
5 HFIP (1.0 M) AgOAc (3) 1: 0 
6 tBuOH (0.2 M) AgOAc (1.5) 1: 0 
7 tBuOH (0.2 M) Ag2CO3(1) 1: 0 
8 tBuOH (0.2 M) AgOAc (1), BQ (0.1) 1: 0 
9 tBuOH (0.2 M) AgCO3 (1), PivOH (1) 1: 0 
10 tBuOH (0.2 M) K2CO3 (2.5), PivOH (0.2) 1: 0 
11 tBuOH (0.2 M) AgCO3 (1), PivOH (0.2) 1: 0 
12 MeOH (0.2 M) DMP (2) Decomp. 
13 tert-Amyl-OH (0.5 M) K2CO3 (3.5), PivOH (0.5) 1: 0
a 
14 Toluene (0.2 M) PhI(OAc)2 (2.5), AcOH (2) -
b 
a
Catalyst used was Pd(TFA)2 (30 mol%)
b
Side product formed 
Table 2.36: Attempted optimisation of sp3 C–H activation–cyclisation methodology 
To conclude, preliminary investigations have proved unsuccessful. No cyclic compounds 
have been detected via 1H NMR analysis of the crude material.  
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3. Palladium-Catalysed Isohypsic−Redox Sequence 
3.1 Introduction and Aims 
Transition metal catalysis is amongst the most commonly used techniques by organic 
chemists to construct new bonds. The vast majority of the transition metal catalysed 
reactions proceed via redox transformations, with respect to the metal catalyst. The 
success of palladium catalysis in recent decades has seen this particular metal become a 
key method[123] in the synthesis of pharmaceuticals[124] and natural products.[49] Most 
palladium-catalysed reactions follow a well-known and studied course: oxidative addition, 
transmetallation and reductive elimination (Scheme 1.31). Here, the palladium centre 
proceeds through a Pd(0)/Pd(II) cycle. However, a small number of palladium-catalysed 
reactions occur without changes to the oxidation state of the metal centre, i.e. are redox-
neutral or isohypsic, with the palladium in the +2 oxidation state throughout the catalytic 
cycle (see Chapter 1 for review).  
The differences in mechanism between a palladium-catalysed redox reaction and a 
palladium-catalysed isohypsic reaction allows for orthogonal reactivity. In an isohypsic 
process, chemical functionality on the molecule will be inert to the palladium(II) catalyst; 
however, by altering the oxidation state of the metal, through addition of a new reagent, 
the manipulation of other functional groups can be performed through traditional 
palladium-catalysed redox chemistry (Scheme 3.1). 
 
Scheme 3.1: Overview of isohypsic−redox sequence 
The isohypsic−redox sequence has a number of advantages. Firstly, product diversity 
through “plug and play” with different palladium-catalysed isohypsic and redox processes. 
Secondly, molecular complexity can be greatly enhanced through multiple bond forming 
reactions. Thirdly, one metal catalyses two processes, making the isohypsic−redox 
sequence efficient and economical. Switching from an isohypsic to a redox manifold is an 
example of “assisted tandem catalysis”[125] where one metal source can effect two 
separate catalytic processes. Through the addition of different reagents at specific points, 
one has the ability to control the change in mechanism. Although the use of an 
isohypsic−redox sequence has the potential for broad utility across organic chemistry, 
very seldom has it been used in Pd-catalysis and never in the context of alkene 
difunctionalisation.[126] 
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As discussed previously, within the France group the development of an isohypsic 
palladium(II)-catalysed alkene difunctionalisation reaction that forms a heterocycle with a 
concomitant sp3−sp3 C−C bond. In this chapter, the development of an Isohypsic−Redox 
Sequence (IRS) based on combining the isohypsic heteroallylation reaction with the more 
traditional redox chemistry such as: Suzuki−Miyaura, Sonogashira and Buchwald−Hartwig 
cross coupling reactions as well as the Wacker oxidation and the 
Feringa−Grubbs−Wacker oxidation (Scheme 3.2).[126c, 127] 
 
Scheme 3.2: Proposed IRS 
3.2 IRS –The  Suzuki−Miyaura Iteration 
Identifying a possible substrate that can combine the oxyallylation reaction and one which 
contains a functional handle that can be used in palladium-catalysed redox reactions was 
the first priority. Bromophenol 3.1 has successfully performed the oxyallylation reaction to 
generate the desired bromobenzofuran 3.2 in good yield, with the bromide remaining 
intact, in the all Pd(II) catalytic process (Scheme 3.3).  
 
Scheme 3.3: Isohypsic oxyallylation reaction with bromide handle 
Synthesis of the desired bromophenol 3.2 was undertaken following a procedure 
established in the group. Allylation of p-bromophenol 3.3 in the presence of 3-chloro-2-
methylpropene, K2CO3 in DMF at 70 °C proceeded in excellent yield to furnish the O-
allylated product 3.4. Subjecting the O-allylated product 3.4 to microwave radiation at 240 
°C for 30 minutes afforded the desired bromophenol 3.1 in a 72% yield (Scheme 3.4). 
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Scheme 3.4: Synthesis of bromophenol 3.1 
It was deemed prudent to start optimisation for the IRS with the Suzuki−Miyaura reaction. 
Primarily, this is because it is the most commonly used C−C bond forming reaction used 
by medicinal chemists.[128] With the isohypsic reaction already optimised, the investigation 
started from the already heterocyclised bromobenzofuran 3.2, in order to develop the 
redox Suzuki−Miyaura cross coupling reaction separately, before combining the two 
processes. SPhos was chosen as the ligand because it is commonly and successfully 
used in many Suzuki−Miyaura cross coupling reactions (for the structure, see Table 3.3). 
The base used in the oxyallylation reaction, NaHCO3, was first used in the 
Suzuki−Miyaura cross coupling reactions (Table 3.1). Starting at 50 °C the reaction 
afforded no desired product 3.5, and only returned starting material (entry 1). The reaction 
temperature was increased to 80 °C, however, no conversion was observed via TLC, and 
as such the temperature was further increased to 100 °C, yet only returned isomerised 
material 3.6, exclusively (entry 2). Employing conditions analogous to those found in the 
literature,[129] K3PO4 was used as the base. Two equivalents of base with 1.5 equivalents 
of phenyl boronic acid at 50 °C resulted in formation of the isomerised material 3.6 (entry 
3). To improve the conversion, the equivalents of base and boronic acid were increased 
as well as the temperature, and to reduce isomerisation the concentration was decreased, 
however, unwanted isomerised material 3.6 was the main product, and complete 
conversion of the starting material was not observed (entry 4). Next, three equivalents of 
base, phenylboronic acid at 0.5 M at 50 °C for 24 h was tried and resulted in complete 
conversion of starting material to the unwanted isomerised product 3.6 (entry 5). This 
result led to the same experimental conditions performed but with a shorter running time 
(entry 6). The desired Suzuki−Miyaura product 3.5 was observed, however, the starting 
material was still present. K3PO4, phenyl boronic acid and time were all reduced next, with 
the temperature being increased to 100 °C (entry 7). This resulted in unwanted isomerised 
product 3.6 and incomplete conversion of the starting material. The conditions were 
repeated, however, the temperature was reduced to room temperature and the reaction 
was run for 48 h but only returned starting material (entry 8). Based on the above results, 
K3PO4 and phenyl boronic acid equivalents were increased to 3 apiece, and the reaction 
was performed at 50 °C for 16 h (entry 9). This resulted in the sole formation of desired 
Suzuki−Miyaura product 3.5, with a small amount of starting material.  Analagous 
conditions were employed, however, the reaction was allowed to stir for slightly longer at 
19 h in order to allow complete conversion of starting material and also limit the synthesis 
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of isomerised product 3.6 (entry 10). This resulted in the complete conversion to the 
desired Suzuki−Miyaura product 3.5. Similar conditions were explored with the 
equivalents of K3PO4 lowered from 3 to 2 which, again, resulted in the complete 
conversion to the desired Suzuki−Miyaura product 3.5 (entry 11). Finally, 2 equivalents of 
base and phenyl boronic acid were utilised, however, this resulted in incomplete 
conversion to the desired product 3.5 (entry 12). Based on the above, the conditions 
developed in Table 3.1 entry 11 were employed in the full IRS sequence. 
 
Entry Base (equiv.) Toluene 
(Conc.) 
Boronic 
Acid 
(equiv.) 
Time 
(h) 
Temp. 
°C 
Result 
3.2 : 3.5 : 3.6 
1 ΝaΗCΟ3 (2) 0.3 Μ 1.5 24  50 1.0 : 0.0 : 0.0 
2 ΝaΗCΟ3 (2) 0.3 Μ 1.5 24  80−100 0.0 : 0.0 : 1.0 
3 K3PO4 (2) 0.5 Μ 1.5 24  50 3.3 : 0.0 : 1.0 
4 K3PO4 (3) 0.3 M 2.0 24 100 1.0 : 0.0 : 2.5 
5 K3PO4 (3) 0.5 M 3.0 24 50 0.0 : 0.0 : 1.0 
6 K3PO4 (3) 0.5 M 3.0 5  50 1.0 : 3.4 : 0.0 
7 K3PO4 (2) 0.5 M 2.0 3.25  100 1.0 : 0.0 : 5.0 
8 K3PO4 (2) 0.5 M 2.0 48  rt 1.0 : 0.0 : 0.0 
9 K3PO4 (3) 0.5 M 3.0 16  50 1.0 : 4.2 : 0.0 
10 K3PO4 (3) 0.5 M 3.0 19  50 0.0 : 1.0 : 0.0 
11 K3PO4 (2) 0.5 M 3.0 19  50 0.0 : 1.0 : 0.0 
12 K3PO4 (2) 0.5 M 2.0 19  50 1.0 : 7.0 : 0.0 
Table 3.1: Optimisation of Suzuki−Miyaura reaction 
Utilising the previously mentioned optimal conditions, the first palladium-catalysed 
isohypsic–redox sequence was successfully performed resulting in the desired IRS 
product 3.5 in a 65% yield overall (Scheme 3.5). It was a relief that the combination of 
both the isohypsic oxyallylation reaction and the newly optimised Suzuki−Miyaura 
coupling worked well, with only the reaction time of the Suzuki−Miyaura reaction having to 
be shortened from 19 h to 16 h. The first step of the sequence, the oxyallylation of phenol 
3.1 was performed using a 5 mol% Pd(II) catalyst in presence of base, NaHCO3, and allyl 
chloride. The reaction proceeded with full conversion to cyclised intermediate 3.2 which 
was then subjected to a Suzuki−Miyaura coupling with different aromatic boronic acids. As 
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can be seen below, only the naphthalene derived IRS product 3.8 and 4-methoxy 
phenylproduct 3.9 derivatives were found. However, compared to the phenyl derivative 
3.5, there was a decrease in the overall yield. Furthermore, the 4-cyano-phenyl 3.10, 3-
pyrrole 3.11 and 2-furanyl 3.12 IRS products were not isolated.  
 
Scheme 3.5: Oxyallylation combined with the Suzuki−Miyaura reaction 
In an attempt to improve the yield of the IRS naphthalene 3.8 and phenyl methoxy 3.9 
derivatives, the equivalents of the freshly ground K3PO4 were increased from 2 to 3. In 
both cases, the yield increased; therefore, the new overall yield was 78% for the 
naphthalene 3.8 and 50% for the 4-methoxyphenyl 3.9 compounds (Scheme 3.6).[130] 
Additionally, 2-acetylphenyl derivative 3.13 worked well with a 46% yield over two steps.  
 
Scheme 3.6: Substrate scope of Suzuki−Miyaura IRS sequence 
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To ascertain whether three equivalents of K3PO4 is the optimal quantity in this case, a 
study was conducted for the phenyl derivative 3.5. As can be seen from Table 3.2, entry 
3, the highest overall yield was achieved when three equivalents of base were employed. 
The yield decreased when the equivalents were further increased to four or five (entry 3 or 
4). 
 
Entry Equivalents of K3PO4 Yield (3.5) 
1 2 65% 
2 3 68% 
3 4 60% 
4 5 55% 
Table 3.2: Investigation into the equivalents of K3PO4 
This new optimisation was then further tested when a scale-up for the formation of the 
desired IRS product 3.5 was performed. Therefore, the reaction was run with 0.2, 0.6 and 
1.8 mmols of phenol starting material 3.1. The overall yields were maintained around 65–
68%, ergo, consistency was ensured.  
Furthermore, thienyl boronic acids were tested (Scheme 3.7). When 2-thienyl boronic acid 
was used, no desired IRS product 3.14 formation was observed via analysis of the 1H 
NMR of the crude material. As trace amounts of the 3-thienyl compound 3.15 were 
observed in the crude NMR, the literature was consulted to determine whether thienyl 
boronic acids were suitable for the Suzuki−Miyaura reaction.[130] 
 
Scheme 3.7: Thienyl boronic acid screen 
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Buchwald and co-workers reported that the formation of the 3,3’-bithiophene 3.18 as a by-
product will have a negative effect on the coupling reaction between 3-thienyl boronic acid 
and aryl chloride 3.16 when SPhos is used as a ligand (Table 3.3, entry 2).[131] Through 
changing the ligand to XPhos, the formation of the bithiophene 3.18 had no influence on 
the Suzuki−Miyaura coupling reaction, which proceeded with high yield and conversion 
(Table 3.3, entry 4).  
 
Entry Ligand Additive Conversion to 
product 3.17 (%) 
1 SPhos None 93 
2 SPhos 3.18 (25 mol%) 7 
3 XPhos None 100 
4 XPhos 3.18 (25 mol%) 100 
Table 3.3: Inhibition by 3,3’-bithiophene 3.18 
Since the bithiophene 3.18 would be an expected by-product in the synthesis of the IRS 
product 3.15, the usual ligand SPhos was exchanged for XPhos and the reaction was 
performed again (Scheme 3.8). This proved to be successful as the desired compound 
3.15 was isolated in a 77% overall yield. 
 
Scheme 3.8: Use of XPhos as ligand 
Additionally, other substrates were sought in order to widen the scope of the IRS 
Suzuki−Miyaura reaction. A halide handle was required and as such both 2,3-
dibromopropene and 2,3-dichloropropene were tested with benzoic acid 2.10 and benzylic 
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alcohol 1.110 (Scheme 3.9). The oxyallylation reaction with 2,3-dibromopropene and 2,3-
dichloropropene using benzoic acid 2.10 produced the desired compounds in low yields. 
However, the oxyallylation reaction using benzylic alcohol 1.110 with 2,3-dibromopropene 
worked well, garnering the desired isobenzofuran 3.21 in an 85% yield with the bromide 
handle attached. 
 
Scheme 3.9: Oxyallylation reaction employing 2,3-dibromopropene and 2,3-
dichloropropene 
Subjecting benzylic alcohol to optimised IRS for the Suzuki−Miyaura reaction proved 
unsuccessful, as the desired product was undetected via 1H NMR of the crude material 
(Scheme 3.10).  
 
Scheme 3.10: Attempted IRS using benzylic alcohol 1.110 
The pyridine moiety is a prominent component of many pharmaceuticals.[132] Because of 
its importance, using a pyridinylboronic acid in the Suzuki−Miyaura IRS reaction was 
desired. However, the reactions pertaining to pyridinylboronic acids have received less 
attention and are renowned to be difficult coupling partners.[131] Using the previously 
optimised conditions for 3-pyridinylboronic acid resulted in no formation of the desired IRS 
product 3.23, and instead only intermediate 3.2 was isolated (Scheme 3.11). 
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Scheme 3.11: Attemped IRS using 3-pyridinylboronic acid 
A search of the literature revealed that a change of solvent and ligand was required.[133] 
Bromoanisole 3.24 has similar electronics to the oxyallylated intermediate 3.2 that would 
be generated in the IRS and as such was deemed an ideal precedent (Scheme 3.12).  
 
Scheme 3.12: Suzuki−Miyaura coupling with 3-pyridinylboronic acid[133] 
Replicating the above result proved difficult. Applying the conditions outlined in the 
literature only resulted in starting material (Table 3.4, entry 1). Increasing the catalyst 
loading and ligand loading resulted in decomposition (entry 2). Decreasing the 
temperature to 50 °C had no effect on the reaction conversion and only returned starting 
material (entry 3). Next, the temperature was returned to 100 °C and the time the reaction 
was performed was investigated (entries 4 – 6). It was found that the reaction time at 8 h 
produced the best ratio of anisole 3.24 to desired compound 3.25. 
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Entry Catalyst/Ligand 
Loading 
Temperature 
(°C) 
Time 
(h) 
Result 
3.24 : 3.25 
1 PdCl2 (1 mol%)/ 
PPhos (2 mol%) 
100 20 1.00 : 0.00 
2 PdCl2 (5 mol%)/ 
PPhos (10 mol%) 
100 20 Decomp. 
3 PdCl2 (5 mol%)/ 
PPhos (10 mol%) 
50 20 1.00 : 0.00 
4 PdCl2 (5 mol%)/ 
PPhos (10 mol%) 
100 2 1.00 : 0.53 
5 PdCl2 (5 mol%)/ 
PPhos (10 mol%) 
100 5 0.31 : 1.00 
6 PdCl2 (5 mol%)/ 
PPhos (10 mol%) 
100 8 0.10 : 1.00 
Table 3.4: Towards the optimisation of Suzuki−Miyaura coupling with 3-pyridinylboronic 
acid 
To prevent the reaction running overnight and leading to decomposition, the equivalents 
of 3-pyridinylboronic acid and base were investigated (Table 3.5). Increasing the 
equivalents of 3-pyridinylboronic acid to 3 resulted in complete conversion to the desired 
Suzuki−Miyaura product 3.25 (entry 1).  Increasing K3PO4 to 3 equivalents resulted in 
incomplete conversion of the anisole 3.24 (entry 2). Increasing the equivalents of both the 
3-pyridinylboronic acid and K3PO4 resulted in complete conversion of the starting material 
to the desired product 3.25 (entry 3). The other IRS Suzuki−Miyaura iterations require 3 
equivalents of base and 3 equivalents of boronic acid; thus, for the purposes of 
consistency, when 3-pyridinylboronic acid was employed three equivalents of each would 
be used.  
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Entry Base  
(Equiv.) 
Boronic Acid 
 (Equiv.) 
Result 
3.24 : 3.25 
1 2 3 0.00 : 1.00 
2 3 2 0.11 : 1.00 
3 3 3 0.00 : 1.00 
Table 3.5: Varying base and boronic acid equivalents 
With the newly developed conditions for the 3-pyridinylboronic acid we sought to 
incorporate it into full IRS. Gratifyingly, combining both the oxyallylation reaction and the 
Suzuki−Miyaura reaction using PPhos as the ligand and nBuOH at 100 °C worked well to 
provide the desired IRS compound 3.23 in a 53% yield, with the reaction time shorted to 2 
h for the Suzuki−Miyaura coupling (Scheme 3.13). 
 
Scheme 3.13: IRS using 3-pyridinylboronic acid 
The use of alkyl boronic acids to extend the IRS Suzuki−Miyaura reaction was attempted. 
Unfortunately, when cyclohexylboronic acid was employed, the desired IRS product 3.26 
was not detected and only the bromobenzofuran intermediate 3.2 was observed via 1H 
NMR analysis of the crude material (Scheme 3.14). 
 
Scheme 3.14: Use of cyclohexylboronic acid 
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3.3 IRS –The  Sonogashira Iteration 
The ensuing step in expanding the IRS’s available scope was to extend the reaction to 
incorporate the Sonogashira reaction. Again, this reaction was chosen as it is commonly 
used by medicinal chemists during the synthesis of bioactive molecules.[128] A patented 
literature reaction provided a substrate similar in electronics to our own which readily 
performed the Sonogashira coupling with 2-methyl-4-bromoanisole 3.27 formed in a 98% 
yield (Scheme 3.15).[134] 
 
Scheme 3.15: Sonogashira reaction of 2-methyl-4-bromoanisole 3.27 
Initial experiments focused on repeating the reaction outlined above (Scheme 3.14). The 
copper iodide was increased from 4 mol% to 10 mol% loading for the purposes of 
practical simplicity and the palladium was increased from 3 mol% to 5 mol% catalyst 
loading in order to replicate the amount of palladium that would be present in the full IRS. 
Attempts at reproducing the reaction with anisole 3.24 proved difficult (Table 3.6). Starting 
at 50 °C, the reaction afforded the desired product 3.29, however, the reaction did not go 
to complete conversion of starting material (entry 1). Increasing the temperature to both 
80 °C and 100 °C had a detrimental effect on the conversion to the desired product 3.29 
(entries 2 and 3). 
 
Entry Temperature 
(°C) 
Result 
3.24 : 3.29 
1 50 1.8 : 1.0 
2 80 10.2 : 1.0 
3 100 7.8 : 1.0 
Table 3.6: Effect of temperature on Sonogashira reaction 
 
120 
 
Owing to the lack of success with bromoanisole 3.24, it was theorised that the 
Sonogashira reaction would perform better starting from the already heterocyclised 
bromobenzofuran 3.2, which is the intermediate produced in the desired IRS. Starting at 
50 °C, the reaction afforded poor conversion to the desired product 3.30 (Table 3.7, entry 
1). Increasing the temperature to 80 °C, then 100 °C, hindered the conversion to the 
desired Sonogashira product 3.30 (entries 2 and 3). With this, the reaction temperature 
was lowered to room temperature, however, this resulted in no conversion to the desired 
product 3.30, and only starting material was recovered (entry 4). 
 
Entry Temperature 
(°C) 
Result 
3.2 : 3.30 
1 50 4.6 : 1.0 
2 80 9.9 : 1.0 
3 100 9.9 : 1.0 
4 rt 1.0 : 0.0 
Table 3.7: Sonogashira reaction using bromobenzofuran 3.2 
The equivalents of the alkyne employed were investigated next, in order to facilitate the 
formation of the desired product 3.29 at 50 °C under air. The equivalents were increased 
to both 3 and 5 equivalents respectively, with no obvious increase in conversion to the 
coupled product 3.29 (Table 3.8, entries 1 and 2). The copper iodide loading was 
decreased to 4 mol%, with the alkyne equivalents returning to 1, which improved the ratio 
of starting material to desired product 3.29; however, incomplete conversion was still an 
issue (entry 3). Increasing the copper iodide loading to 30 mol% and 50 mol% had no 
drastic increase in the conversion of starting material (entry 4 and 5).  
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Entry CuI (mol%) Alkyne Equivalents Results 
3.24 : 3.29 
1 10 3 4.6 : 1.0 
2 10 5 4.5 : 1.0 
3 4 1 2.8 : 1.0 
4 30 1 2.3 : 1.0 
5 50 1 2.4 : 1.0 
Table 3.8: Screening of CuI and Alkyne equivalents under air 
Subsequently, the research was directed towards varying the copper iodide loading and 
the equivalents of alkyne in the reaction under an inert atmosphere. The use of copper 
iodide at 4 mol% loading with 1 equivalent of alkyne under an inert atmosphere improved 
the ratio in favour of the desired product 3.29 (Table 3.9, entry 1). The copper iodide 
loading was then increased to 10 mol% and the alkyne equivalents increased to 3, with 
the ratio of starting material to product not improving (entry 2). The alkyne equivalents 
were then increased to 5, however, this had a detrimental effect on the conversion (entry 
3). The investigation then focused on increasing the copper iodide loading while utilising 1 
equivalent of alkyne. Unfortunately, increasing the loading to 30 mol%, 50 mol%, and 100 
mol% had an adverse effect on the conversion of starting material (entries 4−6). Lastly, 10 
mol% of copper iodide with 1 equivalent of alkyne added initially, followed by the addition 
of another equivalent of alkyne 5 hours later, afforded an improved ratio of starting 
material to desired product up to this point (entry 7).  
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Entry CuI (mol%) Alkyne Equivalents Results 
3.24 : 3.29 
1 4 1 0.8 : 1.0 
2 10 3 0.9 : 1.0 
3 10 5 2.8 : 1.0 
4 30 1 2.4 : 1.0 
5 50 1 3.8 : 1.0 
6 100 1 1.0 : 0.0 
7 10 1+1 0.7 : 1.0 
Table 3.9: Screening of CuI and Alkyne equivalents in an inert atmosphere 
The concentration of the reaction was explored next (Table 3.10). Lowering the 
concentration to 0.25 M had a negligible effect on the conversion of bromoanisole 3.24 
into the Sonogashira product 3.29 (entry 1). Increasing the concentration to 1.0 M 
afforded a promising ratio of starting material to product (entry 2); however, increasing the 
concentration further to 2.0 M had a deleterious effect on the conversion (entry 3). 
Attempting to improve upon the best ratio (entry 1), three equivalents of alkyne were 
added to the reaction mixture in order to force the conversion; however, this had a 
negative effect on the conversion (entry 4).  
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Entry Concentration (M) Alkyne Equivalents Result 
3.24 : 3.29 
1 0.25 1 0.7 : 1.0 
2 1.0 1 0.3 : 1.0 
3 2.0 1 0.5 : 1.0 
4 1.0 3 0.7 : 1.0 
Table 3.10: Concentration effects on the reaction 
The best conditions achieved (Table 3.10, entry 2), thus far, were then performed again 
with bromoanisole 3.24 in order to obtain an isolatable yield (Scheme 3.16). Additionally, 
the conditions were tested with bromobenzofuran 3.2, the intermediate that would be 
generated in the desired IRS. Disappointingly, both bromoanisole 3.24 and 
bromobenzofuran 3.2 achieved a 27% yield when subjected to the conditions outlined in 
Table 3.10, entry 2. Currently, the IRS Sonogashira iteration requires more optimisation. 
 
Scheme 3.16: Best conditions developed for the Sonogashira reaction 
3.4 IRS –TheBuchwald−Hartwig Iteration 
The Buchwald−Hartwig amination is a reaction used widely in the synthesis of 
pharmaceuticals and natural products.[135] From our previous work with the IRS 
Suzuki−Miyaura iteration, it was known that the ligand SPhos was also able to promote 
the Buchwald−Hartwig reaction.[136]  The palladium-catalysed study of bromobenzofuran 
3.2 with the Buchwald−Hartwig reaction started with a palladium(II) catalyst, SPhos as the 
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ligand and piperidine as the amine (Table 3.11). The use of NaOtBu or K3PO4 as base 
resulted in returning only starting material (entries 1 and 2). This indicated that the 
palladium(II) precatalyst was not being reduced to the required palladium(0) catalyst and 
as such the addition of 10 mol% of phenylboronic acid was used to reduce the catalyst 
with a combination of the aforementioned bases (entries 3 and 4). Unfortunately, this 
attempt resulted in no improvement. 
 
Entry Base/ Addidive (10 
mol%) 
Result 
3.2 : 3.31 
1 NaOtBu 1.0 : 0.0 
2 K3PO4 1.0 : 0.0 
3 NaOtBu/ PhB(OH)2 1.0 : 0.0 
4 K3PO4/ PhB(OH)2 1.0 : 0.0 
Table 3.11: Use of SPhos as ligand with base and additive screen 
A report by Buchwald and co-workers demonstrated that 3-methyl-4-bromoanisole 3.32 
with similar electronics to the benzofuran 3.2 substrate could undergo the 
Buchwald−Hartwig amination.[137] Through the use of the ligand BINAP, with low catalyst 
loading at 80 °C in toluene 3-methyl-4-bromoanisole 3.32 underwent the desired 
Buchwald−Hartwig amination in 94% yield with hexylamine (Scheme 3.17). 
 
Scheme 3.17: Buchwald−Hartwig amination on anisole 3.32 
Replicating the above result was the priority in developing the Buchwald−Hartwig iteration. 
Using bromoanisole 3.24, the exact conditions used by Buchwald and co-workers were 
employed, however, only starting material was recovered (Table 3.12, entry 1). The 
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catalyst was changed to Pd(OAc)2 (entry 2), and the base was changed to KOtBu (entry 
3), however, no improvement was observed via 1H NMR analysis of the crude material. 
The temperature was increased to 100 °C, which resulted in the synthesis in a trace 
amount of the desired product 3.34 (entry 4). All reactions below were also performed with 
distilled amine and purified bases, yet, no improvement was witnessed. 
 
Entry Pd Base Temp (°C) Result 
3.24 : 3.34 
1 Pd2(dba)3 NaOtBu 80 1.0 : 0.0 
2 Pd(OAc)2 NaOtBu 80 1.0 : 0.0 
3 Pd2(dba)3 KOtBu 80 1.0 : 0.0 
4 Pd2(dba)3 NaOtBu 100 Trace 
Scheme 3.12: Attempted Buchwald−Hartwig amination 
The lack of success with bromoanisole 3.24 prompted a change in substrate to 3-methyl-
4-bromoanisole 3.32. Using the literature conditions, initial results were positive with the 
Buchwald−Hartwig product being garned in generous amounts after 15 h (Table 3.13, 
entry 1). Increasing the time to 18 h improved the ratio further (entry 2). The reaction was 
then attempted starting from a Pd(II) catalyst and was left to react for 72 hours, however, 
complete conversion of starting material did not occur (entry 3). 
 
Entry Pd Time (h) Result 
3.32 : 3.33 
1 Pd2(dba)3 15 1.0 : 3.5 
2 Pd2(dba)3 18 1.0 : 5.1 
3 Pd(hfacac)2 72 1.0 : 4.5 
Table 3.13: Use of 3-methyl-4-bromoanisole 3.32 as substrate 
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A search of the literature revealed that the ligand in the Buchwald−Hartwig amination is of 
key importance and that BrettPhos instead of BINAP is more suited to the 
Buchwald−Hartwig reaction for our substrate.[136, 138] Utilising similar conditions to those 
previously, albeit with a different ligand, the study of the effect of BrettPhos on our 
Buchwald−Hartwig amination was initiated (Table 3.14). Irrespective of whether the 
catalyst was Pd2(dba)3 or Pd(hfacac)2 at 50 °C or 80 °C the reaction went to complete 
conversion to the desired Buchwald−Hartwig product 3.35 (entries 1 – 4). In instances 
where Pd(II) catalysts were employed, the reduction of the palladium(II) was envisaged to 
occur via a β-hydride elimination from a Pd(II)-amine complex. 
 
Entry Pd Temp (°C) Result 
3.2 : 3.35 
1 Pd2(dba)3 80 0.0 : 1.0 
2 Pd2(dba)3 50 0.0 : 1.0 
3 Pd(hfacac)2 80 0.0 : 1.0 
4 Pd(hfacac)2 50 0.0 : 1.0 
Table 3.14: Effect of BrettPhos on the Buchwald−Hartwig amination 
For the full IRS Buchwald−Hartwig iteration it was found that in order for the reaction to 
proceed to complete conversion, the equivalents of base had to be increased to 3. 
Additionally, the reaction time for each amine was shortened to 3 hours. As can be seen 
below, the coupling works well with primary amines, secondary amines and a secondary 
aniline, with yields ranging from 53% to 83% over the two steps (Scheme 3.18). 
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Scheme 3.18: Heteroallylation−amination sequence 
Not all substrates tested in the IRS Buchwald−Hartwig iteration were successful. The use 
of an amide hydrochloride salt did not produce the desired product 3.41, even when the 
base was increased to 4.2 equivalents to account for the required deprotonation of the 
amine salt (Scheme 3.19). Analysis, via 1H NMR of the crude material, revealed only the 
bromobenzofuran intermediate 3.2. Additionally, a diamine was attempted, however, it 
proved unsuccessful as none of the desired product was detected via 1H NMR of the 
crude material, and only bromobenzofuran intermediate 3.2 was present. 
 
Scheme 3.19: Unsuccessful heteroallylation−amination sequence 
3.5 IRS – Wacker−Tsuji Oxidation Iteration 
The success of the IRS for the Suzuki−Miyaura and Buchwald−Hartwig iterations, where 
the bromide handle was successfully engaged with, prompted the investigation for the 
Wacker−Tsuji oxidation for which the alkene in the isohypsic heteroallylation reaction will 
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be manipulated further. With this, the literature was consulted for a suitable precedent for 
the Wacker−Tsuji oxidation. Tsuji and co-workers report that long chain alkene decene 
3.43, when placed in the presence of 3 mol% palladium(II) catalyst with 1 equivalent of 
copper chloride in a DMF/H2O mixture under an O2 atmosphere generates the alkyl 
ketone 3.44 in good yields after stirring at room temperature overnight (Scheme 3.20).[139] 
 
Scheme 3.20: Wacker−Tsuji oxidation of decene 3.43 
The success of the Wacker−Tsuji oxidation over the years, and in particular the conditions 
outlined above, led to the belief that the procedure would be robust enough to handle the 
full IRS. As such, benzylic alcohol 1.110 was subjected to the oxyallylation reaction 
followed by the Wacker−Tsuji oxidation through the addition of 1 equivalent of copper 
chloride, DMF/H2O under an O2 atmosphere (Scheme 3.21). The reaction was left to stir 
at room temperature overnight; however, none of the desired product 3.45 was observed 
via 1H NMR analysis of the crude material, and only intermediate 2.17 was isolated. 
 
Scheme 3.21: Attemped IRS  
Establishing whether it is the conditions that cause the failed Wacker−Tsuji oxidation or 
the substrate were next explored. Isobenzofuran 2.17 was placed under analogous 
conditions to those developed by Tsuji and co-workers, albeit with the catalyst loading 
increased to 10 mol% (Scheme 3.22). The reaction did generate the desired oxidised 
product 3.45, however, isomerisation of the alkene was also a problem with considerable 
amounts of isomerised alkene 3.46 formed. A ratio of 2.35 : 1.00 of desired 3.45 to 
isomerised isobenzofuran 3.46 was observed. 
 
Scheme 3.22: Wacker−Tsuji oxidation of isobenzofuran 2.17 
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The Wacker−Tsuji oxidation conditions developed by Tsuji and co-workers were next 
tested on the exact substrate used in their publication, decene 3.43. The catalyst loading 
was increased to 5 mol% from the 3 mol% in the report in order to replicate the amount of 
palladium that would be present in the IRS. Pleasingly, the reaction resulted in complete 
conversion to the desired oxidised product 3.44 (Table 3.15, entry 1). The isohypsic 
oxyallylation reaction requires 2 equivalents of NaHCO3. Due to this requirement, the 
Wacker−Tsuji oxidation was tested with 2 equivalents of NaHCO3, however, this had a 
detrimental effect on the conversion of decene 3.43 to the desired ketone 3.44 (entry 2). 
 
Entry Base Result 
3.43 : 3.44 
1 No Base 0.0 : 1.0 
2 NaHCO3 (2 equiv.) 1.0 : 1.7 
Table 3.15: Effect of NaHCO3 on Wacker−Tsuji oxidation 
With the presence of base having a deleterious effect on the Wacker−Tsuji oxidation, and 
with the base being a requirement for the oxyallylation reaction, it was deemed prudent to 
neutralise the base with addition of acetic acid in the second step (Table 3.16). The use of 
2, 4 and 20 equivalents of acetic acid to neutralise NaHCO3 delivered no improvement on 
the reaction and only returned the intermediate isobenzofuran 2.17 (entries 1 – 3). 
 
Entry Acetic Acid  
(equivalents) 
Result 
2.17 : 3.45 
1 2  1.0 : 0.0 
2 4 1.0 : 0.0 
3 20 1.0 : 0.0 
Table 3.16: The use of acetic acid in attempted IRS 
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With the benzylic alcohol 1.110 proving an unsuccessful substrate for the IRS 
Wacker−Tsuji oxidation, a change of tactic was undertaken. From previous investigations 
conducted within the France group, it was already known that tosylamide 2.91 could 
perform the aminoallylation reaction without the presence of base. Because of this 
tosylamide 2.91 was synthesised from 2-allylbenzoic acid 1.15 in one step and in good 
yield following a procedure from Waser and co-workers (Scheme 3.23).[140] 
 
Scheme 3.23: Synthesis of tosylamide 2.91 
Attempting the full IRS for tosylamide 2.91 began with the standard conditions developed 
from a previous project within the France group, with H2O as a co-solvent and 2 
equivalents of KH2PO4.
[44] The presence of base proved to hinder the Wacker−Tsuji 
oxidation with only the cyclised intermediate detected via analysis of the 1H NMR of the 
crude material (Table 3.16, entry 1). Next, the IRS was performed without base which in 
turn did provide the desired oxidised product 3.47. However, unreacted alkene 2.92 and 
isomerised alkene 3.48 were still present in sufficient quantity (entry 2). In light of the 
results, the reaction was performed with no KH2PO4 or water in the aminoallylation 
reaction. Although the desired ketone 3.47 was garnered, the major product of the 
reaction was the isomerised alkene (entry 3). 
 
Entry Base Additive Result 
2.92 : 3.47 : 3.48 
1 KH2PO4 (2 equiv.) H2O (co-solvent) 1.0 : 0.0 : 0.0 
2 None H2O (co-solvent) 1.0 : 1.3 : 0.8 
3 None None 0.0 : 0.5 : 1.0 
Table 3.16: Wacker−Tsuji oxidation IRS with tosylamide 2.91 
As before, determining whether the intermediate generated in the IRS would undergo the 
required Wacker−Tsuji oxidation was paramount. The aminocycle 2.92 was subjected to 
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the conditions developed by Tsuji and co-workers with the exception of the catalyst 
loading which was increased to 10 mol% (Scheme 3.24). Under the reaction conditions, 
the desired oxidised tosylamide 3.47 was formed; however, the predominant product of 
the reaction was the isomerised alkene 3.48. 
 
Scheme 3.24: Wacker−Tsuji oxidation starting from aminocycle 2.92 
The lack of success with the Wacker−Tsuji oxidation conditions developed by Tsuji and 
co-workers for our substrates led to a change in direction. Similar conditions were found to 
those described above, with the exception being the oxidant was changed from copper 
chloride to p-benzoquinone (Scheme 3.25).[141] Subjecting 10-decenol 3.49 to the 
oxidising conditions, provided 11-hydroxy-2-undecanone 3.50 in a 93% yield. 
 
Scheme 3.25: Wacker−Tsuji oxidation with p-benzoquinone as the oxidant 
Subjecting decene 3.43 to the conditions outlined above (Scheme 3.25), resulted in 
complete conversion to the desired ketone 3.44 (Table 3.17, entry 1). With the presence 
of base hindering the reaction in the past, the reaction was attempted in the presence of 2 
equivalents of NaHCO3 which hindered the formation of the desired ketone 3.44 (entry 2). 
Adding 4 equivalents of acetic acid did not bear any improvement on the aforementioned 
reaction (entry 3). Changing from acetic acid to p-toluenesulfonic acid, however did result 
in complete conversion to the desired ketone 3.44 (entry 4). Changing base to KH2PO4 
and adding 4 equivalents of either acetic acid (entry 5), or 4 equivalents of p-
toluenesulfonic acid resulted in complete conversion to the desired ketone 3.44 (entry 6). 
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Entry Base (2 equiv.) Acid (4 
equiv.) 
Result 
3.43 : 3.44 
1 None None 0.0 : 1.0 
2 NaHCO3 None 1.0 : 0.3 
3 NaHCO3 AcOH 1.0 : 0.2 
4 NaHCO3 TsOH 0.0 : 1.0 
5 KH2PO4 AcOH 0.0 : 1.0 
6 KH2PO4 TsOH 0.0 : 1.0 
Table 3.17: Screening Wacker−Tsuji oxidation with different bases and acids 
Benzylic alcohol 1.110 was next subjected to the full IRS for the Wacker−Tsuji oxidation 
under the new conditions (Table 3.18). When no acid was added to the second step (entry 
1), and when 4 equivalents of acetic acid is added to the second step, only intermediate 
2.17 can be observed via analysis of 1H NMR of the crude material (entry 2). However, 
with the addition of 4 equivalents of p-toluenesulfonic acid to the second step, the reaction 
garnered the desired ketone 3.45 (entry 3). Moderate conversion was still an issue.  
 
Entry Acid (4 equiv.) Result 
2.17 : 3.45 
1 None 1.00 : 0.00 
2 AcOH 1.00 : 0.00 
3 TsOH 1.00 : 0.95 
Table 3.18: IRS for the Wacker−Tsuji oxidation for benzylic alcohol 1.110 
Uninspiring results with benzylic alcohol 1.106 led the inquiry towards tosylamide 2.91. 
Combining both the optimised aminoallylation reaction and the Wacker−Tsuji oxidation 
garnered none of the desired ketone 3.47 with only the aminocycle 2.92 detected via 
analysis of the 1H NMR of the crude material (Table 3.19, entry 1). Adding 4 equivalents of 
acetic acid to the Wacker−Tsuji step only resulted in the isomerised alkene 3.48 (entry 2). 
The addition of 4 equivalents of p-toluenesulfonic acid to the second step did generate a 
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small amount of desired ketone 3.47, however, unreacted aminocycle 2.92 was by far 
more prominent (entry 3). 
 
Entry Acid (4 equiv.) Results 
2.92 : 3.47 :  3.48 
1 None 1.00 : 0.00 : 0.00 
2 AcOH 0.00 : 0.00 : 1.00 
3 TsOH 1.00 : 0.22 : 0.00 
Table 3.19: IRS for the Wacker−Tsuji oxidation for tosylamide 2.91 
The IRS for the Wacker−Tsuji oxidation thus far proved unsuccessful in the presence of a 
base and acid. Fortunately, the aminoallylation reaction is known to proceed well without 
base in the reaction mixture. Initial investigations began with water as the co-solvent in the 
first step, 1 equivalent of p-benzoquinone and the second step performed for 24 hours, 
which synthesised the desired ketone 3.47, but unreacted aminocycle 2.92 was still 
present (Table 3.20, entry 1). Removal of the water as a co-solvent in the first step 
resulted in an improved ratio; however, unreacted aminocycle 2.92 was still a problem 
(entry 2). In order to encourage conversion of the aminocycle 2.92 to the desired ketone 
3.47, the equivalents of p-benzoquinone were increased to 2.5, and were tested with and 
without water in the first step of the reaction (entries 3 and 4). Monitoring the reaction via 
TLC analysis revealed complete conversion of the aminocycle 2.92 to the desired ketone 
3.47 occurred after 96 hours for both the reactions. Although the addition or exclusion of 
water in the first step proved successful, the presence of water in the first step appeared 
make the 1H NMR of the crude material cleaner and for this reason it was selected as the 
optimal conditions to take the reaction forward. Applying the optimised IRS to obtain a 
yield resulted in an isolated yield of 54% over the two steps. 
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Entry Water (co-
solvent) 
BQ (Equiv.) Time (h) Result 
2.92 : 3.47 
1 Yes 1 24 1.00 : 1.10 
2 No 1 24 1.00 : 2.16 
3 Yes 2.5 96 0.00 : 1.00 
4 No 2.5 96 0.00 : 1.00 (54%) 
Table 3.20: Optimisation of the IRS for the Wacker−Tsuji oxidation 
With optimised conditions having been developed for tosylamide 2.91, the next goal was 
to increase the substrate scope for the IRS. It was proposed that pyrrole containing 
tosylamide 3.54 would be suitable as it too readily underwent the aminoallylation 
sequence.[44] Pyrrole 3.54 was synthesised in three steps from methyl pyrrole-2-
carboxylate 3.51 following a known procedure (Scheme 3.26).[140] Pyrrole 3.51 was 
subjected to base-promoted allylation conditions to afford N-allyl pyrrole 3.52. The 
substrate was then complete through ester hydrolysis followed by formation of the 
tosylamide 3.54 using tosyl isocyanate. 
 
Scheme 3.26: Synthesis of pyrrole 3.54 
With the pyrrole 3.54 synthesised, there was no guarantee the full IRS sequence would 
work with this substrate. Subjecting pyrrole 3.54 to the optimised conditions for the IRS for 
the Wacker−Tsuji oxidation worked well and produced the desired ketone 3.56 in a 48% 
yield over two steps (Scheme 3.27). 
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Scheme 3.27: Successful heteroallylation−oxidation sequence for pyrrole 3.54 
3.6 IRS – Feringa−Grubbs−Wacker Oxidation Iteration 
The ability to exert control and oxidise the terminal alkene at the internal position to form 
the ketone or at the terminal carbon to form the aldehyde is a powerful tool in palladium-
catalysis. It is only recently that palladium-catalysed aldehyde selective oxidation of an 
alkene has been made possible. Early reports by Grubbs and co-workers describe the 
control to form the aldehyde on styrenyl compounds (Scheme 3.28).[127c] When styrene 
3.57 is placed in an environment with a palladium(II) catalyst, stoichiometric p-
benzoquinone and water, with tBuOH as the solvent at 85 °C the desired aldehyde 3.58 is 
formed in an 83% yield. 
 
Scheme 3.28: Aldehyde selective Wacker oxidation for styrene 3.57 
Although only successful for styrenyl compounds, the conditions developed by Grubbs 
and co-workers, outlined above, were attempted for the full IRS due to the operational 
simplicity of the procedure. Unsurprisingly, the reaction never yielded any of the desired 
aldehyde 3.59 and only alkene intermediate 2.17 was isolated (Scheme 3.29). 
 
Scheme 3.29: Attempted full IRS for aldehyde selective Wacker oxidation 
Extensive work on the aldehyde selective Wacker reaction has been performed by Grubbs 
and co-workers in recent years.[127b, 127f, 142] A relevant paper, by Grubbs and co-workers, 
reports the aldehyde selective oxidation for unbiased alkenes.[143] In the presence of 
catalytic PdCl2(PhCN)2, CuCl2, AgNO2, an O2 atmosphere and a solvent mixture of 
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tBuOH/MeNO2 (15:1) at room temperature, the alkene dodecene 3.60 is oxidised to the 
aldehyde 3.61 in a 63% yield (Scheme 3.30). 
 
Scheme 3.30: Aldehyde selective oxidation for unbiased alkenes 
Applying the exact conditions above, to decene 3.43, resulted in the aldehyde 3.62 being 
synthesised as the major product with the ketone 3.44 formed in a similar ratio to those 
observed by Grubbs and co-workers (Table 3.21, entry 1). The addition of 2 equivalents of 
NaHCO3 (entry 2), and KH2PO4 (entry 3) had a negative effect on the conversion and the 
ratio of desired aldehyde 3.62 to ketone 3.44. Also both formed prominent amounts of the 
isomerised alkene 3.63. The results below, rule out the use of base in the heteroallylation 
reaction. 
 
Entry Base (2 equiv.) Result 
3.62 : 3.44 : 3.63 
1 None 1.00 : 0.22 : 0.00 
2 NaHCO3 0.12 : 0.37 : 1.00 
3 KH2PO4 2.30 : 1.70 : 1.00 
Table 3.21: Effect of base on the aldehyde selective Wacker reaction 
The full IRS – Feringa−Grubbs−Wacker Oxidation was attempted starting from tosylamide 
2.91, with no base present (Table 3.22, entry 1). A small amount of the desired aldehyde 
3.64 was observed via analysis of the 1H NMR of the crude material; however, the major 
product was the aminocycle 2.92. The addition of 2 equivalents of KH2PO4 resulted in only 
the aminocycle 2.92 being isolated, with no formation of the desired aldehyde 3.64. 
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Entry Base (2 equiv.) Result 
2.92 : 3.64 
1 None 1.00 : 0.07  
2 KH2PO4 1.00 : 0.00  
Table 3.22: Full IRS sequence for tosylamide 2.91 
To determine whether our substrate was suitable under the conditions employed, 
aminocycle 2.92 was subjected to the conditions developed by Grubbs and co-workers for 
unbiased alkenes.[143] The AgNO2 loading was increased from 6 mol% to 12 mol% for 
practical purposes. It was noted by Grubbs and co-workers that the AgNO2 loading at 12 
mol% did not have a deleterious effect on the reaction. Applying the standard conditions 
to tosylamide 2.92, with PdCl2(PhCN)2 as the catalyst resulted in complete conversion of 
the aminocycle 2.92 to oxidised products 3.64 and 3.47 (Table 3.23, entry 1). The change 
of catalyst to PdCl2 resulted in no conversion with only starting material 2.92 being 
isolated (entry 2). The use of Pd(hfacac)2 returned only isomerised starting material 3.48 
exclusively (entry 3). 
 
 
 
Pd(II) Result 
2.92 : 3.64 : 3.47 : 3.48 
1 PdCl2(PhCN)2 0.00 : 1.00 : 0.23 : 0.00 
2 PdCl2 1.00 : 0.00: 0.00 : 0.00 
3 Pd(hfacac)2 0.00 : 0.00: 0.00 : 1.00 
Table 3.23: Catalyst screen with aminocycle 2.92 
With the only conceivable difference between the experiments above being the presence 
of PhCN as a ligand on the catalyst, it was decided that screening the volume of PhCN 
was a reasonable pursuit (Table 3.24). The addition of 0.5 mL of PhCN to the second step 
did improve the conversion to oxidised products; however, the intermediate aminocycle 
2.92 was still present (entry 1). Addition of 50 µL of PhCN resulted in complete conversion 
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to oxidised aldehyde 3.64 and ketone 3.47, with the yields being 33% and 19% 
respectively (entry 2). Interestingly, when 100 µL of PhCN was added to the second step it 
had a detrimental effect on the conversion to oxidised products with only aminocycle 2.92 
being observed via 1H NMR analysis of the crude material. 
 
Entry PhCN Result 
2.92 : 3.64 : 3.47 
1 0.5 mL 0.66 : 1.00 : 0.33 
2 50 µL 0.00 : 1.00 (33%) : 0.53 (19%) 
3 100 µL 1.00 : 0.00 : 0.00  
Table 3.24: Screening with different volumes of PhCN 
The newly optimised conditions were then tested against the pyrrole substrate 3.54. The 
full IRS synthesised the desired aldehyde 3.65 in a 24% yield (Scheme 3.31). 
Unfortunately, the yield of the ketone 3.56 could not be determined.  
Scheme 3.31: Aldehyde selective heteroallylation−oxidation sequence for pyrrole 3.54 
3.7 Conclusions 
The successful development of the novel palladium-catalysed IRS that combines the 
isohypsic heteroallylation reaction with traditional redox chemistry such as the 
Suzuki−Miyaura, Buchwald−Hartwig and Sonogashira reactions have led to an interesting 
range of products through the manipulation of a bromide handle (Scheme 3.32). The 
Suzuki−Miyaura and Buchwald−Hartwig iterations afforded products in good to excellent 
yields over two steps and effectively generated molecular complexity quickly and 
efficiently, using one palladium source. The Sonogashira iteration has shown promising 
results however optimisation is still needed. 
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Scheme 3.32: IRS summary 
It has been demonstrated that the terminal alkene formed in the aminoallylation reaction 
can be oxidised to either the ketone or the aldehyde. Transformation of the terminal 
alkene has led to a collection of oxidised products (Figure 3.1). Having control over 
whether the ketone or aldehyde is formed is highly advantageous for a synthetic chemist, 
as it provides options for further synthetic processes.  
 
Figure 3.1:Aminoallylation−oxidation products 
Future work will be to extend the IRS to other palladium-catalysed isohyspic and redox 
reactions. This will allow even more molecular complexity to built up quickly and efficiently 
and complex manifolds to be designed. 
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4. Experimental 
4.1 General Experimental Information 
Reactions involving air-sensitive reagents and dry solvents were performed in glassware 
that had been dried in an oven (150 °C) or flame-dried prior to use. These reactions were 
carried out with the exclusion of air using an argon atmosphere. All microwave reactions 
were carried out using a Biotage Initiator system. NMR spectra were recorded on a Bruker 
DPX-400 spectrometer (1H NMR at 400 MHz and 13C NMR at 100 MHz) or a Bruker DPX-
500 spectrometer (1H NMR at 500 MHz and 13C NMR at 125 MHz). Chemical shifts are 
reported in ppm. 1H NMR spectra were recorded with CDCl3 as the solvent using residual 
CHCl3 (δ = 7.27) as internal standard or C6D6 as the solvent using residual C6D5H (δ = 
7.16), and for 13C NMR spectra the chemical shifts are reported relative to the central 
resonance of CDCl3 (δ = 77.00) or C6D6 (δ = 128.39). Signals in NMR spectra are 
described as singlet (s), doublet (d), triplet (t), quartet (q), quintet (quint), septet (sept), 
multiplet (m), broad (br) or combination of these, which refers to the spinspin coupling 
pattern observed. Spinspin coupling constants reported are uncorrected. Two-
dimensional (COSY, HSQC, HMBC, NOESY) NMR spectroscopy was used where 
appropriate to assist the assignment of signals in the 1H and 13C NMR spectra. IR spectra 
were obtained employing a Shimadzu FTIR-8400 instrument with a Golden Gate™ 
attachment that uses a type IIa diamond as a single reflection element so that the IR 
spectrum of the compound (solid or liquid) could be detected directly (thin layer). High 
resolution mass spectra were recorded under FAB, ESI or CI conditions by the analytical 
services at the University of Glasgow. Flash column chromatography was performed 
using forced flow of the indicated solvent system on EMD Geduran Silica Gel 60 as solid 
support and HPLC graded solvents as eluant. Reactions were monitored by thin layer 
chromatography (TLC) on Merck silica gel 60 covered aluminium sheets. TLC plates were 
developed under UV-light and/or with an acidic ethanolic anisaldehyde solution or a 
KMnO4-solution. Liquid reagents were distilled prior to use where stated. All reagents 
were purchased from commercial suppliers and used without further purification unless 
otherwise stated. All HPLC used to determine enantiomeric purity were calibrated with 
samples of the racemate. 
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4.2 Experimental Details 
(2-(Prop-1’-en-2’-yl)phenyl) methanol (1.110)  
 
Following a literature procedure,[12] to a stirred suspension of methyl triphenyl-
phosphonium bromide (7.2 g, 20 mmol,) in THF (51 mL) was added a solution of 
potassium tert-butoxide (2.3 g, 20 mmol) in THF (21 mL). The resulting bright yellow 
suspension was stirred at room temperature for 15 minutes then a solution of o-
bromoacetophenone (2.14) (3.4 g, 17 mmol) in THF (34 mL) added dropwise. The 
resulting suspension was stirred at room temperature for 3 h then sat. aq. NH4Cl (100 mL) 
was added. The mixture was extracted with Et2O (100 mL then 2 x 50 mL) and the 
combined organic extracts dried (MgSO4), filtered and concentrated in vacuo. Purification 
by flash chromatography (petroleum ether) afforded 1-bromo-2-(prop-1’-en-2’-yl)-benzene 
(2.15) as a colourless oil (3.0 g, 91%). Data corresponded to literature values.[144] 
Following a literature procedure,[12] to a cooled (0 °C) solution of 1-bromo-2-(prop-1’-en-2’-
yl) benzene (2.15) (2.1 g, 11 mmol) in Et2O (21 mL) was added dropwise a solution of n-
butyllithium (2.1 M in hexanes, 5.3 mL, 11 mmol) under argon. The resulting yellow 
suspension was stirred for 15 minutes then added dropwise to a flask charged with carbon 
dioxide pellets (ca. 50 g). The mixture was allowed to warm to room temperature over 2 h 
then sat. aq. NaHCO3 (100 mL) was added. The mixture was extracted with Et2O (2 x 50 
mL) and the aqueous phase adjusted to pH 1 with 1 M aq. HCl. The aqueous phase was 
then extracted with Et2O (3 x 100 mL) and the combined organic extracts dried (MgSO4), 
filtered and concentrated in vacuo to afford 2-(prop-1’-en-2’-yl) benzoic acid (2.10) as a 
sticky white solid (1.7 g, 99%). Data corresponded to literature values.[38] 
Following a literature procedure,[12] to a cooled (0 °C) suspension of lithium aluminium 
hydride (0.47 g, 12 mmol) in Et2O (34 mL) was added dropwise a solution of 2-(prop-1’-
en-2’-yl) benzoic acid (2.10) (0.78 g, 4.8 mmol) in Et2O (20 mL). After 5 minutes, the 
reaction mixture was allowed to warm to room temperature and stirred for 5 h. The 
mixture was re-cooled to 0 °C and sat. aq. potassium sodium tartrate (25 mL) added 
slowly. The biphasic mixture was allowed to stir at room temperature for 16 h then 
extracted with Et2O (3 x 50 mL). The organic extracts were washed with water (50 mL), 
dried (MgSO4), filtered and concentrated in vacuo. Purification by flash chromatography 
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(petroleum ether/EtOAc; 9:1) afforded the title compound (1.110) as a colourless oil (0.64 
g, 90%). Data corresponded to literature values.[145] 
Methyl 2-(prop-1’-en-2’-yl)benzoate (2.18) 
 
To a solution of 2-(prop-1’-en-2’-yl) benzoic acid (2.10) (0.22 g, 1.4 mmol) in MeOH (3.5 
mL) was added KOH (95 mg, 1.7 mmol)  and methyl iodide (0.67 mL, 11 mmol). The 
reaction was allowed to stir for 16 h under reflux. The resulting mixture was then 
quenched with ice water and the organic phase was extracted with chloroform (3 x 5 mL). 
The crude material was then purified by column chromatography (petroleum ether/EtOAc; 
95:5) to afford methyl 2-(prop-1’-en-2’-yl)benzoate (2.18) as a colourless oil (0.18 g, 76%). 
Data corresponded to literature values.[146] 
5-methoxy-2-(prop-1’-en-2’-yl)benzoic acid (2.23) 
 
5-methoxy-2-(prop-1’-en-2’-yl)benzoate (2.22) (0.62 g, 3.0 mmol) was dissolved in EtOH 
(40 mL), and 2 M aq. NaOH (30 mL) added. The mixture was stirred at room temperature 
for 16 h then EtOH was removed in vacuo. The residue was extracted with Et2O (2 x 30 
mL), acidified to pH 3 with 2 M aq. HCl and extracted with EtOAc (3 x 30 mL). The 
combined organic layers were dried (MgSO4), filtered and concentrated in vacuo to afford 
5-methoxy-2-(prop-1’-en-2’-yl)benzoic acid (2.23) as a colourless solid (0.45 g, 78%), 
which was used directly without further purification. 
1H NMR (400 MHz, CDCl3) δ (ppm): 7.47 (1 H, d, J = 2.8 Hz, ArH) 7.19, (1 H, d, J = 8.3 
Hz, ArH), 7.06 (1 H, dd, J = 8.2, 2.9 Hz, ArH), 5.13−5.11 (1 H, m, CHH), 4.90−4.85 (1 H, 
m, CHH), 3.86 (3 H, s, OCH3), 2.12−2.07  (3 H, m, CH3); 
13C NMR (100 MHz, CDCl3) δ 
(ppm): 171.8 (C=O), 158.3 (C), 146.1 (C), 138.5 (C), 130.8 (ArCH), 128.8 (C), 118.9 
(ArCH), 115.0 (ArCH), 114.0 (CH2), 55.5 (OCH3), 24.3 (CH3); IR (thin film) 2955, 2914, 
1693, 1281 cm-1; HRMS (ESI) exact mass calculated for C11H11O3 [M-H]
- m/z 191.0714, 
found m/z 191.0711. 
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Methyl 2-(2’-methylallyl)benzoate (2.53)  
 
Following a modification of a reported procedure,[140] to a suspension of magnesium 
turnings (2.2 g, 92 mmol) and a crystal of iodine in THF (80 mL) was added dropwise 
bromobutane (9.7 mL, 76 mmol). The mixture was stirred for 15 minutes then cooled to –
40 °C before dropwise addition of methyl-2-iodobenzoate (2.52) (10 g, 38 mmol) in THF 
(300 mL). The mixture was stirred at –40 °C for 1.5 h. A freshly prepared solution of LiCl 
(3.2 g, 76 mmol) and CuCN (3.2 g, 38 mmol) in THF (200 mL) was added and the mixture 
was stirred for a further 15 minutes, followed by the addition of 3-chloro-2-methylprop-1-
ene (15.0 mL, 153 mmol). The mixture was stirred at –40 °C for a further 10 minutes, then 
warmed to room temperature. The mixture was diluted with EtOAc (200 mL) and filtered 
over Celite®. The filtrate was washed with 25% aq. NH4OH (200 mL). The aqueous layer 
was further extracted with EtOAc (2 x 200 mL), and the combined organic extracts 
washed with brine (200 mL), dried (MgSO4), filtered and concentrated in vacuo. 
Purification by flash chromatography (petroleum ether/EtOAc; 95:5), afforded methyl 2-(2’-
methylallyl)benzoate (2.53) as a yellow oil (6.9 g, 95%). Material was used directly in the 
next step.[140] 
2-(2’-methylallyl)benzoic acid (2.54) 
 
2-(2’-methylallyl)benzoate (2.53) (6.5 g, 34 mmol) was dissolved in EtOH (350 mL), and 2 
M aq. NaOH (300 mL) added. The mixture was stirred for at room temperature overnight 
then EtOH was removed in vacuo. The aqueous solution was extracted with Et2O (2 x 150 
mL), acidified to pH 1 with 2 M aq. HCl and extracted with EtOAc (3 x 150 mL). The 
combined organic layers were dried (MgSO4), filtered and concentrated in vacuo to afford 
2-(2’-methylallyl)benzoic acid (2.54) as a colourless solid (6.1 g, 93%), which was used 
directly without further purification. Data corresponded to literature values.[89] 
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4-methylpent-4-enoic acid (2.6) 
 
Methyltriphenylphosphonium bromide (3.75 g, 10.5 mmol) was suspended in THF (46 
mL). The colourless suspension was cooled to 0 °C and n-butyllithium (2.10 M in hexanes, 
4.80 mL, 10.5 mmol) was added dropwise. The resulting bright orange solution was stirred 
at 0 °C for 1 h before the dropwise addition of levulinic acid (2.39) (0.410 g, 3.50 mmol). 
The suspension was allowed to warm to room temperature and stirred overnight. The 
reaction was then quenched by adding a 1 M aq. HCl solution (10 mL) and the aqueous 
layer was extracted with Et2O (3 x 40 mL). The combined organic layers were dried over 
MgSO4, filtered and concentrated under reduced pressure. The crude product was purified 
by column chromatography (Petroleum ether/EtOAc; 85:15) to afford 4-methylpent-4-
enoic acid (2.6) (263 mg, 66%) as a clear yellow oil. Data corresponded to literature 
values.[38] 
 
2,2,4-trimethylpent-4-enoic acid (2.41) 
 
Following a reported procedure,[38] isobutyric acid (2.40) (475 mg, 5.39 mmol) was added 
dropwise to a stirred suspension of NaH (60% dispersion in mineral oil, 236 mg, 5.89 
mmol) and diisopropylamine (780 µL, 5.50 mmol) in THF (7.50 mL). The resulting 
suspension was heated at reflux for 20 minutes and then cooled to 0°C for 15 minutes 
prior to the dropwise addition of n-butyllithium (2.20 M in hexanes, 2.50 mL, 5.40 mmol). 
The resulting suspension was stirred at 0 °C for an additional 15 minutes and then heated 
to 35 °C for 30 minutes. The suspension was cooled to 0 °C and methallyl chloride (540 
µL, 5.50 mmol) was added dropwise to give an off-white suspension which was stirred for 
2 h at 35 °C. The suspension was then cooled with an ice-bath and the excess of NaH 
was quenched with water (10 mL). The organic layer was washed with a 1 M aq. NaOH 
solution (3 x 20 mL) and the combined aqueous layers were then extracted with Et2O (20 
mL). The aqueous layer was acidified by addition of a 1 M aq. HCl solution until pH 1 and 
was then extracted with ether (3 x 20 mL). The combined organic layers were dried over 
MgSO4, filtered and the solvent was evaporated in vacuo to afford 2,2,4-trimethylpent-4-
enoic acid as a colourless oil (2.41) (485 mg, 63%) as a colourless oil. Data corresponded 
to literature values.[38] 
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Methyl-2-allyl-benzoate (4.1) 
 
Following a modification of a reported procedure,[140] to a suspension of magnesium 
turnings (2.2 g, 92 mmol) and a crystal of iodine in THF (80 mL) was added dropwise 
bromobutane (9.7 mL, 76 mmol). The mixture was stirred for 15 minutes then cooled to –
40 °C before dropwise addition of methyl-2-iodobenzoate (2.52) (5.80 mL, 38.0 mmol). 
The mixture was stirred at –40 °C for 1.5 h. A freshly prepared solution of LiCl (3.2 g, 76 
mmol) and CuCN (3.20 g, 38.0 mmol) in THF (200 mL) was added and the mixture was 
stirred for a further 15 minutes, followed by the addition of allyl bromide (13.0 mL, 153 
mmol). The mixture was stirred at –40 °C for a further 10 minutes, then warmed to room 
temperature. The mixture was diluted with EtOAc (200 mL) and filtered over Celite®. The 
filtrate was washed with 25% aq. NH4OH (200 mL). The aqueous layer was further 
extracted with EtOAc (2 x 200 mL), and the combined organic extracts washed with brine 
(200 mL), dried (Na2SO4), filtered and concentrated in vacuo. Purification by flash 
chromatography (petroleum ether/EtOAc; 9:1), afforded methyl-2-allyl-benzoate (4.1) as a 
colourless oil (6.39 g, 95%). Data corresponded to literature values.[140] 
2-allylbenzoic acid (1.15) 
 
Methyl 2-allylbenzoate (4.1) (528 mg, 3.00 mmol) was dissolved in EtOH (10 mL), and 2 
M aq. NaOH (10 mL) added. The mixture was stirred for at room temperature overnight 
then EtOH was removed in vacuo. The residue was extracted with Et2O (2 x 10 mL), 
acidified to pH 1 with 2 M aq. HCl and extracted with EtOAc (3 x 10 mL). The combined 
organic layers were dried (MgSO4), filtered and concentrated in vacuo to afford 2-
allylbenzoic acid (1.15) as a colourless solid (400 mg, 82%), which was used directly 
without further purification. Data corresponded to literature values.[140] 
2-allyl-N-tosylbenzamide (2.91) 
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To a solution of 2-allyl benzoic acid (1.15) (2.35 g, 14.5 mmol) in THF (43 mL) was added 
p-tosyl isocyanate (2.20 g, 14.5 mmol). The resulting solution was stirred for 10 minutes 
then triethylamine (2.02 mL, 14.5 mmol) added dropwise. Gas evolution was observed on 
addition. After 1 h, the mixture was diluted with EtOAc (50 mL) and washed with 2 M aq. 
HCl (50 mL) and brine (50 mL). The organic extracts were dried (MgSO4), filtered and 
concentrated in vacuo. The crude product was purified by column chromatography 
(CH2Cl2) to afford the title compound (2.91) as a colourless solid (3.68 g, 81%). Data 
corresponded to literature values.[140] 
1-bromo-2-(1’-phenylvinyl)benzene (2.96) 
 
Following a reported procedure,[38] a solution of 2’-bromoacetophenone (2.14) (2.00 mL, 
15.0 mmol) in THF (2 mL) was added dropwise to a stirred solution of phenylmagnesium 
bromide in THF (16.6 mL,16.6 mmol). The resulting mixture was heated at reflux for 2 h, 
then allowed to cool to room temperature and quenched by addition of sat. aq. NH4Cl (15 
mL). The aqueous layer was extracted with Et2O (3 x 20 mL) and the combined organic 
layers were washed with water, dried over MgSO4, filtered and concentrated in vacuo to 
afford the crude carbinol. The crude carbinol was treated with a solution of H2SO4 in acetic 
acid (4 mL, 20% v/v) at 50 °C for 5 minutes. The mixture was then poured into an 
Et2O/water two-phase system (1:1, 100 mL). The aqueous layer was extracted with diethyl 
ether (2 x 100 mL) and the combined organic layers were washed with 1 M aq. NaHCO3 
(25 mL), dried over MgSO4, filtered and concentrated under reduced pressure. The crude 
product was purified by column chromatography (petroleum ether) to furnish 1-bromo-2-
(1’-phenylvinyl)benzene (2.26) (2.75 g , 71%) as a colourless oil. Data corresponded to 
literature values.[38] 
 
2-(1’-phenylvinyl)benzoic acid (2.24) 
 
2-(1’-phenylvinyl)benzene (2.26) (1.76 g, 6.80 mmol) was dissolved in Et2O (15 mL) and 
the resulting colourless mixture was cooled to 0 °C and stirred for 5 minutes. n-butyllithium 
(2.30 M hexane, 3.10 mL, 7.10 mmol) was added dropwise. After 50 minutes, CO2 was 
bubbled through the mixture for 30 minutes upon which the reaction turned yellow. The 
reaction was then warmed to room temperature and stirred for an additional 2 h. The 
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reaction was quenched by adding sat. aq. NaHCO3 (20 mL). The aqueous layer was 
washed with diethyl ether (3 x 20 mL), acidified to pH 1 with 2 M aq. HCl and extracted 
with Et2O (3 x 20 mL). The combined organic layers were dried over MgSO4, filtered and 
concentrated in vacuo, to afford the product 2-(1-phenylvinyl)benzoic acid (2.24) (579 mg, 
39%) as a colourless solid. Data corresponded to literature values.[38] 
 
2-vinyl benzoic acid (2.79) 
 
To a stirred suspension of methyltriphenylphosphonium bromide (19 g, 53 mmol) in THF 
(80 mL) was added dropwise a solution of potassium tert-butoxide (8.8 g, 79 mmol) in 
THF (40 mL). The resultant yellow solution was stirred for 1.5 h, before the addition of a 
solution of 2-carboxybenzaldehyde 2.83 (5.0 g, 33 mmol) in THF (20 mL). The solution 
was warmed to 60 °C and stirred overnight, before cooling and the addition of acetic acid 
(5.0 mL) and the solution was filtered over Celite®. The filtrate was concentrated in vacuo, 
before being washed with sat. aq. NaHCO3 (3 x 50 mL). The combined aqueous extracts 
were acidified to pH 1 with 1 M aq. HCl, and the aqueous phase was extracted with Et2O 
(3 x 50 mL). The organic extracts were dried (Na2SO4), filtered and concentrated in vacuo 
to afford title compound 2.79 as a colourless solid (1.6 g, 32%). No further purification was 
required. Data corresponded to literature values.[147] 
 
1-bromo-2-(but-2’-en-2’-yl)benzene (2.36) 
 
Following a reported procedure,[38] ethyltriphenylphosphonium bromide (4.40 g, 12.0 
mmol) was added to a suspension of potassium t-butoxide (1.35 g, 12.0 mmol) in toluene 
(44 mL). The resulting orange suspension was stirred at 0 °C for 10 minutes, allowed to 
warm to room temperature and stirred for an additional 1 h. The mixture was cooled to 0 
°C and 2’-bromoacetophenone (2.14) (0.88 g, 4.4 mmol) was added dropwise. The 
mixture was heated at reflux for 8 h, then cooled to room temperature and quenched with 
sat. aq. NH4Cl (50 mL). The aqueous layer was extracted with Et2O (3 x 50 mL) and the 
combined organic layers were dried over MgSO4, filtered and concentrated under reduced 
pressure. The resulting colourless solid was triturated with hexane (50 mL) and 
triphenylphosphine oxide was removed by filtration. The filtrate was concentrated in vacuo 
and purified by column chromatography (petroleum ether) to afford bromostyrene (2.36) 
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(684 mg, 74%, mixture of E and Z isomers) as a colourless oil. Data corresponded to 
literature values.[38] 
 
2-(but-2’-en-2’-yl)benzoic acid (2.32) 
 
n-butyllithium (2.18 M in hexanes, 1.46 mL, 3.20 mmol) was added dropwise to a stirred 
solution of 2.36 (564 mg, 2.70 mmol) in Et2O (3.8 mL) at 0 °C. After 15 minutes CO2 was 
bubbled through the reaction mixture for 10 minutes. The mixture was then allowed to 
warm to room temperature and stirred for an additional 2 h. The reaction was quenched 
with sat. aq. NaHCO3 (15 mL). The aqueous layer was washed with Et2O (3 x 15 mL), 
then acidified to pH 1 with 2 M aq. HCl and extracted with Et2O (3 x 15 mL). The 
combined organic layers were dried over MgSO4, filtered and concentrated in vacuo to 
afford benzoic acid (2.32) (190 mg, 40%, mixture of E and Z isomers) as a colourless 
solid. Data corresponded to literature values.[38] 
 
1-(2’-methylallyl)pyrrole-2-carboxylic acid (2.59) 
 
To a flask containing 60% NaH in mineral oil (480 mg, 12.0 mmol) in DMF (10 mL) was 
added dropwise a solution of methyl pyrrole-2-carboxylate (2.58)  (1.00 g, 8.00 mmol) in 
DMF (2 mL) at 0 °C. The mixture was stirred at 0 °C for 30 minutes before the addition of 
methallyl chloride (1.30 mL, 13.6 mmol). The mixture was then allowed to warm to room 
temperature and was stirred for 2 h before quenching with H2O (20 mL). The aqueous 
layer was then washed with Et2O (3 x 30 mL).  The combined organic layers were then 
washed with H2O (3 x 100 mL) and brine and dried over MgSO4 and concentrated in 
vacuo to afford a crude mixture (1.35 g). The crude mixture was then subsequently 
dissolved in EtOH (18 mL), and 2 M aq. NaOH (21 mL) added. The mixture was stirred at 
room temperature overnight then EtOH was removed in vacuo. The residue was extracted 
with Et2O (2 x 20 mL), acidified to pH 1 with 2 M aq. HCl and extracted with EtOAc (3 x 20 
mL). The combined organic layers were dried (MgSO4), filtered and concentrated in vacuo 
to afford 1-(2’-methylallyl)pyrrole-2-carboxylic acid (2.59) as a colourless solid (840 mg, 
64% over two steps), which was used directly without further purification. 
1H NMR (400 MHz, CDCl3) δ (ppm): 7.12 (1 H, dd, J = 4.0, 1.8 Hz, ArH), 6.93−6.88 (1 H, 
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m, ArH), 6.21 (1 H, dd, J = 4.0, 2.5 Hz, ArH), 4.89 (2 H, s, NCH2), 4.86−4.82 (1 H, m, 
C=CHH), 4.47 (1 H, s, C=CHH), 1.72 (3 H, s, CH3); 
13C NMR (100 MHz, CDCl3) δ (ppm): 
165.5 (C=O), 142.2 (C), 130.1 (ArCH), 121.2 (C), 120.0 (ArCH), 111.1 (ArCH), 108.5 
(CH2), 53.9 (NCH2), 19.9 (CH3); IR (thin film) 2359, 2342, 1651, 1265 cm
-1; HRMS (EI) 
exact mass calculated for C9H11NO2 [M]
+ m/z 165.0790 , found m/z 165.0791. 
1-(2’-methylallyl)indole-2-carboxylic acid (2.61) 
 
To a flask containing 60% NaH in mineral oil (320 mg, 8.00 mmol) in DMF (4 mL) was 
added dropwise a solution of ethyl indole-2-carboxylate (2.60)  (1.00 g, 5.00 mmol) in 
DMF (12 mL) at 0 °C. The mixture was stirred at 0 °C for 30 minutes before the addition of 
methallyl chloride (880 µL, 9.00 mmol). The mixture was then allowed to warm to room 
temperature and was stirred for 2 h before quenching with H2O (20 mL). The aqueous 
layer was then washed with Et2O (3 x 30 mL). The combined organic layers were then 
washed with H2O (3 x 100 mL) and brine and dried over MgSO4 and concentrated in 
vacuo to afford the crude material (940 mg). The intermediate was then subsequently was 
dissolved in EtOH (20 mL), and 2 M aq. NaOH (20 mL) added. The mixture was stirred at 
room temperature overnight then EtOH was removed in vacuo. The residue was extracted 
with Et2O (2 x 20 mL), acidified to pH 1 with 2 M aq. HCl and extracted with EtOAc (3 x 20 
mL). The combined organic layers were dried (MgSO4), filtered and concentrated in vacuo 
to afford 1-(2’-methylallyl)indole-2-carboxylic acid (2.61) as a colourless solid (495 mg, 
46% over two steps), which was used directly without further purification. 
1H NMR (400 MHz, CDCl3) δ (ppm): 7.76−7.71 (1 H, m, ArH), 7.52 (1 H, s, ArH), 
7.39−7.35  (2 H, m, ArH), 7.22−7.15 (1 H, m, ArH), 5.19 (2 H, s, NCH2), 4.84−4.79 (1 H, 
m, C=CHH), 4.35 (1 H, s, C=CHH), 1.76 (3 H, s, CH3); 
13C NMR (100 MHz, CDCl3) δ 
(ppm): 166.3 (C=O), 141.4 (ArC), 140.0 (ArC), 126.3 (C), 125.8 (C), 125.8 (ArCH), 122.9 
(ArCH), 120.8 (ArCH), 112.9 (ArCH), 111.0 (ArCH), 110.6 (CH2), 49.9 (CH2), 20.1 (CH3); 
IR (thin film) 2360, 2332, 1680, 1269 cm-1; HRMS (ESI) exact mass calculated for 
C13H13NO2Na [M+Na]
+ m/z 238.0838, found m/z 238.0842. 
Ethyl 2-(tert-butoxycarbonylamino)acetate (2.68) 
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Following a literature procedure[148], a solution of sodium hydrogen carbonate (1.20 g, 
14.3 mmol) in water (20 mL), a solution of di-tert-butyl dicarbonate (2.67) (3.12 g, 14.3 
mmol) in chloroform (2 mL) and sodium chloride (2.2 g) were added to a stirred 
suspension of glycine ethyl ester hydrochloride (2.00 g, 14.3 mmol) in chloroform (14 mL). 
The resulting biphasic mixture was stirred vigorously at reflux for 1.5 h, allowed to cool 
and the two layers were separated. The aqueous phase was extracted with chloroform (2 
× 50 mL) and the combined organic layers were dried (MgSO4) and concentrated in vacuo 
to yield the title compound (2.68) (2.91 g, quantitative) as a viscous colourless oil. Data 
corresponded to literature values.[149] 
 
2-(2’-methylallyl)phenol (1.83) 
 
To a stirred suspension of K2CO3 (8.8 g, 64 mmol) in DMF (160 mL) was added phenol 
(2.125) (3.0 g, 32 mmol) followed by 3-chloro-2-methyl-1-propene (3.7 mL, 38 mmol). The 
resulting mixture was heated at 70 °C for 16 h then cooled to room temperature, 
quenched with water (250 mL) and extracted with Et2O (2 x 100 mL). The combined 
organic extracts were washed with brine (2 x 100 mL), dried (MgSO4), filtered and 
concentrated in vacuo to afford 1-(2’-methylallyloxy)benzene (2.126) as a colourless oil 
(4.7 g, quant.) which was used without any further purification. Data corresponded to 
literature values.[150] 
A solution of 1-(2’-methylallyloxy)benzene (2.126) (1.5 g, 10 mmol) in DMF (8.4 mL) under 
argon was subjected to microwave irradiation at 240 °C for 2.5 h. The resulting mixture 
was extracted with Et2O (3 x 50 mL) and the combined organic extracts washed with 
water (50 mL) then brine (2 x 50 mL), dried (MgSO4), filtered and concentrated in vacuo. 
Purification by flash chromatography (petroleum ether/EtOAc; 19:1) afforded the title 
compound (1.83) as a yellow oil (1.2 g, 80%). Data corresponded to literature values.[38] 
4-bromo-2-(2’-methylallyl)phenol (3.1) 
 
To a stirred suspension of K2CO3 (3.98 g, 28.8 mmol) in DMF (60 mL) was added 4-
bromophenol (3.3) (2.00 g, 11.6 mmol) followed by 3-chloro-2-methyl-1-propene (1.36 mL, 
13.9 mmol). The resulting mixture was heated at 70 °C for 18 h then cooled to room 
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temperature, quenched with water (25 mL) and extracted with Et2O (2 x 25 mL). The 
combined organic extracts were washed with brine (2 x 25 mL), dried (MgSO4), filtered 
and concentrated in vacuo to afford 1-(2’-methylallyloxy)-4-bromobenzene (3.4) as a 
colourless oil (2.63 g, quant.) which was used without any further purification. Data 
corresponded to literature values.[38] 
A solution of 1-(2’-methylallyloxy)-4-bromobenzene (3.4) (2.00 g, 8.81 mmol) in DMF (5.9 
mL) under argon was subjected to microwave irradiation at 240 °C for 30 minutes. The 
resulting mixture was diluted with water (25 mL), extracted with EtOAc (3 x 25 mL) and 
the combined organic extracts washed with brine (3 x 25 mL), dried (MgSO4), filtered and 
concentrated in vacuo. Purification by flash chromatography (petroleum ether/EtOAc, 9:1) 
afforded the title compound (3.1) as a colourless oil (1.43 g, 72%). Data corresponded to 
literature values.[38] 
Dimethyl 2-(2’-methylallyl)malonate (2.44) 
 
Following a modification of the reported procedure,[89] to a cooled (0 °C) suspension of 
NaH (60% dispersion in mineral oil, 540 mg, 13.5 mmol) in THF (150 mL) was added 
dropwise dimethyl malonate (2.43) (2.0 mL, 18 mmol). Once effervescence had ceased, 
3-chloro-2-methyl-1-propene (970 µL, 10.0 mmol) was added then the cooling bath was 
removed. The mixture was stirred at room temperature for 2 h then heated at reflux for 18 
h. After cooling to room temperature, the reaction was quenched by addition of water (50 
mL) and extracted with Et2O (2 x 50 mL). The combined organic extracts were washed 
with brine (25 mL), dried (MgSO4), filtered and concentrated in vacuo. Purification by flash 
chromatography (petroleum ether/EtOAc; 95:5) afforded dimethyl 2-(2’-
methylallyl)malonate (2.44) as a colourless oil (1.35 g, 73%). Data corresponded to 
literature values.[151] 
2-(2’-methylallyl)malonic acid (2.45) 
 
Dimethyl 2-(2’-methylallyl)malonate (2.44)  (0.50 g, 2.7 mmol) was dissolved in EtOH (30 
mL), and 2 M aq. NaOH (23 mL) added. The mixture was stirred for at room temperature 
overnight then EtOH was removed in vacuo. The residue was extracted with Et2O (2 x 10 
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mL), acidified to pH 1 with 2 M aq. HCl and extracted with EtOAc (3 x 10 mL). The 
combined organic layers were dried (MgSO4), filtered and concentrated in vacuo to afford 
2-(2’-methylallyl)malonic acid (2.45) as a colourless solid (0.43 g, quantitative), which was 
used directly without further purification. Data corresponded to literature values. [152] 
Ethyl 2-(tert-butoxycarbonylamino)acetate (2.69) 
 
Following a modified literature procedurefor a related compound,[153] to a 0 °C solution of 
ethyl 2-(tert-butoxycarbonylamino)acetate (2.68) (2.43 g, 12.0 mmol) in 30 mL DMF was 
added allyl bromide (1.80 mL, 18.0 mmol) followed by NaH (60% dispersion in mineral oil, 
720 mg, 18.0 mmol). The reaction was maintained at 0 °C for 90 minutes. Sat. aq NH4Cl 
and EtOAc were added. The layers were separated and the aqueous layer was extracted 
with EtOAc. The organic layers were combined, washed with brine, dried over MgSO4, 
ﬁltered, and concentrated in vacuo. The crude product was puriﬁed by ﬂash 
chromatography (petroleum ether/EtOAc; 95:5) to yield the title compoundas a colourless 
oil (2.69) of a colourless oil (1.37 g, 44%). 
1H NMR (400 MHz, C6D6, 50 °C due to rotameric mixture) δ (ppm): 4.71 (2 H,  br. s, CH2), 
4.00–3.90 (4 H, m, 2 x CH2), 3.87–3.69 (2 H, m, CH2), 1.60 (3 H, br. s, CH3), 1.42 (9 H, br. 
s, 3 x CH3), 0.94 (3 H, br. s, CH3); IR (thin film) 2361, 2341, 1737, 1681 cm
-1; HRMS (CI) 
exact mass calculated for C13H23NO4H [M+H]
+ m/z 258.1705, found m/z 258.1703. 
13C NMR unavailable due to complex mixture of rotamers. 
2-(tert-butoxycarbonyl(2’-methylallyl)amino)acetic acid (2.70) 
 
Ethyl 2-(tert-butoxycarbonyl(2’-methylallyl)amino)acetate (2.69) (0.40 mg, 1.6 mmol) was 
dissolved in EtOH (15 mL), and 2 M aq. NaOH (10 mL) was added. The mixture was 
stirred at room temperature overnight then EtOH was removed in vacuo. The residue was 
extracted with Et2O (2 x 10 mL), acidified to pH 1 with 2 M aq. HCl and extracted with 
EtOAc (3 x 10 mL). The combined organic layers were dried (MgSO4), filtered and 
concentrated in vacuo to afford 2-(tert-butoxycarbonyl(2’-methylallyl)amino)acetic acid 
(2.70) as a colourless solid (0.36 g, quantitative), which was used directly without further 
purification. 
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1H NMR (400 MHz, C6D6, 50 °C due to rotameric mixture) δ (ppm): 4.74–4.53 (2 H, m, 
CH2), 3.96–3.52 (4 H, m, 2 x CH2), 1.53 (3 H, br. s, CH3), 1.40 (9 H, br. s, 3 x CH3); IR 
(thin film) 2976, 2359, 1697, 1159 cm-1; HRMS (CI) exact mass calculated for C11H19NO4H 
[M+H]+ m/z 230.1392, found m/z 230.1400. 
13C NMR unavailable due to complex mixture of rotamers. 
1-allyl-N-tosyl-pyrrole-2-carboxamide (3.54) 
 
Following a modification of a reported procedure,[140] to a cooled (0 °C) suspension of NaH 
(60% dispersion in mineral oil, 480 mg, 12 mmol) in DMF (10 mL) was added a solution of 
methyl-2-pyrrole-carboxylate (3.51) (1.0 g, 8.0 mmol) in DMF (2 mL). The resulting 
mixture was stirred for 20 min at 0 °C, then allyl bromide (1.2 mL, 14 mmol) added 
dropwise. The mixture was allowed to warm to room temperature, and stirred for 2 h, then 
quenched by pouring onto ice (30 g). The mixture was extracted with Et2O (3 x 15 mL) 
and the combined organic extracts were washed with water (4 x 15 mL), brine (1 x 15 
mL), dried (MgSO4), filtered and concentrated in vacuo to afford methyl-1-allyl-pyrrole-2-
carboxylate (3.52) as a colourless oil (1.3 g, 98%) which was used directly without further 
purification.  
To a solution of methyl-1-allyl-pyrrole-2-carboxylate (3.52) (1.30 g, 7.87 mmol) in EtOH 
(20 mL) was added 1 M aq. NaOH (20 mL). The mixture was refluxed for 1.5 h, then EtOH 
was removed in vacuo. The aqueous phase was washed with EtOAc (3 x 25 mL) then 
acidified to pH 2 with 4 M aq. HCl and extracted with EtOAc (3 x 25 mL). The combined 
organic extracts were dried (MgSO4), filtered and concentrated in vacuo, to afford 1-allyl-
pyrrole-2-carboxylic acid (3.53) as a colourless solid (1.0 g, 89%) which was used directly 
without further purification.  
To a flask charged with 1-allyl-pyrrole-2-carboxylic acid (3.53) (0.50 g, 3.3 mmol) in THF 
(10 mL) was added p-tosyl isocyanate (0.77 g, 6.6 mmol). The resulting solution was 
stirred for 10 minutes then triethylamine (0.50 mL, 3.6 mmol) added dropwise. Gas 
evolution was observed on addition. After 1 h, the mixture was diluted with EtOAc (50 mL) 
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and washed with 2 M aq. HCl (50 mL) and brine (50 mL). The organic extracts were dried 
(MgSO4), filtered and concentrated in vacuo. The crude product was purified by column 
chromatography (CH2Cl2) to afford the title compound (3.54) as a colourless solid (0.71 g, 
61%). Data corresponded to literature values.[140] 
Ethyl 4-(4’-bromophenyl)-4-oxobutanoate (2.48) 
 
NaHMDS (7.7 g, 42 mmol) was added to a stirred solution of p-bromoacetophenone 2.47 
(7.6 g, 38 mmol) in dry THF (100 mL) at −78 °C, under argon, over 20 minutes. To the 
mixture was added ethyl bromoacetonate (8.9 mL, 80 mmol) in THF (30 mL) over 30 
minutes and the temperature was maintained at −78 °C for 35 minutes. The mixture was 
warmed to −10 °C over 3 h and after this time H2O (30 mL) was added to the reaction 
mixture. The solvent was removed by rotary evaporation and the residue was diluted with 
brine (100 mL). The suspension was extracted with EtOAc (2 x 100 mL). The solution was 
dried over MgSO4, filtered and concentrated. The crude mixture was then purified by 
column chromatography (petroleum ether/EtOAc; 95:5) to give the desired product 2.48 
as a colourless oil(3.8 g, 35%). 
1H NMR (500 MHz, CDCl3) δ (ppm): 7.86 (2 H, d, J = 8.6 Hz, ArH), 7.62 (2 H, d, J = 8.5 
Hz, ArH), 4.17 (2 H, q, J = 7.1 Hz, CH2CH3), 3.28 (2 H, t, J = 6.6 Hz, CH2CH2), 2.76 (2 H, 
t, J = 6.6 Hz, CH2CH2), 1.28 (3 H, t, J = 7.1 Hz, CH2CH3); 
13C NMR (125 MHz, CDCl3) δ 
(ppm): 197.1 (C=O), 172.7 (C=O), 135.3 (ArC), 131.9 (2 x ArCH), 129.5 (2 x ArCH), 128.4 
(ArC), 60.7 (CH2), 33.3 (CH2), 28.2 (CH2), 14.2 (CH3); IR (thin film) 1730, 1685, 1585, 
1163 cm-1; HRMS (ESI) exact mass calculated for C12H13O3Br [M+Na]
+ m/z 306.9946, 
found m/z 306.9944. 
Ethyl 4-(4’-bromophenyl)pent-4-enoate (2.49) 
 
Following the literature procedure of a related compound,[44] to a stirred suspension of 
methyl triphenylphosphonium bromide (2.3 g, 6.5 mmol) in THF (13 mL) was added 
potassium tert-butoxide (0.73 g, 6.5 mmol). The resulting bright yellow suspension was 
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stirred at room temperature for 15 minutes then a solution of 2.48 (1.2 g, 5.4 mmol) in 
THF (12 mL) was added dropwise. The resulting suspension was stirred at room 
temperature for 3 h then sat. aq. NH4Cl (100 mL) was added. The mixture was extracted 
with Et2O (100 mL then 2 x 50 mL) and the combined organic extracts were dried 
(MgSO4), filtered and concentrated in vacuo. Purification by flash chromatography 
(petroleum ether/EtOAc; 98:2) afforded the title compound 2.49 as a colourless oil (1.1 g, 
71%).  
1H NMR (400 MHz, CDCl3) δ (ppm): 7.46 (2 H, d, J = 8.7 Hz, ArH), 7.30–7.25 (2 H, m, 
ArH), 5.31–5.29 (1 H, m, C=CHH), 5.13–5.10 (1 H, m, C=CHH), 4.13 (2 H, q, J = 6.9 Hz, 
OCH2CH3), 2.81 (2 H, t, J = 7.2 Hz, CH2CH2), 2.49–2.43 (2 H, m, CH2CH2), 1.25 (3 H, t, J 
= 7.2 Hz, OCH2CH3); 
13C NMR (100 MHz, CDCl3) δ (ppm): 172.9 (C=O), 145.9 (C=CH2), 
139.5 (ArC), 131.5 (2 x ArCH), 127.7 (2 x ArCH), 121.5 (ArC), 113.4 (C=CH2), 60.4 (CH2), 
33.1 (CH2), 30.3 (CH2), 14.2 (CH3); IR (thin film) 1730, 1488, 1154 cm
-1; HRMS (CI) exact 
mass calculated for C13H15O2BrH [M+H]
+ m/z 283.0334, found m/z 283.0331. 
4-(4’-bromophenyl)pent-4-enoic acid (2.50) 
 
Following the literature procedure of a related compound,[12] ethyl 4-(4’-bromophenyl)pent-
4-enoate (2.49) (1.0 g, 3.9 mmol) was dissolved in EtOH (32 mL), and 2 M aq. NaOH (32 
mL) was added. The mixture was stirred at room temperature overnight, and then EtOH 
was removed in vacuo. The residue was extracted with Et2O (2 x 50 mL), acidified to pH 
1, with 2 M aq. HCl and extracted with EtOAc (3 x 150 mL). The combined organic 
extracts were dried (MgSO4), filtered and concentrated in vacuo to afford 2.50 as a 
colourless solid (0.79 g, 79%), which was used directly without further purification. 
1H NMR (400 MHz, CDCl3) δ (ppm): 7.50–7.44 (2 H, m, ArH), 7.31–7.24 (2 H, m, ArH), 
5.33 (1 H, d, J = 0.8 Hz, C=CHH), 5.14 (1 H, d, J = 0.80 Hz, C=CHH), 2.82 (2 H, t, J = 7.3 
Hz, CH2CH2), 2.57–2.50 (2 H, m, CH2CH2); 
13C NMR (100 MHz, CDCl3) δ (ppm): 178.4 
(C=O), 145.5 (ArC), 139.3 (ArC), 131.5 (C=CH2), 127.7 (2 x ArCH), 121.7 (2 x ArCH), 
113.6 (C=CH2), 32.6 (CH2), 29.9 (CH2); IR (thin film) 2931, 1694, 1336 cm
-1; HRMS (CI) 
exact mass calculated for C11H11O2BrH [M+H]
+ m/z 255.0021, found m/z 255.0019. 
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Pd(tfacac)2 (2.99) 
 
To a solution of 1,1,1-trifluoropentane-2,4-dione (2.98) in EtOH (0.36 M) at room 
temperature, was added a solution of NaOH 50 % aq. MeOH via syringe. After the 
addition of NaOH was complete, Na2PdCl4 in H2O (0.070 M) was added dropwise via 
syringe. The reaction was allowed to stir overnight. The mixture was then washed with 
CH2Cl2 (2 x 10 mL) and the organic layers were then dried over MgSO4 and the solvent 
was evaporated to yield a brown solid. The amorphous solid was then dissolved in Et2O 
and filtered. The solvent was then evaporated to give compound 2.99 as a yellow solid (42 
mg, 36%). Data corresponded to literature values.[154] 
 
3-(but-3’-en-1’-yl)-3-methylisobenzofuranone (2.13) 
 
A 4 mL screw-top glass vial was charged with 2-(prop-1’-en-2’-yl)benzoic acid (2.10) (65 
mg, 0.40 mmol), toluene (1.3 mL), NaHCO3 (67 mg, 0.80 mmol), allyl bromide (0.17 mL, 
2.0 mmol) and Pd(hfacac)2 (10 mg, 0.020 mmol). The mixture was heated at 50 °C for 5 h. 
The reaction mixture was cooled to room temperature, and subjected directly to flash 
chromatography (petroleum ether/EtOAc; 9:1) to afford the title compound (2.13) as a 
colourless oil (69 mg, 85%). 
1H NMR (400 MHz, CDCl3) δ (ppm): 7.87 (1 H, dt, J = 7.6, 0.9 Hz, ArH), 7.66 (1 H, td, J = 
7.5, 1.1 Hz, ArH), 7.50 (1 H,  td, J = 7.5, 0.8 Hz, ArH), 7.36 (1 H, d, J = 7.7 Hz, ArH), 5.69 
(1 H, ddt, J = 16.7, 10.0, 6.3 Hz, CH=CH2), 4.94–4.89 (2 H, m, CH=CH2), 2.15 (1 H, ddd, J 
= 13.6, 11.2, 4.8, CHH), 2.10–2.02 (1 H, m, CHH), 1.96 (1 H, ddd, J = 13.7, 11.0, 4.6 Hz, 
CHH), 1.80–1.73 (1 H, m, CHH), 1.65 (3 H, s, CH3); 
13C NMR (100 MHz, CDCl3) δ (ppm): 
169.9 (C=O), 153.9 (ArC), 137.3 (CH=CH2), 134.2 (ArC), 129.1 (ArCH), 126.5 (ArCH), 
126.0 (ArCH), 121.0 (ArCH), 115.2 (CH=CH2), 87.3(CCH3), 39.3 (CH2), 28.0 (CH2), 26.3 
(CH3); IR (thin film) 1751, 1285, 1030 cm
-1; HRMS (EI) exact mass calculated for C13H14O2 
[M]+ m/z 202.0994, found m/z 202.0991.  
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3-methyl-3-(pent-4’-en-1’-yl)isobenzofuranone (2.37) 
 
A 4 mL screw-top glass vial was charged with 2-(prop-1’-en-2’-yl)benzoic acid (2.10) (65 
mg, 0.40 mmol), toluene (1.3 mL), NaHCO3 (67 mg, 0.80 mmol), homoallyl bromide (0.2 
mL, 2 mmol) and Pd(hfacac)2 (10 mg, 0.020 mmol). The mixture was heated at 50 °C for 6 
h. The reaction mixture was cooled to room temperature, and subjected directly to flash 
chromatography (petroleum ether/EtOAc; 9:1) to afford the title compound (2.37) as a 
colourless oil (44 mg, 52%). 
1H NMR (400 MHz, CDCl3) δ (ppm): 7.86 (1 H, d, J = 7.8 Hz, ArH), 7.69−7.61 (1 H, m, 
ArH), 7.54−7.46  (1 H, m, ArH), 7.36 (1 H, d, J = 7.6 Hz, ArH), 5.67 (1 H, ddt, J = 17.1, 
10.1, 6.8, CH=CH2), 4.98−4.87 (2 H, m, CH=CH2), 2.08−1.95  (3 H, m, CHH and CH2), 
1.92−1.80 (1 H, m, CHHCH2), 1.64 (3 H, s, CH3), 1.49−1.32 (1 H, m, CHHCH2), 1.12−0.99 
(1 H, m, CHHCH2); 
13C NMR (100 MHz, CDCl3) δ (ppm): 169.9 (C=O), 153.8 (ArC), 137.7 
(CH=CH2), 134.0 (ArCH), 128.9 (ArCH), 126 (ArC), 125.7 (ArCH), 120.8 (ArCH), 115.0 
(CH=CH2), 87.5 (CCH3), 39.1 (CH2), 33.2 (CH2), 25.9 (CH3), 22.6 (CH2); IR (thin film) 
2931, 2854, 1750, 1287 cm-1; HRMS (ESI) exact mass calculated for C14H16O2Na [M+Na]
+ 
m/z 239.1043, found m/z 239.1041. 
3-(but-3’-en-1’-yl)-3-phenylisobenzofuranone (2.27) 
 
A 4 mL screw-top glass vial was charged with 2-(1’-phenylvinyl)benzoic acid (2.24) (90 
mg, 0.40 mmol), toluene (1.3 mL), NaHCO3 (67 mg, 0.80 mmol), allyl bromide (0.17 mL, 
2.0 mmol) and Pd(hfacac)2 (10 mg, 0.020 mmol). The mixture was heated at 50 °C for 5 h 
then additional Pd(hfacac)2 (10 mg, 0.020 mmol) added. The reaction was heated 50 °C 
for a further 19 h. The reaction mixture was cooled to room temperature, and subjected 
directly to flash chromatography (petroleum ether/EtOAc; 9:1) to afford the title compound 
(2.27) as a colourless oil (74 mg, 70%). 
1H NMR (400 MHz, CDCl3) δ (ppm): 7.82 (1 H, d, J = 7.6 Hz, ArH), 7.63−7.57 (1 H, m, 1H 
ArH), 7.50−7.42 (4 H, m, ArH), 7.33−7.27 (2 H, m, ArH), 7.26−7.21 (1 H, m, ArH), 5.65 (1 
H, ddt, J = 17.2, 10.0, 6.3 Hz, CH=CH2), 4.90−4.80 (2 H, m, CH=CH2), 2.55 (1 H, ddd, J = 
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14.0, 11.6, 4.8 Hz, CHHCH2), 2.26−2.17 (1 H, m, CHHCH2), 2.01−1.91 (1 H, m, CHHCH2), 
1.88−1.76 (1 H, m, CHHCH2); 
13C NMR (100 MHz, CDCl3) δ (ppm): 169.8 (C=O), 152.7 
(ArC), 140.2 (ArC), 136.9 (CH=CH2), 134.3 (ArCH), 129.1 (ArCH), 128.7 (2 x ArCH), 
128.1 (ArCH), 125.9 (ArCH), 125.9 (ArC), 124.9 (2 x ArCH), 122.1 (ArCH), 115.1 
(CH=CH2), 89.7 (CPh), 39.3 (CH2), 28.0 (CH2); IR (thin film) 3055, 2918, 1760, 1259 cm
-1; 
HRMS (ESI) exact mass calculated for C18H16O2Na [M+Na]
+ m/z 287.1043, found m/z 
287.1038. 
Bicyclic lactone (2.89) 
 
A 4 mL screw-top glass vial was charged with 2-(cyclopent-2’-en-1’-yl)acetic acid (2.88) 
(48 mg, 0.40 mmol), toluene (1.3 mL), NaHCO3 (67 mg, 0.80 mmol), allyl bromide (0.17 
mL, 2.0 mmol) and Pd(hfacac)2 (10 mg, 0.020 mmol). The mixture was heated at 50 °C for 
5 h. The reaction mixture was cooled to room temperature, and subjected directly to flash 
chromatography (petroleum ether/EtOAc; 9:1) to afford the title compound (2.89) as a 
colourless oil (39 mg, 78%). Data corresponded to literature values.[155] 
3-(but-3’-en-1’-yl)-6-methoxy-3-methylisobenzofuranone (2.24) 
 
A 4 mL screw-top glass vial was charged with 5-methoxy-2-(prop-1’-en-2’-yl)benzoic acid 
(2.23) (77 mg, 0.40 mmol), toluene (1.3 mL), NaHCO3 (67 mg, 0.80 mmol), allyl bromide 
(0.17 mL, 2.0 mmol) and Pd(hfacac)2 (10 mg, 0.020 mmol). The mixture was heated at 50 
°C overnight. The reaction mixture was cooled to room temperature, and subjected 
directly to flash chromatography (petroleum ether/EtOAc; 9:1) to afford the title compound 
(2.24) as a colourless oil (73 mg, 79%). 
1H NMR (400 MHz, CDCl3) δ (ppm): 7.32−7.30 (1 H, m, ArH), 7.29−7.26 (1 H, m, ArH), 
7.26−7.22 (1 H, m, ArH), 5.71 (1 H, ddt, J = 16.7, 10.0, 6.3 Hz, CH=CH2), 4.96−4.88 (2 H, 
m, CH=CH2), 3.88 (3 H, s, OCH3), 2.19−2.10 (1 H, m, CH2CHH), 2.09−1.99 (1 H, m, 
CH2CHH), 1.98−1.89 (1 H, m, CH2CHH), 1.80−1.69 (1 H, m, CH2CHH), 1.65 (3 H, s, CH3); 
13C NMR (100 MHz, CDCl3) δ (ppm): 169.7 (C=O), 160.5 (ArC), 146.0 (ArC), 137.1 
(CH=CH2), 127.4 (ArC), 122.9 (ArCH), 121.8 (ArCH), 115.0 (CH=CH2), 107.5 (ArCH), 86.9 
(CCH3), 55.7 (OCH3), 39.0 (CH2), 27.8 (CH2), 26.2 (CH3); IR (thin film) 2978, 2930, 2359, 
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1751 cm-1; HRMS (ESI) exact mass calculated for C14H16O3Na [M+Na]
+ m/z 255.0992, 
found m/z 255.0994. 
3-methyl-3-vinylisobenzofuranone (2.38) 
 
A 4 mL screw-top glass vial was charged with 2-(but-2’-en-2’-yl)benzoic acid (2.32) (70 
mg, 0.40 mmol), toluene (1.3 mL), NaHCO3 (67 mg, 0.80 mmol), allyl bromide (0.17 mL, 
2.0 mmol) and Pd(hfacac)2 (10 mg, 0.020 mmol). The mixture was heated at 50 °C for 5 h. 
The reaction mixture was cooled to room temperature, and subjected directly to flash 
chromatography (petroleum ether/EtOAc; 9:1) to afford the title compound (2.38) as a 
colourless oil (59 mg, 84%). Data corresponded to literature values.[156] 
3-(but-3’-en-1’-yl)-3-(tert-butyl)isobenzofuranone (2.31) 
 
A 4 mL screw-top glass vial was charged with 2-(3’,3’-dimethylbut-1’-en-2’-yl)benzoic acid 
(2.30) (82 mg, 0.40 mmol), toluene (1.3 mL), NaHCO3 (67 mg, 0.80 mmol), allyl bromide 
(0.17 mL, 2.0 mmol) and Pd(hfacac)2 (10 mg, 0.020 mmol). The mixture was heated at 50 
°C for 4 h. The reaction mixture was cooled to room temperature, and subjected directly to 
flash chromatography (petroleum ether/EtOAc; 9:1) to afford the title compound (2.31) as 
a colourless oil (77 mg, 79%). 
1H NMR (400 MHz, CDCl3) δ (ppm): 7.88−7.84 (1 H, m, ArH), 7.66−7.61 (1 H, m, ArH), 
7.53−7.48 (1 H, m, ArH), 7.44−7.40 (1 H, m, ArH), 5.63 (1 H, ddt, J = 16.9, 13.1, 6.4 Hz, 
CH=CH2), 4.86 (2 H, m, CH=CH2), 2.37−2.27 (1 H, m, CHHCH2), 2.14−2.01 (1 H, m, 
CHHCH2), 1.83−1.69  (1 H,m, CHHCH2), 1.29−1.17 (1 H,m, CHHCH2), 0.99 (9 H, s, CH3); 
13C NMR (100 MHz,CDCl3) δ (ppm): 170.6 (C=O), 150.6 (ArC), 137.3 (CH=CH2), 133.5 
(ArCH), 128.7 (ArCH), 127.4 (ArCC), 125.3 (ArCH), 122.5 (ArCH), 114.9 (CH=CH2), 94.3 
(CC(CH3)3), 38.3 (C(CH3)3), 31.5 (CH2), 27.1 (CH2), 25.4 (3 x CH3); IR (thin film) 2972, 
2249, 1753, 1290 cm-1; HRMS (ESI) exact mass calculated for C16H20O2Na [M+Na]
+ m/z 
267.1356, found m/z 267.1353. 
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5-(but-3’-en-1’-yl)-5-methyldihydrofuranone (2.9) 
 
A 4 mL screw-top glass vial was charged with 4-methylpent-4-enoic acid (2.6) (57 mg, 
0.40 mmol), toluene (1.3 mL), NaHCO3 (67 mg, 0.80 mmol), allyl bromide (0.17 mL, 2.0 
mmol) and Pd(hfacac)2 (10 mg, 0.020 mmol). The mixture was heated at 50 °C for 5 h 
then additional Pd(hfacac)2 (10 mg, 0.020 mmol) added. The reaction was heated 50 °C 
for a further 19 h. The reaction mixture was cooled to room temperature, and subjected 
directly to flash chromatography (petroleum ether/EtOAc; 9:1) to afford the title compound 
(2.9) as a colourless oil (37 mg, 61%). 
1H NMR (400 MHz, CDCl3) δ (ppm): 5.83 (1 H, ddt, J = 16.8, 10.3, 6.4 Hz, CH=CH2), 5.06 
(1 H, ddd, J = 17.2, 3.4, 1.8 Hz, CH=CHH), 5.00 (1 H, ddd, J = 10.2, 2.9, 1.3 Hz, 
CH=CHH), 2.70−2.53 (2 H, m, CH2), 2.22−2.06 (3 H, m, CH2 and CHH), 2.05−1.96 (1 H, 
m, CHH), 1.84−1.69 (2 H, m, CH2), 1.41 (3 H, s, CH3); 
13C NMR (100 MHz, CDCl3) δ 
(ppm): 176.6 (C=O), 137.4 (CH=CH2), 115.1 (CH=CH2), 86.4 (CCH3), 40.1 (CH2), 33.0 
(CH2), 29.1 (CH2), 28.1 (CH2), 25.6 (CH3); IR (thin film) 2976, 2932, 1761, 1205 cm
-1; 
HRMS (ESI) exact mass calculated for C9H14O2Na [M+Na]
+ m/z 177.0886, found m/z 
177.0884. 
5-(but-3’-en-1’-yl)-3,3,5-trimethyldihydrofuranone (2.42) 
 
A 4 mL screw-top glass vial was charged with 2,2,4-trimethylpent-4-enoic acid (2.41) (57 
mg, 0.40 mmol), toluene (1.3 mL), NaHCO3 (67 mg, 0.80 mmol), allyl bromide (0.17 mL, 
2.0 mmol) and Pd(hfacac)2 (10 mg, 0.020 mmol). The mixture was heated at 50 °C for 5 h 
then additional Pd(hfacac)2 (10 mg, 0.020 mmol) added. The reaction was heated 50 °C 
for a further 19 h. The reaction mixture was cooled to room temperature, and subjected 
directly to flash chromatography (petroleum ether/EtOAc; 9:1) to afford the title compound 
(2.42) as a colourless oil (58 mg, 79%). 
1H NMR (400 MHz, CDCl3) δ (ppm): 5.79 (1 H, ddt, J = 16.7, 10.3, 6.5 Hz, CH=CH2), 5.03 
(1 H, ddd, J = 17.1, 3.3, 1.6 Hz, CH=CHH), 4.97 (1 H, ddd, J = 10.0, 2.8, 1.1 Hz, 
CH=CHH), 2.18−2.09 (2 H, m, CH2CH2), 2.06 (1 H, d, J = 13.1 Hz, C(CH3)2CHH), 1.95 (1 
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H, d, J = 13.4 Hz, C(CH3)2CHH), 1.78−1.69 (2 H, m, CH2CH2), 1.42 (3 H, s, CH3), 1.33 (3 
H, s, CH3), 1.29 (3 H, s, CH3); 
13C NMR (100 MHz, CDCl3) δ (ppm): 182.1 (C=O), 137.5 
(CH=CH2), 115.0 (CH=CH2.), 82.6 (CCH3), 47.5 (CH2), 41.7 (CH2), 40.7 (C(CH3)2), 28.1 
(CH2), 27.8 (CH3), 27.5 (CH3), 27.4 (CH3); IR (thin film) 2970, 2360, 1759, 1267 cm
-1; 
HRMS (ESI) exact mass calculated for C11H18O2Na [M+Na]
+ m/z 205.1199 , found m/z 
205.1199. 
allyl 2-(tert-butoxycarbonyl(2’-methylallyl)amino)acetate (2.72) 
 
A 4 mL screw-top glass vial was charged with 2-(tert-butoxycarbonyl(2’-
methylallyl)amino)acetic acid (2.70) (92 mg, 0.40 mmol), toluene (1.3 mL), NaHCO3 (67 
mg, 0.80 mmol), allyl chloride (0.16 mL, 2.0 mmol) and Pd(hfacac)2 (10 mg, 0.020 mmol). 
The mixture was heated at 50 °C for 5 h then additional Pd(hfacac)2 (10 mg, 0.020 mmol) 
added. The reaction was heated 50 °C for a further 19 h. The reaction mixture was cooled 
to room temperature, and subjected directly to flash chromatography (petroleum 
ether/EtOAC; 9:1) to afford the title compound (2.72) as a colourless oil (101 mg, 94%). 
1H NMR (400 MHz, C6D6, 50°C due to rotameric mixture) δ (ppm): 5.68 (1 H, br. s, CH), 
5.14−4.91 (2 H, m, CH2), 4.75−4.66 (2 H, m, CH2), 4.41 (2 H, br. s, CH2), 3.95 (2 H, br. s, 
CH2), 3.87−3.71 (2 H, m, CH2), 1.57 (3 H, br. s, CH3), 1.41 (9 H, br. s, 3 x CH3); IR (thin 
film) 2361, 1676, 1267 cm-1; HRMS (ESI) exact mass calculated for C14H23O4 [M+Na]
+ m/z 
292.1519, found m/z 292.1519. 
13C NMR unavailable due to complex mixture of rotamers. 
3-(but-3’-en-1’-yl)-3-methylisochromanone (2.55) 
 
A 4 mL screw-top glass vial was charged with 2-(2’-methylallyl)benzoic acid (2.54) (76 mg, 
0.40 mmol), toluene (1.3 mL), NaHCO3 (67 mg, 0.80 mmol), allyl chloride (0.16 mL, 2.0 
mmol) and Pd(hfacac)2 (10 mg, 0.020 mmol). The mixture was heated at 50 °C for 5 h 
then additional Pd(hfacac)2 (10 mg, 0.020 mmol) added. The reaction was heated 50 °C 
for a further 19 h. The reaction mixture was cooled to room temperature, and subjected 
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directly to flash chromatography (petroleum ether/EtOAc; 9:1) to afford the title compound 
(2.55) as a colourless oil (57 mg, 62%). 
1H NMR (400 MHz, CDCl3) δ (ppm): 8.13−8.07 (1 H, m, ArH), 7.55 (1 H, dd, J = 7.5, 1.3 
Hz, ArH), 7.39 (1 H, t, J = 7.6 Hz, ArH), 7.23 (1 H, d, J = 7.6 Hz, ArH), 5.79 (1 H, ddt, J = 
16.7, 11.5, 6.6 Hz, CH=CH2), 5.09−4.95 (2 H, m, CH=CH2), 3.14 (1 H, d, J = 16.3 Hz, 
CHH), 2.96 (1 H, d, J = 16.2 Hz, CHH), 2.31−2.19 (2 H, m, CH2CH2), 1.93−1.73 (2 H, m, 
CH2CH2), 1.43 (3 H, s, CH3);  
13C NMR (100 MHz, CDCl3) δ (ppm): 164.7 (C=O), 137.9 
(ArC), 137.6 (CH=CH2), 133.8 (ArCH), 130.0 (ArCH), 128.0 (ArCH), 127.4 (ArCH), 124.9 
(ArC), 115.0 (CH=CH2), 82.4 (CCH3), 39.6 (CH2), 37.7 (CH2), 28.0 (CH2), 25.0 (CH3); IR 
(thin film) 2939, 2359, 1712 cm-1; HRMS (ESI) exact mass calculated for C14H16O2Na 
[M+Na]+ m/z 239.1043, found m/z 239.1049. 
3-(but-3’-en-1’-yl)-2-tosyl-3,4-dihydroisoquinolinone (2.92) 
 
A 4 mL screw-top glass vial was charged with 2-allyl-N-tosyl-benzamide (2.91) (50 mg, 
0.16 mmol), toluene (0.64 mL), H2O (0.64 mL), KH2PO4 (44 mg, 0.32 mmol), allyl chloride 
(0.070 mL, 0.79 mmol) and Pd(hfacac)2 (4.0 mg, 0.01 mmol). The mixture was heated at 
50 °C for 16 h. The mixture was cooled to room temperature, and subjected directly to 
flash chromatography (petroleum ether/EtOAc; 9:1) to yield the title compound as a white 
powdered solid (2.92) (53 mg, 95%). Data corresponded to literature values.[44] 
1-(but-3’-en-1’-yl)-1-methyl-1,3-dihydroisobenzofuran (2.17) 
 
A 4 mL screw-top glass vial was charged with (2-(prop-1’-en-2’-yl)phenyl)methanol (1.110) 
(200 mg, 1.35 mmol), toluene (4.5 mL), NaHCO3 (226 mg, 2.70 mmol), allyl bromide (5.90 
mL, 6.75 mmol) and Pd(hfacac)2 (73.0 mg, 0.0675 mmol). The mixture was heated at 50 
°C overnight. The reaction mixture was cooled to room temperature, and subjected 
directly to flash chromatography (petroleum ether/CH2Cl2; 1:1) to afford the title compound 
(2.17) as a colourless oil (193 mg, 76%). Data corresponded to literature values.[44] 
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Pyrrole tosylamide (3.55) 
 
A 4 mL glass screw-top vial was charged with 1-allyl-N-tosyl-pyrrole-2-carboxamide (3.54) 
(48 mg, 0.16 mmol), toluene (0.64 mL), H2O (0.64 mL), KH2PO4 (44 mg, 0.32 mmol), allyl 
chloride (0.07 mL, 0.79 mmol) and Pd(hfacac)2 (4.0 mg, 0.01 mmol). The mixture was 
heated at 80 °C for 19 h. The mixture was cooled to room temperature, and subjected 
directly to column chromatography (petroleum ether/EtOAc; 9:1) to yield the title 
compound (3.55) as a white powdered solid (32 mg, 58%). Data corresponded to 
literature values.[44] 
2-(but-3’-en-1’-yl)-2-methyl-2,3-dihydrobenzofuran (2.16) 
 
A 4 mL screw-top glass vial was charged with 2-(2-methylallyl)phenol (1.83) (59 mg, 0.40 
mmol), toluene (1.3 mL), NaHCO3 (67 mg, 0.80 mmol), allyl bromide (0.17 mL, 2.0 mmol) 
and Cu(hfacac)2 (512 mg, 1.2 mmol). The mixture was heated at 50 °C overnight. The 
reaction mixture was cooled to room temperature. The reaction was then quenched using 
a 10% aq. EDTANa2 and the organic layers were separated using Et2O (3 x 20 mL), dried 
over MgSO4 and purified with flash chromatography (petroleum ether/CH2Cl2; 85:15) to 
afford the title compound (2.16) as a colourless oil (21 mg, 28%). Data corresponded to 
literature values.[44] 
5-bromo-2-(but-3’-en-1’-yl)-2-methyl-2,3-dihydrobenzofuran (3.2) 
 
A 4 mL screw-top glass vial was charged with 4-bromo-2-(2’-methylallyl)phenol (3.1) (45 
mg, 0.20 mmol), toluene (0.65 mL), NaHCO3 (34 mg, 0.40 mmol), allyl bromide (80 μL, 
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1.0 mmol) and Pd(hfacac)2 (5.0 mg, 0.010 mmol). The mixture was heated at 50 °C 
overnight. The reaction mixture was cooled to room temperature, and subjected directly to 
flash chromatography (petroleum ether/CH2Cl2; 85:15) to afford the title compound (3.2) 
as a colourless oil (38 mg, 71%). Data corresponded to literature values.[44] 
3-(3’-bromobut-3’-en-1’-yl)-3-methylisobenzofuranone (3.18) 
 
A 4 mL screw-top glass vial was charged with 2-(prop-1’-en-2’-yl)benzoic acid (2.10) (65 
mg, 0.40 mmol), toluene (1.3 mL), NaHCO3 (67 mg, 0.80 mmol), 2,3-dibromopropene 
(0.20 mL, 2.0 mmol) and Pd(hfacac)2 (10 mg, 0.020 mmol). The mixture was heated at 50 
°C for 5 h. The reaction mixture was cooled to room temperature, and subjected directly to 
flash chromatography (petroleum ether/EtOAc; 9:1) to afford the title compound (3.18) as 
a colourless oil (31 mg, 28%). 
1H NMR (500 MHz, CDCl3) δ (ppm): 7.88 (1 H, d, J = 7.7 Hz, ArH), 7.69 (1 H, td, J = 7.7, 
0.8 Hz, ArH), 7.54 (1 H, t, J = 7.8 Hz, ArH), 7.42 (1 H, d, J = 7.7 Hz, ArH), 5.48−5.46 (1 H, 
m, CBr=CHH), 5.31 (1 H, d, J = 1.7 Hz, CBr=CHH), 2.49−2.39 (1 H, m, CH2CHH), 
2.38−2.30 (1 H, m, CH2CHH), 2.21−2.14 (1 H, m, CH2CHH), 2.09−2.02 (1 H, m, 
CH2CHH), 1.67 (3 H, s, CH3); 
13C NMR (125 MHz, CDCl3) δ (ppm): 169.7 (C=O), 153.0 
(C), 141.0 (C), 134.3 (C), 132.7 (C), 129.2 (ArCH), 125.8 (ArCH), 120.9 (ArCH), 117.3 
(ArCH), 86.6 (CBr=CH2), 38.2 (CH2), 35.7 (CH2), 26.3 (CH3); IR (thin film) 2953, 1759, 
1035, 696 cm-1; HRMS (ESI) exact mass calculated for C13H13O2BrNa [M+Na]
+ m/z 
302.9991, found m/z 302.9980. 
3-(3’-chlorobut-3’-en-1’-yl)-3-methylisobenzofuranone (3.20) 
 
A 4 mL screw-top glass vial was charged with 2-(prop-1’-en-2’-yl)benzoic acid (2.10) (65 
mg, 0.40 mmol), toluene (1.3 mL), NaHCO3 (67 mg, 0.80 mmol), 2,3-chloropropene (0.19 
mL, 2.0 mmol) and Pd(hfacac)2 (10 mg, 0.020 mmol). The mixture was heated at 50 °C for 
5 h. The reaction mixture was cooled to room temperature, and subjected directly to flash 
chromatography (petroleum ether/EtOAc; 9:1) to afford the title compound (3.20) as a 
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colourless oil (23 mg, 24%). 
1H NMR (500 MHz, CDCl3) δ (ppm): 7.90−7.86 (1 H, m, ArH), 7.69 (1 H, td, J = 7.5, 1.1 
Hz, ArH), 7.54 (1 H, dd, J = 7.7, 0.9 Hz, ArH), 7.43−7.39 (1 H, m, ArH), 5.07 (1 H, d, J = 
1.4 Hz, CCl=CHH), 5.04−5.02 (1 H, m, CCl=CHH), 2.40−2.29 (2 H, m, CH2CH2), 
2.22−2.15 (1 H, m, CH2CHH), 2.04−1.93 (1 H, m, CH2CHH), 1.67 (3 H, s, CH3); 
13C NMR 
(125 MHz, CDCl3) δ (ppm): 169.7 (C=O), 153.0 (C), 141.2 (C), 137.5 (C), 134.3 (ArCH), 
129.2 (ArCH), 125.8 (ArCH), 120.9 (ArCH), 112.8 (CH=CH2), 86.7 (CCH3), 37.5 (CH2), 
33.5 (CH2), 26.2 (CH3); IR (thin film) 2982, 1761, 912, 694 cm
-1; HRMS (ESI) exact mass 
calculated for C13H13O2ClNa [M+Na]
+ m/z 259.0496, found m/z 259.0490. 
1-(3’-bromobut-3’-en-1’-yl)-1-methyl-1,3-dihydroisobenzofuran (3.21) 
 
A 4 mL screw-top glass vial was charged with (2-(prop-1’-en-2’-yl)phenyl)methanol (1.110) 
(65 mg, 0.40 mmol), toluene (1.3 mL), NaHCO3 (67 mg, 0.80 mmol), 2,3-dibromopropene 
(0.20 mL, 2.0 mmol) and Pd(hfacac)2 (10 mg, 0.020 mmol). The mixture was heated at 50 
°C for 5 h. The reaction mixture was cooled to room temperature, and subjected directly to 
flash chromatography (petroleum ether/EtOAc; 9:1) to afford the title compound (3.20) as 
a colourless oil (91 mg, 85%). 
1H NMR (500 MHz, CDCl3) δ (ppm): 7.32−7.25  (2 H, m, ArH), 7.22−7.18  (1 H, m, ArH), 
7.13−7.10 (1 H, m, ArH), 5.51−5.46 (1 H, m, CBr=CHH), 5.31 (1 H, d, J = 1.3 Hz, 
CBr=CHH), 5.11 (1 H, d, J = 12.4 Hz, OCHH), 5.06 (1 H, d, J = 12.4 Hz, OCHH), 
2.56−2.49 (1 H, m, CHHCH2), 2.20−2.01 (3 H, m, CHHCH2 and CH2), 1.50 (3 H, s, CH3); 
13C NMR (125 MHz, CDCl3) δ (ppm): 144.6 (C), 138.9 (C), 134.6 (C), 127.5 (2 x ArCH), 
121.0 (ArCH), 120.8 (ArCH), 116.1 (CBr=CH2), 87.6 (CCH3), 71.7 (CH2O), 40.1 (CH2), 
36.5 (CH2), 27.6 (CH3); IR (thin film) 3026, 2848, 883, 721 cm
-1; HRMS (ESI) exact mass 
calculated for C13H15OBrNa [M+Na]
+ m/z 289.0198, found m/z 289.0192. 
Procedure for 2-vinylbenzoic acid subjected to standard Pd-catalysed oxyallylation 
condition in the synthesis of lactones 
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A 4 mL screw-top glass vial was charged with 2-vinylbenzoic acid (2.79) (59 mg, 0.40 
mmol), toluene (1.3 mL), NaHCO3 (67 mg, 0.80 mmol), allyl bromide (0.17 mL, 2.0 mmol) 
and Pd(hfacac)2 (10 mg, 0.02 mmol). The mixture was heated at 50 °C for 18 h. The 
reaction mixture was cooled to room temperature and filtered through a cotton wool plug. 
Analysis of the crude material revealed no formation of compound 2.86 but instead gave 
unreacted starting material 2.79, exo-methylene lactone 2.85 and isocoumarin 2.84 in a 
ratio of 4.3: 0.9: 1.0 respectively. Data corresponded to literature values.[157] 
Use of (S)-(+)-COP-Cl in Oxyallylation reaction 
 
A 4 mL screw-top glass vial was charged with 2-(prop-1’-en-2’-yl)benzoic acid (2.10) (32 
mg, 0.20 mmol), toluene (0.65 mL), NaHCO3 (34 mg, 0.40 mmol), allyl bromide (0.90 mL, 
1.0 mmol) and (S)-(+)-COP-Cl (15 mg, 0.010 mmol). The mixture was heated at 50 °C for 
5 h. The reaction mixture was cooled to room temperature, and subjected directly to flash 
chromatography (petroleum ether/EtOAC; 9:1) to afford the title compound (2.13) as a 
colourless oil (69 mg, 85%). Chiral HPLC (Chiralpak AD-H, 95: 5 n-hexane/IPA, 0.5 
mL/min, 280 nm) shows that 2.13 was formed in a 6% ee. Data corresponded to 
compound 2.13. 
General Procedure for Pd-catalysed heteroallylation of mono-substituted alkenes: 
A 4 mL screw-top glass vial was charged with Pd(II) (10 mol%), Toluene (0.4 mL), allyl 
halide (5.0 equiv.), NaHCO3 (2.0 equiv.) and lastly the substrate (1.0 equiv.). The vial was 
sealed under ambient atmosphere. The resulting mixture was heated to 50 °C by 
immersion of the entire vial into a pre-heated aluminium block, and was left to stir 
overnight. The reaction mixture was cooled to room temperature then purified directly by 
flash chromatography on silica gel. 
General Procedure for asymmetric Pd-catalysed heteroallylation of unactivated 
alkenes: 
A 4 mL screw-top glass vial was charged with Pd(II) (5 mol%), Ligand (7.5 mol%), 
Toluene (0.3 M) and the mixture was allowed to stir for 30 minutes at 50 °C. Next, allyl 
halide (5.0 equiv.), NaHCO3 (2.0 equiv.) and lastly the substrate (1.0 equiv.) was added 
and the vial was sealed under ambient atmosphere. The resulting mixture was heated to 
50 °C by immersion of the entire vial into a pre-heated aluminium block and was left to stir 
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overnight. The reaction mixture was cooled to room temperature then purified directly by 
flash chromatography on silica gel. 
General Procedure for asymmetric Pd-catalysed heteroallylation of unactivated 
alkenes with chiral phosphoric acids: 
A 4 mL screw-top glass vial was charged with Pd(II) (5 mol%), phosphoric acid (15 mol%), 
Toluene (0.3 M) and NaHCO3 (2.0 equiv.) and the mixture was allowed to stir for 30 
minutes at room temperature. Next, allyl halide (5.0 equiv.), and lastly the substrate (1.0 
equiv.) were added and the vial was sealed under ambient atmosphere and left to stir 
overnight at room temperature. The reaction mixture was directly purified by flash 
chromatography on silica gel. 
 
Chiral HPLC (Chiralpak AD-H, 95: 5 n-hexane/IPA, 0.5 mL/min, 280 nm) 
 
Chiral HPLC (Chiralpak OD-H, 100% n-hexane, 0.5 mL/min, 280 nm) 
 
Chiral HPLC (Chiralpak OD-H, 100% n-hexane, 0.5 mL/min, 280 nm) 
For ee’s please refer toChapter 2. 
Synthesis of pyridine-oxazoline ligand (2.121)  
 
Following a literature procedure,[101a] 6-methylpicolinic acid (2.122) (0.70 g, 5.1 mmol) was 
placed under an atmosphere of argon and dry dichloromethane (50 mL) was added and 
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the reaction vessel was submerged in a brine ice bath. 4-Methylmorpholine (0.84 mL, 7.7 
mmol) was added slowly by syringe and the mixture was stirred for 15 minutes. 
Isobutylchloroformate (0.77 mL, 5.9 mmol) was added dropwise by syringe and the 
mixture was stirred for 30 minutes. A solution of (S)-phenylglycinol (2.123) (0.84 g, 6.2 
mmol) in 10 mL of dichloromethane and with additional 4-methylmorpholine (0.64 mL, 5.9 
mmol) was added dropwise and the mixture was stirred at reduced temperature for 1 h 
and then allowed to warm to room temperature and stir overnight (18 h). The reaction 
mixture was diluted with dichloromethane and washed twice with sat. aq. NH4Cl, then 
water and brine. The organic layer was dried over MgSO4, filtered, and concentrated to a 
yellow-pink oil. Purification by flash chromatography (petroleum ether/EtOAc; 1:1) 
afforded amide (2.124) as a clear oil (1.1 g, 91%). Data corresponded to literature 
values.[101a] 
Amide (2.124) (1.2 g, 4.6 mmol) was placed under an argon atmosphere and anhydrous 
1,2-dichloroethane (45 mL) was added via cannula. The rubber septum was quickly 
removed and DMAP (56 mg, 0.46 mmol) and p-toluenesulfonyl chloride (1.3 g, 6.9 mmol) 
were added. The septum was replaced and triethylamine (2.5 mL, 18 mmol) was added 
via syringe. The mixture was stirred at room temperature for 3 h, then heated at reflux for 
15 h during which time the mixture turned dark red. After cooling to room temperature, 
CH2Cl2 was added and the organic layer was washed with sat. aq. NaHCO3, H2O, brine 
and dried over MgSO4, filtered and concentrated. The crude mixture was then purified by 
flash column chromatography (petroleum ether/ EtOAc; 7:3) to give the desired ligand 
(2.121) (0.94 g, 90%) as a yellow oil. Data corresponded to literature values.[101a] 
Synthesis of (S)-TRIP  
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(S)-2,2'-dimethoxy-1,1'-binaphthyl (2.139)[106] 
Following a literature procedure, (S)-BINOL (2.138) (10.0 g, 34.6 mmol) was placed under 
an atmosphere of argon. Subsequently, the vessel was charged with acetone (320 mL), 
upon complete dissolution of BINOL (2.138), potassium carbonate (15.8 g, 114 mmol) 
was added followed by methyl iodide (8.70 mL, 140 mmol). The resulting mixture was 
heated to reflux for 24 h. After that time the volatile compounds were removed under 
reduced pressure. The resulting slurry was redissolved in water (180 mL) and stirred for 2 
h. The resulting solid is collected, washed with water and dried in vacuo furnishing 10.9 g 
(quant.) of the title compound (2.139) as a slightly yellow solid. Data corresponded to 
literature values.[106] 
(S)-3,3'-dibromo-2,2'-dimethoxy-1,1'-binaphthyl (2.140)[106] 
Following a literature procedure, dried Et2O (500 mL) was added, followed by freshly 
distilled tetramethylethylenediamine (11.5 mL, 77.0 mmol). To the resulting solution, n-
butyllithium (2.5 M in hexanes, 49 mL, 120 mmol) was added slowly at room temperature 
via syringe, the mixture was allowed to stir for 1 h. Compound 2.139 (11.0 g, 35.0 mmol) 
was added as a solid at room temperature and the resulting solution was stirred for 3.5 h. 
After this time, the reaction was cooled to −78 °C and bromine (8.90 mL, 175 mmol) was 
added dropwise. After complete addition, the cooling bath was removed and the 
yellowish-brown reaction mixture is allowed to stir for 20 h at room temperature. Sat. aq. 
Na2SO3 (80 mL) was added to the reaction and the mixture was stirred for 1 h. The 
mixture was extracted with Et2O (3 x 50 mL), the organic phases were combined, washed 
with brine (100 mL) and dried over MgSO4, filtered and concentrated. After filtration, the 
solvent was removed in vacuo and the crude mixture was subjected to purification by 
column chromatography (petroleum ether/EtOAc; 95:5) resulting in a yellowish solid 
material, which was recrystallised from CH2Cl2/hexanes. The mother liquor was subjected 
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to a second column chromatography and the resulting material was crystallized (same 
conditions as above). In total, 7.24 g (44%) of the title compound 2.140 was obtained as 
slightly yellow crystals. Data corresponded to literature values.[106] 
(2,4,6-triisopropylphenyl)magnesium bromide (2.142)[106] 
Mg (1.3 g, 52 mmol, activated with a spatula tip of iodine) was covered with Et2O (5 mL), 
subsequently, 2-bromo-1,3,5-triisopropylbenzene (2.141) (7.7 g, 26 mmol) Et2O (35 mL) 
and 1,2-dibromoethane (0.1 mL, as activator) were charged in different syringes and 
added in a manner of maintaining the exothermic Grignard-reaction active. After complete 
addition of the compounds, the resulting grey suspension was placed in an oil bath and 
was heated at reflux for 24 h. Data corresponded to literature values.[106] 
(1S,3S)-2,2'-dimethoxy-3,3'-bis(2,4,6-triisopropylphenyl)-1,1'-binaphthyl(2.143)[106] 
Compound 2.140 (2.3 g, 4.8 mmol) and Ni(PPh3)2Cl2 (0.31 g, 0.48 mmol) were placed 
under an argon atmosphere. Subsequently, Et2O (25 mL) was added and to the resulting 
suspension the Grignard-solution 2.142 was added dropwise at room temperature via 
cannula. After complete addition, the resulting mixture was refluxed for 6 h. The resulting 
brown solution was allowed to cool to room temperature and then further cooled to 0 °C 
with an ice bath and quenched with 1 M aq. HCl (30 mL). The resulting mixture was 
extracted with Et2O (3 x 25 mL), the organic phase is dried over MgSO4, filtered and the 
solvent is removed in vacuo. The resulting slightly yellow solid crude (7.6 g) was 
subjected to the next step without further purification.  
(1S, 3S)-3,3'-bis(2,4,6-triisopropylphenyl)-1,1'-binaphthyl-2,2'-diol (2.144)[106] 
The crude material 2.143 dissolved in 105 mL dry dichloromethane under argon. 
Subsequently, the solution was cooled with an ice bath followed by slow addition of BBr3 
(1 M in dichloromethane, 29.7 mL, 29.7 mmol). After complete addition, the resulting clear 
solution was allowed to stir for 24 h at room temperature. Subsequently, water (40 mL) 
was added to the reaction. The aqueous layer was extracted with CH2Cl2 (3 x 25 mL), the 
combined organic layers are dried over MgSO4, filtered and the solvent was reduced in 
vacuo. Column chromatography (petroleum ether/EtOAc; 99:1) gave compound 2.144 as 
a yellow oil (2.00 g). Data corresponded to literature values.[106] 
(S)-TRIP[106] 
A flask was charged with 2.144 (2.0 g, 2.9 mmol) and set under argon. Subsequently, 
pyridine (10 mL) was added, followed by POCl3 (0.80 mL, 8.70 mmol). The resulting 
mixture was heated at reflux for 14 h. After this time the reaction was allowed to cool to 
room temperature, followed by addition ofwater (10 mL). The resulting brownish slurry 
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was heated to reflux and hydrolysed for 3 h. After, the reaction was cooled to room 
temperature, CH2Cl2 (5 mL) was added. The resulting organic phase was thoroughly 
washed with 1 M aq. HCl (3 x 5 mL). The resulting organic layer was dried over MgSO4, 
filtered and concentrated. The crude material was recrystallised from MeCN the title 
compound (S)-TRIP as a white solid (1.1 g, 31% over three steps). Data corresponded to 
literature values.[106] 
N-methyl-N-phenylmethacrylamide (2.159) 
 
Following a modified literature procedure, N-Methylaniline (4.2) (1.1 mL, 10 mmol) was 
dissolved in CH2Cl2 (130 mL) followed by addition of methacrylolyl chloride (2.9 mL, 30 
mmol). Pyridine (1.6 mL, 20 mmol) was then added slowly. After 10 h at room 
temperature, H2O (100 mL) was added and the mixture was extracted with CH2Cl2 (3 x 50 
mL). The organic layer was washed with sat. aq. NaHCO3 (2 x 50 mL), once with brine (20 
mL) and dried over MgSO4, filtered and concentrated. Solvent evaporation gave the crude 
anilide as yellow oil. Purification by flash chromatography (CH2Cl2/EtOAc; 95:5) to give the 
title compound 2.159 as a white solid (1.97 g, quant.). Data corresponded to literature 
values.[158] 
Synthesis of Phenol (1.12)  
 
To a stirring suspension of NaH (60% in mineral oil, 0.70 g, 18 mmol) in benzene (25 mL) 
at 0 °C was added a benzene (15 mL) solution of the phenol (2.125) (1.5 g, 16 mmol). 
Crotyl chloride (1.7 mL, 18 mmol) was added to the mixture which was then allowed to 
warm to room temperature. After 24 h stirring, benzene was removed under reduced 
pressure and H2O (50 mL) and petroleum ether (50 mL) were added. The mixture was 
extracted with 20% aqueous NaOH (3 x 20 mL) and "Claisen's alkali" (20 mL; 6 g KOH in 
5 mL H2O diluted with 25 mL MeOH). The combined alkali extracts were acidified with 6 N 
H2SO4 and extracted with Et2O (3 x 50 mL). Combination of the organic extracts, which 
were dried over MgSO4, filtered and concentration in vacuo and purification by flash 
column chromatography on silica gel (petroleum ether/EtOAc; 4:1) provided the o-
substituted phenol 1.12 as a yellow oil (1.5 g, 65%). Data corresponded to literature 
values.[23] 
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Glyoxal-bis(2,4,6-trimethylphenyl)imine (4.4)  
 
Following a modified procedure of Arduengo and co-workers,[159] to a solution of 2,4,6- 
trimethylaniline 4.3 (12.7 mL, 90.0 mmol) in ethanol (100 mL) were added a mixture of 
40% aqueous solution of glyoxal (5.14 mL, 45.0 mmol), and ethanol (100 mL). The 
mixture was stirred for 16 h at ambient temperature and then for 4 h at 60 °C. Upon 
addition of water (300 mL), a yellow solid precipitated and was collected by filtration and 
dried in vacuo to yield 4.4 as a yellow crystalline solid (10.6 g, 80%). Data corresponded 
to literature values.[159] 
1,3-Bis(2,4,6-trimethylphenyl)imidazolium chloride (4.5)  
 
Following the procedure of Arduengo and co-workers,[159] to a solution of 
chloromethylethyl ether (0.72 mL, 7.5 mmol) in THF (5 mL) was added a solution of 
glyoxal-bis(2,4,6-trimethylphenyl)imine 4.4 (2.00 g, 6.85 mmol) in THF (25 mL). The 
reaction mixture was stirred under argon atmosphere for 5 days. The precipitate was 
isolated by filtration and washed with fresh THF to yield 4.5 as a pale yellow solid (0.800 
g, 34%). Data corresponded to literature values.[159] 
1,3-Bis(2,4,6-trimethylphenyl)imidazolium tetrafluoroborate (4.6) 
 
Imidazolium chloride 4.5 (0.61 g, 2.1 mmol) in toluene (4 mL) was cooled to 0 °C. HBF4 
(48 wt. % in H2O, 0.40 mL, 2.1 mmol), was added dropwise and the mixture was left to stir 
at room temperature for 30 minutes, followed by heating at 40 °C for 12 h. The solution 
was allowed to cool to room temperature and was filtered to yield the title compound 4.6 
as a yellow solid (0.40 g, 50%). Data corresponded to literature values.[160] 
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Synthesis of SIMes.HCl (4.8)  
 
Following a literature procedure,[161] ethylenediimine 4.4 (3.00 g, 10.3 mmol) was 
dissolved in anhydrous THF (100 mL) under an atmosphere of Argon. The solution was 
cooled to 0 °C and LiAlH4 pellets (0.780 g, 20.6 mmol) were added. The reaction mixture 
was stirred overnight at room temperature and then poured carefully into an excess of an 
ice/concentrated HCl mixture. The reaction mixture was basified by using 2 M aq. NaOH 
and extracted with diethyl ether (3 x 250 mL). The combined organic layers were dried 
over MgSO4, filtered, and the solvent was evaporated in vacuo to give the desired product 
4.7 as a yellow solid (2.92 g, 97%). Data corresponded to literature values.[161] 
Following a literature procedure,[161] diamine 4.7 (2.92 g, 10.0 mmol) and NH4Cl (0.530 g, 
10.0 mmol) was suspended in HC(OEt)3 (5.00 mL, 30.0 mmol) and 3 drops of formic acid 
was added. The reaction mixture was stirred at 120 °C for 4 h and then poured into water 
(500 mL). The aqueous phase was washed with diethyl ether (2 x 300 mL) and extracted 
with CH2Cl2 (3 x 300 mL). The combined organic layers were dried over MgSO4, filtered 
and the solvent was evaporated in vacuo to give the imidazolinium salt 4.8 as a white 
solid (2.90 g, 85%). Data corresponded to literature values.[161] 
N-(2’-(chloromethyl)phenyl)-4-methylbenzenesulfonamide 
 
Following a literature procedure,[162] a solution of 2-aminobenzyl alcohol (3.80 g, 13.7 
mmol), 4.9 and pyridine (2.35 mL, 29.2 mmol) in dry CHCl3 (90 mL) was treated dropwise 
with a solution p-toluenesulfonyl chloride (5.10 g, 27 mmol) in CHCl3 (25 mL) at room 
temperature. The reaction mixture was stirred overnight. The volatiles were evaporated 
and to the resulting residue was added ethyl acetate (50 mL) and sat. aq. NH4Cl. The 
organic phase was separated, dried over MgSO4, filtered and the solvent was evaporated. 
The crude was then recrystallised in iPrOH to give N-(2’-(hydroxymethyl)phenyl)-4-
methylbenzenesulfonamide 4.10 as a white solid (5.20 g, 77%). Data corresponded to 
literature values.[162] 
Following a literature procedure,[163] to a solution of thionyl chloride (1.20 mL, 16.5 mmol) 
in CHCl3 (10 mL), was added a solution of benzyl alcohol 4.10 (3.80 g, 13.7 mmol) in 
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CHCl3(60 mL) over 1 min. The reaction was heated to 40 °C overnight, cooled to rt, then 
poured into ice water (30 mL). The layers were separated and the aqueous layer was 
extracted with CHCl3 (3 x 40 mL). The combined organic layers were washed with brine 
(30 mL), and dried over MgSO4. Purification by flash column chromatography on silica gel 
(petroleum ether/EtOAc; 4:1) provided the title compound 4.11 as a white solid (2.5 g, 
62%). Data corresponded to literature values.[163] 
(Z)-N-(2’-(but-2’’-en-1’-yl)phenyl)-4-methylbenzenesulfonamide (4.12) 
 
Following a literature procedure,[164] to an oven dried flask equipped with a condenser was 
placed magnesium turnings (0.360 g, 15.0 mmol) and THF (6 mL) in an inert atmosphere. 
A solution of the cis-1-bromo-prop-1-ene (1.28 mL, 15.0 mmol) in 2 mL of THF was 
introduced slowly into the flask at room temperature with good stirring. After the formation 
of the Grignard reagent, a solution of N-(2’-(chloromethyl)phenyl)-4-
methylbenzenesulfonamide 4.11 (1.50 g, 5.00 mmol) in THF (10 mL) was added slowly at 
room temperature and the mixture was stirred for 1 hour. The excess Grignard reagent 
was destroyed by adding water and the crude mixture was extracted with ethyl ether (100 
mL). The ether solution was then dried over MgSO4 and concentrated in vacuo. The 
resulting residue was purified by flash column chromatography (petroleum ether/EtOAc; 
9:1) to give the desired tosyl amide 4.12 as a white solid (249 mg, 17%). Data 
corresponded to literature values.[165] 
4-methyl-N-(2’-(2’’-methylallyl)phenyl)benzenesulfonamide (4.13) 
 
Following a literature procedure,[164] to an oven dried flask equipped with a condenser was 
placed magnesium turnings (0.360 g, 15.0 mmol) and THF (6 mL) in an inert atmosphere. 
A solution of the 2-bromopropene (1.33 mL, 15.0 mmol) in 2 mL of THF was introduced 
slowly into the flask at room temperature with good stirring. After the formation of the 
Grignard reagent a solution of N-(2’-(chloromethyl)phenyl)-4-methylbenzenesulfonamide 
4.11 (1.50 g, 5.00 mmol) in THF (10 mL) was added slowly at room temperature and the 
mixture was stirred for 1 hour. The excess Grignard reagent was destroyed by adding 
water and the crude mixture was extracted with ethyl ether (100 mL). The ether solution 
was then dried over MgSO4 and concentrated in vacuo. The resulting residue was purified 
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by flash column chromatography (petroleum ether/EtOAc; 9:1) to give the desired tosyl 
amide 4.13 as a white solid (574 mg, 38%). Data corresponded to literature.[164] 
General procedure for Pd-carbene catalysed aerobic intramolecular Wacker-type 
cyclisation 
 
Following literarture procedures,[166] a solution of freshly prepared carbene (6 mol%) in 
toluene[167] (0.8 mL) was transferred via cannula to a round bottom flask containing a 1 M 
toluene solution of Pd(TFA)2 (5 mol%) and the resulting mixture was stirred at room 
temperature for 15 minutes. 4-(N,N-Dimethylamino)-pyridine (10.0 mg, 0.080 mmol), 
sodium carbonate (85 mg, 0.80 mmol) and 3 Å MS (0.50 g) were added under a positive 
stream of argon and the resulting mixture was stirred for 5 minutes before addition of 
phenol 1.12 (60 mg, 0.40 mmol) in toluene (0.2 mL). The reaction mixture was submitted 
to three freeze and thaw cycles employing molecular oxygen. The reaction mixture was 
heated to 80 °C for 12 hours. After this, the reaction mixture was concentrated under 
vacuum, and the residue was taken up in dichloromethane, washed with water, dried and 
evaporated under reduced pressure. 
General procedure for Pd-carbene catalysed intramolecular Wacker-type 
cyclisation−methylation 
 
Following literarture procedures,[166] a solution of freshly prepared carbene[167] (6 mol%) in 
toluene (0.8 mL) was transferred via cannula to a flame-dried round bottom flask 
containing a 1 M toluene solution of Pd(TFA)2 (5 mol%) and the resulting mixture was 
stirred at room temperature for 15 minutes. 4-(N,N-Dimethylamino)-pyridine (10 mg, 0.080 
mmol), Na2CO3 (85 mg, 0.80 mmol), methyl iodide (0.25 mL, 4.0 mmol) and 3 Å MS (0.50 
g) were added under a positive stream of argon and the resulting mixture was stirred for 5 
minutes before addition of phenol 1.83 (60 mg, 0.40 mmol) in toluene (0.2 mL). The 
reaction mixture was heated to 80 °C over a period of 12 hours. After this, the reaction 
mixture was concentrated under vacuum, and the residue was taken up in 
dichloromethane, washed with water, dried and evaporated under reduced pressure. 
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General procedure for Pd-catalysed arylallylation of unactivated alkenes in the 
synthesis of oxindoles: 
 
To a solution of anilide 2.159 (35 mg, 0.20 mmol) in Solvent were added Additives, allyl X 
(2.0 mmol, 5.0 equiv.) and Pd(II) (10 mol%). The reaction mixture was heated and stirred 
overnight. The reaction was cooled to room temperature and the volatile components 
were evaporated under reduced pressure. The remaining mixture was partitioned between 
water and EtOAc and the aqueous layer was extracted with EtOAc. The aqueous layers 
were then combined and extracted with EtOAc (3 x 10 mL). The organic layers were then 
dried over MgSO4, filtered and the solvents were evaporated. 
Synthesis of Amide 2.182 
 
To a stirred suspension of LiAlH4 (0.750 g, 19.7 mmol) in diethyl ether (20 mL) cooled to 0 
°C was added 3-pentenoic acid (2.186) (2.00 mL, 19.7 mmol) in diethyl ether slowly via 
cannula. The reaction was allowed to warm to room temperature and was stirred 
overnight. Sat. aq. sodium potassium tartrate was added and the reaction was left to stir 
overnight. The reaction was dried with MgSO4, filtered and carefully concentrated by 
rotary evaporation to give 3-penten-1ol 2.187 as a colourless oil (1.48 g, 90%). Data 
corresponded to literature values.[120] 
Following a modified literature procedure,[121] to a flask was placed Triton B (40% in 
methanol, 0.450 mL, 1.40 mmol) and the solvent was removed under reduced pressure. 
Alcohol 2.187 (1.20 g, 14.0 mmol) was added, followed, after 15 minutes, by tert-butyl 
acrylate (10.30 mL, 70.0 mmol). The reaction was then heated at 50 °C overnight. After 
completion of the reaction, the resulting solution was filtered over a mixture Celite-silica 
gel and concentrated under vacuum. The product 2.188 was used without purification for 
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the next step (3.22 g, 76%). 
1H NMR (500 MHz, CDCl3) δ (ppm): 5.56–5.37 (2 H, m, CH=CH), 3.67 (2 H, t, J = 6.5 Hz, 
OCH2), 3.45 (2 H, t, J = 6.9 Hz, CH2O), 2.49 (2 H, t, J = 6.5 Hz, CH2COO), 2.29–2.22 (2 
H, m, CH2CH=CH), 1.67–1.64 (3 H, m, CH3), 1.46 (9 H, s, C(CH3)3); 
13C NMR (125 MHz, 
CDCl3) δ (ppm): 171.0 (C=O), 127.4 (CH=CH), 126.8 (CH=CH), 80.4 (C(CH3)3), 70.9 
(CH2), 66.4 (CH2), 36.4 (CH2), 32.9 (CH2), 28.1 (C(CH3)3), 17.5 (CH3); IR (thin film) 1730, 
1367, 1158 cm-1; HRMS (ESI) exact mass calculated for C12H22O3Na [M+Na]
+ m/z 
237.1461, found m/z 237.1451. 
Following a modification of a literature procedure,[121] to a dried flask containing tert-butyl 
ester 2.188 (5.50 g, 25.6 mmol) was added dichloromethane (12 mL) and trifluoroacetic 
acid (5.80 mL, 76.8 mmol). The mixture was stirred at reflux overnight. After completion of 
the reaction, the mixture was concentrated in vacuo and required no further purification, to 
yield 2.189 as a yellow oil (4.10 g, quant.). 
Following a modified literature procedure,[122] thionyl chloride (89.0 mL, 1.23 mol) was 
added to a round bottom flask containing acid 2.189 (3.30 g, 18.9 mmol). The mixture was 
stirred at 65 °C for 1 h in an inert atmosphere. After this time, the volatiles were removed 
in vacuo. To the resulting acid chloride was added CH2Cl2 (160 mL), DIPEA (32.7 mL, 189 
mmol) and 8-aminoquinoline (1.63 g, 11.3 mmol). The reaction was left to stir overnight at 
room temperature. The reaction was quenched with H2O (100 mL) and the organic 
extracts were separated with CH2Cl2. The organic layer was then washed with sat. aq. 
NaHCO3 (100 mL) and brine (100 mL) and dried over MgSO4, filtered and concentrated. 
The crude mixture was then purified by flash column chromatography (petroleum 
ether/EtOAc; 85: 15) to yield the amide 2.182 as a yellow oil (1.65 g, 51%).  
1H NMR (500 MHz,  CDCl3) δ (ppm): 10.54–10.50 (1 H, br. s, CONH), 8.83–8.79 (2 H, m, 
ArH), 8.16 (1 H, dd, J = 8.3, 1.7 Hz, ArH), 7.57–7.49 (2 H, m, ArH), 7.45 (1 H, dd, J = 8.2, 
4.2 Hz, ArH), 5.57–5.45 (2 H, m, CH=CH), 3.87 (2 H, t, J = 5.80 Hz, OCH2), 3.60 (2 H, t, J 
= 7.1 Hz, CH2O), 2.82 (2 H, t, J = 5.9 Hz, CH2COO), 2.48–2.39 (2 H, m, CH2CH=CH), 
1.62–1.59 (3 H, m, CH3); 
13C NMR (125 MHz, CDCl3) δ (ppm): 170.3 (C=O), 148.0 
(ArCH), 138.6 (ArC), 136.2 (ArCH), 134.9 (ArC), 127.9 (ArC), 127.3 (2 x CH=CH), 127.0 
(ArCH), 121.4 (ArCH), 121.4 (ArCH), 116.7 (ArCH), 71.4 (CH2), 66.6 (CH2), 38.8 (CH2), 
32.9 (CH2), 17.9 (CH3); IR (thin film) 1684, 1522, 1486, 1109 cm
-1; HRMS (CI) exact mass 
calculated for C17H20O4N2H [M+H]
+ m/z 285.1603, found m/z 285.1600. 
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General procedure for sp3 C−H activation−cyclisation:  
 
To a solution of compound 2.182 (57 mg, 0.20 mmol) in Solvent were added Additives, 
and Pd(OAc)2 (5 mg, 0.02 mmol). The reaction mixture was heated and stirred overnight. 
The reaction was cooled to room temperature and the volatile solvent was evaporated 
under reduced pressure.  
Side product 2.190 was isolated as a yellow oil. 
 
 
1H NMR (500 MHz, CDCl3) δ (ppm): 10.50–10.46 (1 H, br. s, CONH), 8.86–8.78 (2 H, m, 
ArH), 8.17 (1 H, dd, J = 10.04, 1.8 Hz, ArH), 7.48 (1 H, dd, J = 8.9, 4.1 Hz, ArH), 7.31 (1 
H, d, J = 8.6 Hz, ArH), 5.56–5.42 (2 H, m, CH=CH), 3.86 (2 H, t, J = 5.8 Hz, OCH2), 3.60 
(2 H, t, J = 6.9 Hz, CH2O), 2.81 (2 H, t, J = 5.6 Hz, CH2COO), 2.45 (3 H, s, CH3COO), 
1.63–1.59 (5 H, m, CH2 and CH3); 
13C NMR (125 MHz, CDCl3)  δ (ppm): 170.2 (C=O), 
169.4 (C=O), 148.4 (ArCH), 140.4 (ArC), 138.9 (ArC), 133.2 (ArC), 130.2 (C-H), 127.3 (C-
H), 127.1 (C-H), 121.9 (ArC), 121.7 (C-H), 119.2 (C-H), 116.1 (C-H), 71.4 (CH2), 66.6 
(CH2), 38.7 (CH2), 32.9 (CH2), 20.9 (CH3COO), 17.9 (CH3); IR (thin film) 1768, 1527, 
1491, 1196 cm-1; HRMS (CI) exact mass calculated for C19H22O4N2H [M+H]
+ m/z 
343.1658, found m/z 343.1654. 
2-(but-3’-en-1’-yl)-2-methyl-5-phenyl-2,3-dihydrobenzofuran (3.6)  
 
A 4 mL screw-top glass vial was charged with 4-bromo-2-(2’-methylallyl)phenol (3.1) (45.0 
mg, 0.200 mmol), toluene (0.65 mL), allyl chloride (80.0 μL, 1.00 mmol), NaHCO3 (34.0 
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mg, 0.400 mmol) and Pd(hfacac)2 (5.00 mg, 0.0100 mmol) and the vial was sealed under 
ambient atmosphere. The resulting mixture was heated to 50 °C by immersion of the 
entire vial into a preheated aluminium block until the substrate had been consumed, as 
judged by TLC analysis. The reaction mixture was cooled to room temperature and the 
volatile components were evaporated in vacuo. To the vial was added toluene (0.4 mL), 
SPhos (8.00 mg, 0.0200 mmol), freshly ground K3PO4 (127 mg, 0.600 mmol) and 
phenylboronic acid (73.0 mg, 0.600 mmol) and the vial was sealed under ambient 
atmosphere. The mixture was then heated at 50 °C for 16 h. The reaction mixture was 
cooled to room temperature then purified directly by flash chromatography on silica gel 
(petroleum ether, then petroleum ether/EtOAc; 98:2) to give the title compound 3.6 as a 
yellow oil (36 mg, 68%).  
1H NMR (400 MHz, CDCl3) δ (ppm): 7.47–7.40 (2 H, m, ArH), 7.35–7.24 (4 H, m, ArH), 
7.23–7.16 (1 H, m, ArH), 6.71 (1 H, d, J = 8.6 Hz, ArH), 5.91 (1 H, ddt, J = 16.8, 10.1, 6.7, 
CH=CH2), 4.96 (1 H, ddd, J = 17.1, 3.4, 1.7 Hz, CH=CHH), 4.88 (1 H, ddd, J = 10.2, 2.7, 
1.7 Hz, CH=CHH), 3.09 (1 H, d, J = 15.6 Hz, ArCHH), 2.91 (1 H, d, J = 15.6 Hz, CCHH), 
2.15–2.09 (2 H, m, CH2CH2), 1.81–1.75 (2 H, m, CH2CH2), 1.40 (3 H, s, CH3); 
13C NMR 
(100 MHz, CDCl3) δ (ppm): 158.7 (ArC), 141.5 (ArC), 138.3 (CH=CH2), 133.6 (ArC), 128.7 
(2 x ArCH), 127.5 (ArC) , 127.1 (2 x ArCH), 126.7 (ArCH), 126.4 (ArCH), 123.9 (ArCH), 
114.6 (CH=CH2), 109.5 (ArCH), 88.9 (OCCH3), 41.3 (CH2), 40.4 (CH2), 28.5 (CH2), 26.5 
(CH3); IR (thin film) 2976, 2360, 1479, 1265 cm
-1; HRMS (EI) exact mass calculated for 
C19H20O [M]
+ m/z 264.1514, found m/z 264.1519. 
1-(2-(2’-(but-3’’-en-1’’-yl)-2’-methyl-2’,3’-dihydrobenzofuran-5’-yl)phenyl)ethanone 
(3.13) 
A 4 mL screw-top glass vial was charged with 4-bromo-2-(2’-methylallyl)phenol (3.1) (45.0 
mg, 0.200 mmol), toluene (0.65 mL), allyl chloride (80.0 μL, 1.00 mmol), NaHCO3 (34.0 
mg, 0.400 mmol) and Pd(hfacac)2 (5.00 mg,  0.0100 mmol) and the vial was sealed under 
ambient atmosphere. The resulting mixture was heated to 50 °C by immersion of the 
entire vial into a preheated aluminium block until the substrate had been consumed, as 
judged by TLC analysis. The reaction mixture was cooled to room temperature and the 
volatile components were evaporated in vacuo. To the vial was added toluene (0.4 mL), 
SPhos (8.00 mg, 0.0200 mmol), freshly ground K3PO4 (127 mg, 0.600 mmol) and (2-
acetylphenyl)boronic acid (98.0 mg, 0.600 mmol) and the vial was sealed under ambient 
180 
 
atmosphere. The mixture was then heated at 50 °C for 16 h. The reaction mixture was 
cooled to room temperature then purified directly by flash chromatography on silica gel 
(petroleum ether, then petroleum ether/EtOAc; 98:2) to give the title compound 3.13 as a 
yellow oil (28 mg, 46%).  
1H NMR (400 MHz, CDCl3) δ (ppm): 7.53–7.46 (2 H, m, ArH), 7.39–7.38 (1 H, m, ArH), 
7.37–7.35 (1 H, m, ArH), 7.12–7.05 (2 H, m, ArH), 6.78 (1 H, d, J = 8.3 Hz), 5.85 (1 H, ddt, 
J = 16.7, 10.3, 6.3, CH=CH2), 5.05 (1 H, ddd, J = 17.1, 3.4, 1.6 Hz, CH=CHH), 4.98 (1 H, 
ddd, J = 10.2, 3.0, 1.3 Hz, CH=CHH), 3.14 (1 H, d, J = 15.7 Hz, CCHH), 2.99 (1 H, d, J = 
15.2 Hz, CCHH), 2.25–2.15 (2 H, m, CH2CH2), 2.03 (3 H, s, COCH3), 1.90–1.84  (2 H, m, 
CH2CH2), 1.48 (3 H, s, CCH3); 
13C NMR (100 MHz, CDCl3) δ (ppm): 205.5 (C=O), 159.1 
(ArC), 140.9 (ArC), 140.6 (ArC), 138.1 (CH=CH2), 132.5 (ArC), 130.5 (ArCH), 130.1 
(ArCH), 128.9 (ArCH), 127.7 (ArCH), 127.6 (ArC), 126.8 (ArCH), 125.6 (ArCH), 114.7 
(CH=CH2), 109.5 (ArCH), 89.2 (CCH3), 41.0 (CH2), 40.3 (CH2), 30.5 (CH3), 28.4 (CH2), 
26.4 (CH3); IR (thin film) 2914, 1681, 1275 cm
-1; HRMS (ESI) exact mass calculated for 
C21H22O2Na [M+Na]
+ m/z 329.1512, found m/z 329.1469. 
3-(2’-(but-3’’-en-1’’-yl)-2’-methyl-2’,3’-dihydrobenzofuran-5’-yl)pyridine (3.23) 
A 4 mL screw-top glass vial was charged with 4-bromo-2-(2’-methylallyl)phenol (3.1) (57.0 
mg, 0.250 mmol), toluene (0.83 mL), allyl chloride (100 μL, 1.25 mmol), NaHCO3 (42.0 
mg, 0.500 mmol) and Pd(hfacac)2 (7.0 mg,  0.0125 mmol) and the vial was sealed under 
ambient atmosphere. The resulting mixture was heated to 50 °C by immersion of the 
entire vial into a preheated aluminium block until the substrate had been consumed, as 
judged by TLC analysis. The reaction mixture was cooled to room temperature and the 
volatile components were evaporated in vacuo. Following a modified literature 
procedure,[133] to the vial was added PPhos (16.0 mg, 0.0250 mmol), nBuOH (1 mL) and 
argon was bubbled through the mixture. The reaction was allowed to stir for 5 minutes at 
room temperature.  Freshly ground K3PO4 (159 mg, 0.750 mmol), 3-pyridinylboronic acid 
(92.0 mg, 0.750 mmol) and nBuOH (1 mL) were added to the reaction mixture and the vial 
was sealed under an argon atmosphere. The mixture was then heated to 100 °C for 2 h 
using the aluminium block. The reaction was allowed to cool to room temperature and 
quenched with water and the organic layers were extracted with EtOAc (3 x 20 mL). The 
combined organic extracts were dried over MgSO4, and concentrated in vacuo. The crude 
mixture was purified by flash chromatography on silica gel (petroleum ether/EtOAc; 8:2) to 
give the title compound 3.23 as a yellow oil (35 mg, 53%).  
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1H NMR (400 MHz, CDCl3) δ (ppm): 8.81 (1 H, br. s, ArH), 8.54 (1 H, br. s, ArH), 
7.84−7.76 (1 H, m, ArH), 7.39−7.29 (3 H, m, ArH), 6.83 (1 H, d, J = 8.2 Hz, ArH), 5.85 (1 
H, ddt, J = 16.8, 10.3, 6.4, CH=CH2), 5.05 (1 H, ddd, J = 17.1, 3.4, 1.5 Hz, CH=CHH), 
4.97 (1 H, ddd, J = 10.3, 2.9, 1.3 Hz, CH=CHH), 3.17 (1 H, d, J = 15.7 Hz, OCCHH), 3.01 
(1 H, d, J = 15.7 Hz, OCCHH), 2.24−2.16 (2 H, m, CH2CH2), 1.90−1.84  (2 H, m, CH2CH2), 
1.49 (3 H, s, CH3); 
13C NMR (100 MHz, CDCl3) δ (ppm): 159.3 (ArC), 147.9 (ArCH), 147.5 
(ArCH), 138.1 (CH=CH2), 133.8 (ArCH), 129.9 (ArC), 128.0 (2 x ArC), 127.3 (2 x ArCH), 
123.9 (ArCH), 114.7 (CH=CH2), 109.9 (ArCH), 89.2 (CCH3), 41.1 (CH2), 40.3 (CH2), 28.4 
(CH2), 26.4 (CH3); IR (thin film) 3074, 2928, 849, 711 cm
-1; HRMS (ESI) exact mass 
calculated for C18H19NOH [M+H]
+ m/z 266.1539, found m/z 266.1532. 
2-(but-3’-en-1’-yl)-N-hexyl-2-methyl-2,3-dihydrobenzofuran-5-amine (3.35) 
 
A 4 mL screw-top glass vial was charged with 4-bromo-2-(2’-methylallyl)phenol (3.1) (45 
mg, 0.20 mmol), toluene (0.65 mL), allyl chloride (80 μL, 1.0 mmol), NaHCO3 (34 mg, 0.40 
mmol) and Pd(hfacac)2 (5.0 mg,  0.010 mmol) and the vial was sealed under ambient 
atmosphere. The resulting mixture was heated to 50 °C by immersion of the entire vial into 
a preheated aluminium block until the substrate had been consumed, as judged by TLC 
analysis. The reaction mixture was cooled to room temperature and the volatile 
components were evaporated in vacuo. To the vial was added BrettPhos (10 mg, 0.020 
mmol), NaOtBu (58 mg, 0.60 mmol) and toluene (0.2 mL). The mixture was allowed to stir 
for 5 minutes at room temperature. Next, toluene (0.2 mL) and hexylamine (30 μL, 0.24 
mmol) were added and the vial was sealed under ambient atmosphere. The mixture was 
then heated at 50 °C for 3 h. The reaction mixture was cooled to room temperature, 
quenched with water and the organic layers were extracted with Et2O (3 x 20 mL). The 
combined organic extracts were then washed with brine, dried over MgSO4 and 
concentrated in vacuo. The crude mixture was then purified by flash chromatography on 
silica gel (petroleum ether/EtOAc; 95:5) to give the title compound 3.35 as a yellow oil (40 
mg, 70%).  
1H NMR (500 MHz, CDCl3) δ (ppm): 6.59 (1 H, d, J = 8.3 Hz, ArH), 6.50 (1 H, s, ArH), 
6.44−6.39  (1 H, m, ArH), 5.84 (1 H, ddt, J = 16.6, 10.2, 6.4 Hz, CH=CH2), 5.05 (1 H, ddd, 
J = 17.1, 3.4, 1.6 Hz, CH=CHH), 4.95 (1 H, ddd, J = 10.0, 3.0, 1.1 Hz, CH=CHH), 
3.07−3.02 (3 H, m, OCCHH and CH2), 2.88 (1 H, d, J = 15.4 Hz, OCCHH), 2.21−2.13 (2 
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H, m, CH2), 1.84−1.78 (2 H, m, CH2), 1.64−1.56 (2 H, m, CH2), 1.44−1.38 (5 H, m, CH2 
and CCH3), 1.35−1.30 (4 H, m, 2 x CH2), 0.91 (3 H, t, J = 6.9 Hz, CH2CH3); 
13C NMR (125 
MHz, CDCl3) δ (ppm): 152.1 (ArC), 141.5 (ArC), 138.4 (CH=CH2), 127.7 (ArC), 114.4 
(CH=CH2), 113.5 (ArCH), 111.3 (ArCH), 109.4 (ArCH), 87.8 (CCH3), 46.0 (CH2), 41.6 
(CH2), 40.3 (CH2), 31.6 (CH2), 29.3 (CH2), 28.4 (CH2), 26.8 (CH2), 26.4 (CH3), 22.6 (CH2), 
14.0 (CH3); IR (thin film) 2928, 1641, 910, 731 cm
-1; HRMS (ESI) exact mass calculated 
for C19H29NOBrH [M+H]
+ m/z 288.2322, found m/z 288.2309. 
2-(but-3’-en-1’-yl)-N,2-dimethyl-N-phenyl-2,3-dihydrobenzofuran-5-amine (3.40) 
A 4 mL screw-top glass vial was charged with 4-bromo-2-(2’-methylallyl)phenol (3.1) (45 
mg, 0.20 mmol), toluene (0.65 mL), allyl chloride (80 μL, 1.0 mmol), NaHCO3 (34 mg, 0.40 
mmol) and Pd(hfacac)2 (5.0 mg,  0.010 mmol) and the vial was sealed under ambient 
atmosphere. The resulting mixture was heated to 50 °C by immersion of the entire vial into 
a preheated aluminium block until the substrate had been consumed, as judged by TLC 
analysis. The reaction mixture was cooled to room temperature and the volatile 
components were evaporated in vacuo. To the vial was added BrettPhos (10 mg, 0.020 
mmol), NaOtBu (58 mg, 0.60 mmol) and toluene (0.2 mL). The mixture was allowed to stir 
for 5 minutes at room temperature. Next, toluene (0.2 mL) and N-methylaniline (25 mg, 
0.24 mmol) were added and the vial was sealed under ambient atmosphere. The mixture 
was then heated at 50 °C for 3 h. The reaction mixture was cooled to room temperature, 
quenched with water and the organic layers were extracted with Et2O (3 x 20 mL). The 
combined organic extracts were then washed with brine, dried over MgSO4 and 
concentrated in vacuo. The crude mixture was then purified by flash chromatography on 
silica gel (petroleum ether/EtOAc; 95:5) to give the title compound 3.40 as a yellow oil (47 
mg, 80%). 
1H NMR (500 MHz, CDCl3) δ (ppm): 7.24−7.18 (2 H, m, ArH), 7.00−6.97 (1 H, m, ArH), 
6.96−6.91 (1 H, m, ArH), 6.81−6.76 (3 H, m, ArH), 6.73 (1 H, d, J = 8.3 Hz, ArH), 5.87 (1 
H, ddt, J = 17.0, 10.3, 6.4 Hz, CH=CH2), 5.06 (1 H, ddd, J = 17.1, 3.4, 1.7 Hz, CH=CHH), 
4.98 (1 H, ddd, J = 10.2, 3.0, 1.7 Hz, CH=CHH), 3.26 (3 H, s, NCH3), 3.09 (1 H, d, J = 
15.7 Hz, OCCHH), 2.94 (1 H, d, J = 15.7 Hz, OCCHH), 2.24−2.16 (2 H, m, CH2CH2), 
1.89−1.82 (2 H, m, CH2CH2), 1.48 (3 H, s, CH3); 
13C NMR (125 MHz, CDCl3) δ (ppm): 
156.2 (ArC), 149.8 (ArC), 141.6 (ArC), 138.3 (CH=CH2), 128.8 (2 x ArCH), 128.1 (ArC), 
125.7 (ArCH), 123.0 (ArCH), 117.9 (ArCH), 115.0 (2 x ArCH), 114.6 (CH=CH2), 109.8 
(ArCH), 88.8 (CCH3), 41.3 (CH2), 40.8 (NCH3), 40.3 (CH2), 28.4 (CH2), 26.4 (CH3); IR (thin 
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film) 3068, 914, 729 cm-1; HRMS (ESI) exact mass calculated for C20H23NOH [M+H]
+ m/z 
294.1852, found m/z 294.1827. 
N-benzyl-2-(but-3’-en-1’-yl)-2-methyl-2,3-dihydrobenzofuran-5-amine (3.37) 
 
A 4 mL screw-top glass vial was charged with 4-bromo-2-(2’-methylallyl)phenol (3.1) (45 
mg, 0.20 mmol), toluene (0.65 mL), allyl chloride (80 μL, 1.0 mmol), NaHCO3 (34 mg, 0.40 
mmol) and Pd(hfacac)2 (5.0 mg, 0.010 mmol) and the vial was sealed under ambient 
atmosphere. The resulting mixture was heated to 50 °C by immersion of the entire vial into 
a preheated aluminium block until the substrate had been consumed, as judged by TLC 
analysis. The reaction mixture was cooled to room temperature and the volatile 
components were evaporated in vacuo. To the vial was added BrettPhos (10 mg, 0.020 
mmol), freshly ground NaOtBu (58 mg, 0.60 mmol) and toluene (0.2 mL). The mixture was 
allowed to stir for 5 minutes at room temperature. Next, toluene (0.2 mL) and benzylamine 
(26 μL, 0.24 mmol) were added and the vial was sealed under ambient atmosphere. The 
mixture was then heated at 50 °C for 3 h. The reaction mixture was cooled to room 
temperature, quenched with water and the organic layers were extracted with Et2O (3 x 20 
mL). The combined organic extracts were then washed with brine, dried over MgSO4 and 
concentrated in vacuo. The crude mixture was then purified by flash chromatography on 
silica gel (petroleum ether/EtOAc, 95:5) to give the title compound 3.37 as a yellow oil (49 
mg, 83%). 
1H NMR (500 MHz, CDCl3) δ (ppm): 7.41−7.34 (4 H, m, ArH), 7.31−7.28 (1 H, m, ArH), 
6.59 (1 H, d, J = 8.5 Hz, ArH), 6.54−6.52 (1 H, m, ArH), 6.47−6.43 (1 H, m, ArH), 5.85 (1 
H, ddt, J = 17.0, 10.3, 6.4 Hz, CH=CH2), 5.03 (1 H, ddd, J = 17.1, 3.3, 1.6 Hz, CH=CHH), 
4.96 (1 H, ddd, J = 10.2, 3.1, 1.4 Hz, CH=CHH), 4.27 (2 H, s, CH2N), 3.69 (1 H, br. s, NH), 
3.04 (1 H, d, J = 15.5 Hz, OCCHH), 2.88 (1 H, d, J = 15.5 Hz, OCCHH), 2.21−2.14 (2 H, 
m, CH2CH2), 1.83−1.78 (2 H, m, CH2CH2), 1.42 (3 H, s, CH3); 
13C NMR (125 MHz, CDCl3) 
δ (ppm): 151.7 (ArC), 142.3 (ArC), 139.8 (CH=CH2), 138.4 (ArC), 128.6 (2 x ArCH), 127.7 
(ArC), 127.6 (2 x ArCH), 127.1 (ArCH), 114.4 (CH=CH2), 112.6 (ArCH), 110.6 (ArCH), 
109.4 (ArCH), 87.7 (CCH3), 49.7 (CH2), 41.7 (CH2), 40.3 (CH2), 28.4 (CH2), 26.4 (CH3); IR 
(thin film) 3066, 1492, 1222, 904 cm-1; HRMS (ESI) exact mass calculated for C20H23NH 
[M+H]+ m/z 294.1852, found m/z 294.1838. 
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4-(2’-(but-3’’-en-1’’-yl)-2’-methyl-2’,3’-dihydrobenzofuran-5’-yl)morpholine (3.38) 
 
A 4 mL screw-top glass vial was charged with 4-bromo-2-(2’-methylallyl)phenol (3.1) (45 
mg, 0.20 mmol), toluene (0.65 mL), allyl chloride (80 μL, 1.0 mmol), NaHCO3 (34 mg, 0.40 
mmol) and Pd(hfacac)2 (5.0 mg, 0.010 mmol) and the vial was sealed under ambient 
atmosphere. The resulting mixture was heated to 50 °C by immersion of the entire vial into 
a preheated aluminium block until the substrate had been consumed, as judged by TLC 
analysis. The reaction mixture was cooled to room temperature and the volatile 
components were evaporated in vacuo. To the vial was added BrettPhos (10 mg, 0.020 
mmol), NaOtBu (58 mg, 0.60 mmol) and toluene (0.2 mL). The mixture was allowed to stir 
for 5 minutes at room temperature. Next, toluene (0.2 mL) and morpholine (20 μL, 0.24 
mmol) were added and the vial was sealed under ambient atmosphere. The mixture was 
then heated at 50 °C for 3 h. The reaction mixture was cooled to room temperature, 
quenched with water and the organic layers were extracted with Et2O (3 x 20 mL). The 
combined organic extracts were then washed with brine, dried over MgSO4 and 
concentrated in vacuo.  The crude mixture was then purified by flash chromatography on 
silica gel (petroleum ether/EtOAc, 85:15) to give the title compound 3.38 as a yellow oil 
(37 mg, 67%). 
1H NMR (400 MHz, CDCl3) δ (ppm): 6.83−6.78 (1 H, m, ArH), 6.74−6.69 (1 H, m, ArH), 
6.66 (1 H, d, J = 8.7 Hz, ArH), 5.84 (1 H, ddt, J = 16.7, 10.0, 6.8 Hz, CH=CH2), 5.07−4.99 
(1 H, m, CH=CHH), 4.98−4.92 (1 H, m, CH=CHH), 3.89−3.82 (4 H, m, 2 x CH2), 3.08 (1 H, 
d, J = 15.7 Hz, OCCHH), 3.05−3.01 (4 H, m, 2 x CH2), 2.92 (1 H, d, J = 15.7 Hz, OCCHH), 
2.21−2.12 (2 H, m, CH2CH2), 1.86−1.76 (2 H, m, CH2CH2), 1.43 (3 H, s, CH3); 
13C NMR 
(100 MHz, CDCl3) δ (ppm): 153.8 (ArC), 145.5 (ArC), 138.3 (CH=CH2), 127.6 (ArC), 116.9 
(ArCH), 114.9 (ArCH), 114.5 (CH=CH2), 109.3 (ArCH), 88.3 (CCH3), 67.0 (2 x CH2), 51.7 
(2 x CH2), 41.6 (CH2), 40.3 (CH2), 28.4 (CH2), 26.4 (CH3); IR (thin film) 2962, 1492, 1120, 
883 cm-1; HRMS (ESI) exact mass calculated for C17H23NO2H [M+H]
+ m/z 274.1802, found 
m/z 274.1792. 
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tert-butyl 4-(2’-(but-3’’-en-1’’-yl)-2’-methyl-2’,3’-dihydrobenzofuran-5’-yl)piperazine-
1-carboxylate (3.39) 
 
A 4 mL screw-top glass vial was charged with 4-bromo-2-(2’-methylallyl)phenol (3.1) (45 
mg, 0.20 mmol), toluene (0.65 mL), allyl chloride (80 μL, 1.0 mmol), NaHCO3 (34 mg, 0.40 
mmol) and Pd(hfacac)2 (5.0 mg, 0.010 mmol) and the vial was sealed under ambient 
atmosphere. The resulting mixture was heated to 50 °C by immersion of the entire vial into 
a preheated aluminium block until the substrate had been consumed, as judged by TLC 
analysis. The reaction mixture was cooled to room temperature and the volatile 
components were evaporated in vacuo. To the vial was added BrettPhos (10 mg, 0.020 
mmol), NaOtBu (58 mg, 0.60 mmol) and toluene (0.2 mL). The mixture was allowed to stir 
for 5 minutes at room temperature. Next, toluene (0.2 mL) and tert-butyl piperazine-1-
carboxylate (40 mg, 0.24 mmol) were added and the vial was sealed under ambient 
atmosphere. The mixture was then heated at 50 °C for 3 h. The reaction mixture was 
cooled to room temperature, quenched with water and the organic layers were extracted 
with Et2O (3 x 20 mL). The combined organic extracts were then washed with brine, dried 
over MgSO4 and concentrated in vacuo. The crude mixture was then purified directly by 
flash chromatography on silica gel (petroleum ether/EtOAc, 85:15) to give the give the title 
compound 3.39 as a yellow oil (40 mg, 53%). 
1H NMR (400 MHz, CDCl3) δ (ppm): 6.83−6.79 (1 H, m, ArH), 6.75−6.69 (1 H, m, ArH), 
6.65 (1 H, d, J = 8.5 Hz, ArH), 5.83 (1 H, ddt, J = 16.8, 10.2, 6.7 Hz, CH=CH2), 5.02 (1 H, 
dd, J = 17.2, 1.5 Hz, CH=CHH), 4.95 (1 H, d, J = 10.2 Hz, CH=CHH), 3.60−3.53 (4 H, m, 
2 x CH2), 3.05 (1 H, d, J = 15.6 Hz, OCCHH), 3.00−2.94 (4 H, m, 2 x CH2), 2.93 (1 H, d, J 
= 15.4 Hz, OCCHH), 2.21−2.10 (2 H, m, CH2CH2), 1.86−1.76 (2 H, m, CH2CH2), 1.49 (9 
H, s, C(CH3)3), 1.42 (3 H, s, CCH3); 
13C NMR (100 MHz, CDCl3) δ (ppm): 154.7 (C=O), 
154.1 (ArC), 145.5 (ArC), 138.3 (CH=CH2), 127.6 (ArC), 117.8 (ArCH), 115.9 (ArCH), 
114.5 (CH=CH2), 109.2 (ArCH), 88.4 (CCH3), 79.8 (C(CH3)3), 51.6 (2 x CH2), 44.0 (2 x 
CH2), 41.6 (CH2), 40.3 (CH2), 28.4 (CH2 and C(CH3)3), 26.4 (CCH3); IR (thin film) 3074, 
2972, 1693, 910 cm-1; HRMS (ESI) exact mass calculated for C22H32N2O3Na [M+Na]
+ m/z 
395.2305, found m/z 395.2286. 
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((4-methoxyphenyl)ethynyl)trimethylsilane (3.29) 
 
Following a literature procedure,[134]  a solution of 1-bromo-4-methoxybenzene (74 mg, 
0.40 mmol) in toluene (0.4 mL) was treated with tetrakis(triphenylphosphine)palladium(0) 
(24 mg, 0.020 mmol), followed by diisopropylethylamine (0.29 mL, 1.6 mmol), trimethylsilyl 
acetylene (60 μL, 0.40 mmol) and copper(I) iodide (10 mg, 0.040 mmol). The reaction was 
heated at 50 °C in an argon atmosphere overnight, cooled to room temperature and the 
volatiles were removed in vacuo. The resultant residue was purified with flash 
chromatography on silica gel (petroleum ether/CH2Cl2; 9:1) to give the title compound 
(3.29) as a yellow oil(22 mg, 27%). 
1H NMR (400 MHz, CDCl3) δ (ppm): 7.42 (2 H, d, J = 8.8 Hz, ArH), 6.83 (2 H, d, J = 8.8 
Hz, ArH), 3.81 (3 H, s, OCH3), 0.25 (9 H, s, Si(CH3)3); 
13C NMR (100 MHz, CDCl3) δ 
(ppm): 159.74 (ArC), 133.46 (2 x ArCH), 115.27 (ArC), 113.80 (2 x ArCH), 105.18 (C≡C), 
92.41 (C≡C), 55.26 (OCH3), 0.08 (Si(CH3)3); IR (thin film) 2958, 1458, 854 cm
-1; LRMS 
(EI)  m/z 204.1. 
((2-(but-3’-en-1’-yl)-2-methyl-2,3-dihydrobenzofuran-5-yl)ethynyl)trimethylsilane 
(3.30) 
 
Following a literature procedure,[134] a solution of 5-bromo-2-(but-3’-enyl)-2-methyl-2,3-
dihydrobenzofuran 3.2 (106 mg, 0.40 mmol) in toluene (0.4 mL) was treated with 
tetrakis(triphenylphosphine)palladium(0) (24 mg, 0.020 mmol), followed by 
diisopropylethylamine (0.29 mL, 1.6 mmol), trimethylsilyl acetylene (60 μL, 0.40 mmol) 
and copper(I) iodide (10 mg, 0.040 mmol). The reaction was heated at 50 °C in an argon 
atmosphere overnight, cooled to room temperature and the volatiles were removed in 
vacuo. The resultant residue was purified with flash chromatography on silica gel 
(petroleum ether/CH2Cl2; 9:1) to give the title compound (3.30) as a yellow oil (31 mg, 
27%). 
1H NMR (400 MHz, CDCl3) δ (ppm): 7.28−7.22 (2 H, m, ArH), 6.65 (1 H, d, J = 8.9 Hz, 
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ArH), 5.82 (1 H, ddt, J = 17.0, 10.3, 6.4 Hz, CH=CH2), 5.03 (1 H, dd, J = 17.1, 1.4 Hz, 
CH=CHH), 4.99−4.93 (1 H, m, CH=CHH), 3.04 (1 H, d, J = 15.7 Hz, OCCHH), 2.92 (1 H, 
d, J = 15.7 Hz, OCCHH), 2.19−2.10 (2 H, m, CH2CH2), 1.85−1.78 (2 H, m, CH2CH2), 1.44 
(3 H, s, CCH3), 0.24 (9 H, s, Si(CH3)3); 
13C NMR (100 MHz, CDCl3) δ (ppm): 159.4 (ArC), 
138.1 (CH=CH2), 132.6 (ArCH), 128.8 (ArCH), 127.1 (ArC), 114.7 (CH=CH2), 114.4 (ArC), 
109.3 (ArCH), 105.8 (C≡C), 91.5 (C≡C), 89.3 (CCH3), 40.7 (CH2), 40.3 (CH2), 28.3 (CH2), 
26.4 (CH3), 0.1 (Si(CH3)3); IR (thin film) 2958, 1247, 1508, 864 cm
-1; HRMS (ESI) exact 
mass calculated for C18H24OSiNa [M+Na]
+ m/z 307.1489, found m/z 307.1453. 
3-(3’-oxobutyl)-2-tosyl-3,4-dihydroisoquinolinone (3.47) 
 
A 4 mL screw-top glass vial was charged with 2-allyl-N-tosyl-benzamide (2.91) (50 mg, 
0.16 mmol), toluene (0.64 mL), H2O (0.64 mL), allyl chloride (0.070 mL, 0.79 mmol) and 
Pd(hfacac)2 (4.0 mg, 0.01 mmol). The mixture was heated at 50 °C overnight. The 
reaction mixture was cooled to room temperature and the volatile components were 
evaporated in vacuo. Following a modification of a literature procedure,[141] to the mixture 
was added p-benzoquinone (43 mg, 0.4 mmol), DMF (0.53 mL) and water (50 μL). The 
vial was then sealed and heated at 90 °C for four days. The mixture was allowed to cool to 
room temperature before being poured into water and the organic layers were extracted 
with EtOAc (3 x 20 mL), dried over MgSO4, and concentrated in vacuo. The crude mixture 
was then purified by flash chromatography on silica gel (toluene/Et2O; 9:1) to give the title 
compound (3.47) as a yellow oil (32 mg, 54%). 
1H NMR (400 MHz, CDCl3) δ (ppm): 7.99−7.92 (3 H, m, ArH), 7.48 (1 H, td, J = 7.4, 1.3 
Hz, ArH), 7.34−7.28 (3 H, m, ArH), 7.20 (1 H, d, J = 7.5 Hz, ArH), 5.00−4.93 (1 H, m, 
CH2CH), 3.38 (1 H, dd, J = 16.2, 5.5 Hz, CHHCH), 2.94 (1 H, dd, J = 16.2, 1.9 Hz, 
CHHCH), 2.81 (1 H, dt, J = 18.3, 7.7 Hz, CHHCH2), 2.60 (1 H, dt, J = 18.3, 6.5 Hz, 
CHHCH2), 2.41 (3 H, s, CH3), 2.18 (3 H, s, CH3), 1.89−1.82 (2 H, m, CH2CH2); 
13C NMR 
(100 MHz, CDCl3) δ (ppm):  207.6 (C=O), 162.6 (C=O), 144.8 (ArC), 136.9 (ArC), 136.3 
(ArC), 133.7 (ArCH), 129.4 (2 x ArCH), 128.9 (ArCH), 128.8 (2 x ArCH), 128.2 (ArCH), 
127.9 (ArC), 127.5 (ArCH), 55.0 (CH), 39.8 (CH2), 34.1 (CH2), 30.0 (CH2), 27.7 (CH2), 
21.6 (CH3); IR (thin film) 2958, 1710, 1685, 736 cm
-1; HRMS (ESI) exact mass calculated 
for C20H21NO4SNa [M+Na]
+ m/z 394.1083, found m/z 394.1072. 
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Oxidised pyrrole tosylamide (3.56) 
 
A 4 mL glass screw-top vial was charged with 1-allyl-N-tosyl-pyrrole-2-carboxamide (3.54) 
(48 mg, 0.16 mmol), toluene (0.64 mL), H2O (0.64 mL), allyl chloride (0.07 mL, 0.79 mmol) 
and Pd(hfacac)2 (4.0 mg, 0.01 mmol). The mixture was heated at 80 °C for 19 h. The 
reaction mixture was cooled to room temperature and the volatile components were 
evaporated in vacuo. Following a modification of a literature procedure,[141] to the mixture 
was added p-benzoquinone (43 mg, 0.40 mmol), DMF (0.53 mL) and water (50 μL). The 
vial was then sealed and heated at 90 °C for four days. The mixture was allowed to cool to 
room temperature before being poured into water and the organic layers were extracted 
with EtOAc (3 x 20 mL), dried over MgSO4, and concentrated in vacuo. The crude mixture 
was then purified by flash chromatography on silica gel (toluene/EtOAc; 8:2) to give the 
title compound (3.56) as a yellow oil (28 mg, 48%). 
1H NMR (400 MHz, CDCl3) δ (ppm): 7.95 (2 H, d, J = 8.4 Hz, ArH), 7.31 (2 H, d, J = 8.4 
Hz, ArH), 6.97 (1 H, dd, J = 4.0, 1.5 Hz, ArH), 6.78−6.75 (1 H, m, ArH), 6.23 (1 H, dd, J = 
3.9, 2.4 Hz, ArH), 5.01−4.93 (1 H,  m, CH2CH), 4.29 (1 H, dd, J = 13.2, 4.1 Hz, CHHCH), 
4.13 (1 H, dd, J = 13.2, 1.5 Hz, CHHCH), 2.86 (1 H, ddd, J = 18.7, 8.3, 6.5 Hz, CHHCH2), 
2.59 (1 H, dt, J = 18.7, 6.5 Hz, CHHCH2), 2.42 (3 H, s, CH3), 2.19 (3 H, s, CH3), 2.05−1.93 
(1 H, m, CHHCH2), 1.91−1.73 (1 H, m, CHHCH2); 
13C NMR (100 MHz, CDCl3) δ (ppm): 
207.5 (C=O), 155.8 (C=O), 144.9 (ArC), 136.1 (ArC), 129.4 (2 x ArCH), 128.9 (2 x ArCH), 
125.3 (ArCH), 122.3 (ArC), 116.9 (ArCH), 111.1 (ArCH), 55.1 (CH), 49.0 (CH2), 39.2 
(CH2), 30.0 (CH3), 26.9 (CH2), 21.6 (CH3); IR (thin film) 3250, 1723, 1674, 731 cm
-1; 
HRMS (ESI) exact mass calculated for C18H20N2O4SNa [M+Na]
+ m/z 383.1036, found m/z 
383.1032. 
4-(1’-oxo-2’-tosyl-1’,2’,3’,4’-tetrahydroisoquinolin-3’-yl)butanal (3.64) 
 
A 4 mL screw-top glass vial was charged with 2-allyl-N-tosyl-benzamide (2.91) (63 mg, 
0.20 mmol), toluene (0.65 mL), H2O (0.65 mL), allyl chloride (0.080 mL, 1.0 mmol) and 
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Pd(hfacac)2 (13 mg, 0.024 mmol). The mixture was heated at 50 °C for 16 h. The reaction 
mixture was cooled to room temperature and the volatile components were evaporated in 
vacuo. Following a modification of a literature procedure,[143] to the vial was added 
benzonitrile (50 μL, 0.48 mmol),  CuCl2•2H2O (4.0 mg, 0.024 mmol) and AgNO2 (4.0 mg, 
0.024 mmol). The vial was sparged for 45 seconds with oxygen (1 atm balloon) then 
subsequently tBuOH (3 mL), MeNO2 (0.2 mL) were added via syringe. The solution was 
saturated with oxygen by an additional 45 seconds of sparging. The reaction was then 
allowed to stir at room temperature overnight. Next, the reaction was quenched by 
addition to water and extracted three times with Et2O (3 x 20 mL). The combined organic 
layers were subsequently dried over MgSO4. Immediately prior to NMR analysis 
trimethoxybenzene (34 mg, 0.2 mmol) was added as an internal standard. The resulting 
solution was subsequently subjected to 1H NMR analysis to determine yield (33%) of 
aldehyde (3.64) and (19%) ketone (3.47). The title compound (3.64) was obtained using 
flash chromatography on silica gel (toluene/EtOAc; 9:1). 
1H NMR (400 MHz, CDCl3) δ (ppm): 9.74 (1 H, t, J = 1.3 Hz, CHO), 8.02−7.94 (3 H, m, 
ArH), 7.49 (1 H, td, J = 7.5, 1.3 Hz, ArH), 7.35−7.30 (3 H, m, ArH), 7.21 (1 H, d, J = 7.5 
Hz, ArH), 5.00−4.89 (1 H, m, CH2CH), 3.37 (1 H, dd, J = 16.2, 5.4 Hz, CHHCH), 2.98 (1 H, 
dd, J = 16.2, 1.8 Hz, CHHCH), 2.50−2.39 (5 H, m, CH2 and CH3),1.81−1.68 (3 H, m CHH 
and CH2), 1.64−1.54 (1 H, m, CHH); 
13C NMR (125 MHz, CDCl3) δ (ppm): 201.5 (C=O), 
162.6 (C=O), 144.8 (ArC), 136.6 (ArC), 136.5 (ArC), 133.7 (ArCH), 129.3 (2 x ArCH), 
128.9 (3 x ArCH), 128.2 (ArCH), 128.0 (ArC), 127.5 (ArCH), 55.3 (CH), 43.2 (CH2), 33.1 
(CH2), 32.5 (CH2), 21.6 (CH2), 18.8 (CH3); IR (thin film) 1722, 1683, 906, 725 cm
-1; HRMS 
(ESI) exact mass calculated for C20H21NO4SNa [M+Na]
+ m/z 394.1083, found m/z 
394.1087. 
Oxidised pyrrole tosylamide(3.65) 
 
A 4 mL screw-top glass vial was charged with 1-allyl-N-tosyl-pyrrole-2-carboxamide (3.54) 
(61 mg, 0.20 mmol), toluene (0.65 mL), H2O (0.65 mL), allyl chloride (0.080 mL, 1.0 mmol) 
and Pd(hfacac)2 (13 mg, 0.024 mmol). The mixture was heated at 80 °C for 16 h. The 
reaction mixture was cooled to room temperature and the volatile components were 
evaporated in vacuo. Following a modification of a literature procedure,[143] to the vial was 
added benzonitrile (50 μL, 0.48 mmol), CuCl2•2H2O (4.0 mg, 0.024 mmol) and AgNO2 (4.0 
mg, 0.024 mmol). The vial was sparged for 45 seconds with oxygen (1 atm balloon) then 
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subsequently tBuOH (3 mL), MeNO2 (0.2 mL) were added via syringe. The solution was 
saturated with oxygen by an additional 45 seconds of sparging. The reaction was then 
allowed to stir at room temperature overnight. Next, the reaction was quenched by 
addition to water and extracted three times with Et2O (3 x 20 mL). The combined organic 
layers were subsequently dried over MgSO4. Immediately prior to NMR analysis 
trimethoxybenzene (34 mg, 0.2 mmol) was added as an internal standard. The resulting 
solution was subsequently subjected to 1H NMR analysis to determine yield (24%) of 
aldehyde (3.65). The title compound (3.65) was obtained using flash chromatography on 
silica gel (toluene / EtOAc; 8:2). 
1H NMR (400 MHz, CDCl3) δ (ppm): 9.75 (1 H, t, J = 1.1 Hz, CHO), 7.99 (2 H, d, J = 8.4 
Hz, ArH), 7.32 (2 H, d, J = 8.4 Hz, ArH), 6.97 (1 H, dd, J = 4.0, 1.5 Hz, ArH), 6.79−6.77 (1 
H, m, ArH), 6.24 (1 H, dd, J = 4.0, 2.4 Hz, ArH), 4.98−4.89 (1 H, m, CH2CH), 4.32 (1 H, 
dd, J = 13.1, 3.8 Hz, CHHCH), 4.17 (1 H, dd, J = 13.1, 1.4 Hz, CHHCH), 2.56−2.47 (2 H, 
m, CH2CH2), 2.43 (3 H, s, CH3), 1.80−1.60 (4 H, m, CH2); 
13C NMR (100 MHz, CDCl3) δ 
(ppm): 201.3 (C=O), 155.8 (C=O), 144.9 (ArC), 136.4 (ArC), 129.4 (2 x ArCH), 129.0 (2 x 
ArCH), 125.2 (ArCH), 122.4 (ArC), 116.9 (ArCH), 111.1 (ArCH), 55.6 (CH), 47.2 (CH2), 
43.1 (CH3), 32.1 (CH2), 21.7 (CH3), 18.4 (CH2); IR (thin film) 1673, 910, 731 cm
-1; HRMS 
(ESI) exact mass calculated for C18H20N2O4SNa [M+Na]
+ m/z 383.1036, found m/z 
383.1028. 
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